KEGG Orthology (KO) - Homo sapiens (human)

[ Brite menu | Organism menu | Download htext ]
    

1st Level  2nd Level  3rd Level  4th Level 

     KO
 Metabolism
 
 Genetic Information Processing
 
 Environmental Information Processing
 
   Membrane transport
 
   Signal transduction
     02020 Two-component system
     02022 Two-component system
     04014 Ras signaling pathway [PATH:hsa04014]
     04015 Rap1 signaling pathway [PATH:hsa04015]
     04010 MAPK signaling pathway [PATH:hsa04010]
       773 CACNA1A; calcium channel, voltage-dependent, P/Q type, alpha 1A subunit
       774 CACNA1B; calcium channel, voltage-dependent, N type, alpha 1B subunit
       775 CACNA1C; calcium channel, voltage-dependent, L type, alpha 1C subunit
       776 CACNA1D; calcium channel, voltage-dependent, L type, alpha 1D subunit
       777 CACNA1E; calcium channel, voltage-dependent, R type, alpha 1E subunit
       778 CACNA1F; calcium channel, voltage-dependent, L type, alpha 1F subunit
       8913 CACNA1G; calcium channel, voltage-dependent, T type, alpha 1G subunit
       8912 CACNA1H; calcium channel, voltage-dependent, T type, alpha 1H subunit
       8911 CACNA1I; calcium channel, voltage-dependent, T type, alpha 1I subunit
       779 CACNA1S; calcium channel, voltage-dependent, L type, alpha 1S subunit
       781 CACNA2D1; calcium channel, voltage-dependent, alpha 2/delta subunit 1
       9254 CACNA2D2; calcium channel, voltage-dependent, alpha 2/delta subunit 2
       55799 CACNA2D3; calcium channel, voltage-dependent, alpha 2/delta subunit 3
       93589 CACNA2D4; calcium channel, voltage-dependent, alpha 2/delta subunit 4
       782 CACNB1; calcium channel, voltage-dependent, beta 1 subunit
       783 CACNB2; calcium channel, voltage-dependent, beta 2 subunit
       784 CACNB3; calcium channel, voltage-dependent, beta 3 subunit
       785 CACNB4; calcium channel, voltage-dependent, beta 4 subunit
       786 CACNG1; calcium channel, voltage-dependent, gamma subunit 1
       10369 CACNG2; calcium channel, voltage-dependent, gamma subunit 2
       10368 CACNG3; calcium channel, voltage-dependent, gamma subunit 3
       27092 CACNG4; calcium channel, voltage-dependent, gamma subunit 4
       27091 CACNG5; calcium channel, voltage-dependent, gamma subunit 5
       59285 CACNG6; calcium channel, voltage-dependent, gamma subunit 6
       59284 CACNG7; calcium channel, voltage-dependent, gamma subunit 7
       59283 CACNG8; calcium channel, voltage-dependent, gamma subunit 8
       5566 PRKACA; protein kinase, cAMP-dependent, catalytic, alpha 
       5567 PRKACB; protein kinase, cAMP-dependent, catalytic, beta 
       5568 PRKACG; protein kinase, cAMP-dependent, catalytic, gamma 
       5613 PRKX; protein kinase, X-linked 
       5578 PRKCA; protein kinase C, alpha 
       5579 PRKCB; protein kinase C, beta 
       5582 PRKCG; protein kinase C, gamma 
       2768 GNA12; guanine nucleotide binding protein (G protein) alpha 12
       55970 GNG12; guanine nucleotide binding protein (G protein), gamma 12
       648044 guanine nucleotide binding protein (G protein)
       5530 PPP3CA; protein phosphatase 3, catalytic subunit, alpha isozyme 
       5532 PPP3CB; protein phosphatase 3, catalytic subunit, beta isozyme 
       5533 PPP3CC; protein phosphatase 3, catalytic subunit, gamma isozyme 
       5534 PPP3R1; protein phosphatase 3, regulatory subunit B, alpha 
       5535 PPP3R2; protein phosphatase 3, regulatory subunit B, beta 
       5923 RASGRF1; Ras protein-specific guanine nucleotide-releasing factor 1
       5924 RASGRF2; Ras protein-specific guanine nucleotide-releasing factor 2
       10125 RASGRP1; RAS guanyl releasing protein 1 (calcium and DAG-regulated)
       10235 RASGRP2; RAS guanyl releasing protein 2 (calcium and DAG-regulated)
       25780 RASGRP3; RAS guanyl releasing protein 3 (calcium and DAG-regulated)
       115727 RASGRP4; RAS guanyl releasing protein 4
       9693 RAPGEF2; Rap guanine nucleotide exchange factor (GEF) 2
       4763 NF1; neurofibromin 1
       5921 RASA1; RAS p21 protein activator (GTPase activating protein) 1
       5922 RASA2; RAS p21 protein activator 2
       5906 RAP1A; RAP1A, member of RAS oncogene family
       5908 RAP1B; RAP1B, member of RAS oncogene family
       4803 NGF; nerve growth factor (beta polypeptide)
       627 BDNF; brain-derived neurotrophic factor
       4908 NTF3; neurotrophin 3
       4909 NTF4; neurotrophin 4
       1950 EGF; epidermal growth factor
       2246 FGF1; fibroblast growth factor 1 (acidic)
       2247 FGF2; fibroblast growth factor 2 (basic)
       2248 FGF3; fibroblast growth factor 3
       2249 FGF4; fibroblast growth factor 4
       8822 FGF17; fibroblast growth factor 17
       2251 FGF6; fibroblast growth factor 6
       2252 FGF7; fibroblast growth factor 7
       2253 FGF8; fibroblast growth factor 8 (androgen-induced)
       2254 FGF9; fibroblast growth factor 9
       2255 FGF10; fibroblast growth factor 10
       2256 FGF11; fibroblast growth factor 11
       2257 FGF12; fibroblast growth factor 12
       2258 FGF13; fibroblast growth factor 13
       2259 FGF14; fibroblast growth factor 14
       8823 FGF16; fibroblast growth factor 16
       2250 FGF5; fibroblast growth factor 5
       8817 FGF18; fibroblast growth factor 18
       9965 FGF19; fibroblast growth factor 19
       26281 FGF20; fibroblast growth factor 20
       26291 FGF21; fibroblast growth factor 21
       27006 FGF22; fibroblast growth factor 22
       8074 FGF23; fibroblast growth factor 23
       5154 PDGFA; platelet-derived growth factor alpha polypeptide
       5155 PDGFB; platelet-derived growth factor beta polypeptide
       4914 NTRK1; neurotrophic tyrosine kinase, receptor, type 1 
       4915 NTRK2; neurotrophic tyrosine kinase, receptor, type 2 
       1956 EGFR; epidermal growth factor receptor 
       2260 FGFR1; fibroblast growth factor receptor 1 
       2263 FGFR2; fibroblast growth factor receptor 2 
       2261 FGFR3; fibroblast growth factor receptor 3 
       2264 FGFR4; fibroblast growth factor receptor 4 
       5156 PDGFRA; platelet-derived growth factor receptor, alpha polypeptide 
       5159 PDGFRB; platelet-derived growth factor receptor, beta polypeptide 
       2885 GRB2; growth factor receptor-bound protein 2
       6654 SOS1; son of sevenless homolog 1 (Drosophila)
       6655 SOS2; son of sevenless homolog 2 (Drosophila)
       3265 HRAS; Harvey rat sarcoma viral oncogene homolog
       3845 KRAS; Kirsten rat sarcoma viral oncogene homolog
       4893 NRAS; neuroblastoma RAS viral (v-ras) oncogene homolog
       6237 RRAS; related RAS viral (r-ras) oncogene homolog
       22800 RRAS2; related RAS viral (r-ras) oncogene homolog 2
       22808 MRAS; muscle RAS oncogene homolog
       673 BRAF; v-raf murine sarcoma viral oncogene homolog B 
       5894 RAF1; v-raf-1 murine leukemia viral oncogene homolog 1 
       4342 MOS; v-mos Moloney murine sarcoma viral oncogene homolog 
       5604 MAP2K1; mitogen-activated protein kinase kinase 1 
       5605 MAP2K2; mitogen-activated protein kinase kinase 2 
       8649 LAMTOR3; late endosomal/lysosomal adaptor, MAPK and MTOR activator 3
       5594 MAPK1; mitogen-activated protein kinase 1 
       5595 MAPK3; mitogen-activated protein kinase 3 
       8569 MKNK1; MAP kinase interacting serine/threonine kinase 1 
       2872 MKNK2; MAP kinase interacting serine/threonine kinase 2 
       6197 RPS6KA3; ribosomal protein S6 kinase, 90kDa, polypeptide 3 
       6195 RPS6KA1; ribosomal protein S6 kinase, 90kDa, polypeptide 1 
       6196 RPS6KA2; ribosomal protein S6 kinase, 90kDa, polypeptide 2 
       27330 RPS6KA6; ribosomal protein S6 kinase, 90kDa, polypeptide 6 
       468 ATF4; activating transcription factor 4
       2002 ELK1; ELK1, member of ETS oncogene family
       2005 ELK4; ELK4, ETS-domain protein (SRF accessory protein 1)
       4609 MYC; v-myc avian myelocytomatosis viral oncogene homolog
       6722 SRF; serum response factor (c-fos serum response element-binding transcription factor)
       2353 FOS; FBJ murine osteosarcoma viral oncogene homolog
       4137 MAPT; microtubule-associated protein tau
       3925 STMN1; stathmin 1
       123745 PLA2G4E; phospholipase A2, group IVE 
       5321 PLA2G4A; phospholipase A2, group IVA (cytosolic, calcium-dependent) 
       8681 JMJD7-PLA2G4B; JMJD7-PLA2G4B readthrough
       100137049 PLA2G4B; phospholipase A2, group IVB (cytosolic) 
       8605 PLA2G4C; phospholipase A2, group IVC (cytosolic, calcium-independent) 
       283748 PLA2G4D; phospholipase A2, group IVD (cytosolic) 
       255189 PLA2G4F; phospholipase A2, group IVF 
       7124 TNF; tumor necrosis factor
       3552 IL1A; interleukin 1, alpha
       3553 IL1B; interleukin 1, beta
       7040 TGFB1; transforming growth factor, beta 1
       7042 TGFB2; transforming growth factor, beta 2
       7043 TGFB3; transforming growth factor, beta 3
       7132 TNFRSF1A; tumor necrosis factor receptor superfamily, member 1A
       3554 IL1R1; interleukin 1 receptor, type I
       7850 IL1R2; interleukin 1 receptor, type II
       7046 TGFBR1; transforming growth factor, beta receptor 1 
       7048 TGFBR2; transforming growth factor, beta receptor II (70/80kDa) 
       356 FASLG; Fas ligand (TNF superfamily, member 6)
       355 FAS; Fas cell surface death receptor
       929 CD14; CD14 molecule
       5879 RAC1; ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)
       5880 RAC2; ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2)
       5881 RAC3; ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3)
       998 CDC42; cell division cycle 42
       836 CASP3; caspase 3, apoptosis-related cysteine peptidase 
       7186 TRAF2; TNF receptor-associated factor 2
       1616 DAXX; death-domain associated protein
       7189 TRAF6; TNF receptor-associated factor 6, E3 ubiquitin protein ligase
       1647 GADD45A; growth arrest and DNA-damage-inducible, alpha
       4616 GADD45B; growth arrest and DNA-damage-inducible, beta
       10912 GADD45G; growth arrest and DNA-damage-inducible, gamma
       10454 TAB1; TGF-beta activated kinase 1/MAP3K7 binding protein 1
       23118 TAB2; TGF-beta activated kinase 1/MAP3K7 binding protein 2
       51295 ECSIT; ECSIT signalling integrator
       8491 MAP4K3; mitogen-activated protein kinase kinase kinase kinase 3 
       9448 MAP4K4; mitogen-activated protein kinase kinase kinase kinase 4 
       11184 MAP4K1; mitogen-activated protein kinase kinase kinase kinase 1 
       5058 PAK1; p21 protein (Cdc42/Rac)-activated kinase 1 
       5062 PAK2; p21 protein (Cdc42/Rac)-activated kinase 2 
       6789 STK4; serine/threonine kinase 4 
       6788 STK3; serine/threonine kinase 3 
       5871 MAP4K2; mitogen-activated protein kinase kinase kinase kinase 2 
       1326 MAP3K8; mitogen-activated protein kinase kinase kinase 8 
       4214 MAP3K1; mitogen-activated protein kinase kinase kinase 1, E3 ubiquitin protein ligase 
       4296 MAP3K11; mitogen-activated protein kinase kinase kinase 11 
       10746 MAP3K2; mitogen-activated protein kinase kinase kinase 2 
       4215 MAP3K3; mitogen-activated protein kinase kinase kinase 3 
       9175 MAP3K13; mitogen-activated protein kinase kinase kinase 13 
       7786 MAP3K12; mitogen-activated protein kinase kinase kinase 12 
       51776 ZAK; sterile alpha motif and leucine zipper containing kinase AZK 
       9064 MAP3K6; mitogen-activated protein kinase kinase kinase 6 
       4217 MAP3K5; mitogen-activated protein kinase kinase kinase 5 
       6885 MAP3K7; mitogen-activated protein kinase kinase kinase 7 
       4216 MAP3K4; mitogen-activated protein kinase kinase kinase 4 
       9344 TAOK2; TAO kinase 2 
       51347 TAOK3; TAO kinase 3 
       57551 TAOK1; TAO kinase 1 
       6416 MAP2K4; mitogen-activated protein kinase kinase 4 
       5609 MAP2K7; mitogen-activated protein kinase kinase 7 
       5606 MAP2K3; mitogen-activated protein kinase kinase 3 
       5608 MAP2K6; mitogen-activated protein kinase kinase 6 
       9479 MAPK8IP1; mitogen-activated protein kinase 8 interacting protein 1
       23542 MAPK8IP2; mitogen-activated protein kinase 8 interacting protein 2
       23162 MAPK8IP3; mitogen-activated protein kinase 8 interacting protein 3
       2316 FLNA; filamin A, alpha
       2318 FLNC; filamin C, gamma
       2317 FLNB; filamin B, beta
       1398 CRK; v-crk avian sarcoma virus CT10 oncogene homolog
       1399 CRKL; v-crk avian sarcoma virus CT10 oncogene homolog-like
       408 ARRB1; arrestin, beta 1
       409 ARRB2; arrestin, beta 2
       5599 MAPK8; mitogen-activated protein kinase 8 
       5602 MAPK10; mitogen-activated protein kinase 10 
       5601 MAPK9; mitogen-activated protein kinase 9 
       5600 MAPK11; mitogen-activated protein kinase 11 
       6300 MAPK12; mitogen-activated protein kinase 12 
       5603 MAPK13; mitogen-activated protein kinase 13 
       1432 MAPK14; mitogen-activated protein kinase 14 
       8550 MAPKAPK5; mitogen-activated protein kinase-activated protein kinase 5 
       9261 MAPKAPK2; mitogen-activated protein kinase-activated protein kinase 2 
       7867 MAPKAPK3; mitogen-activated protein kinase-activated protein kinase 3 
       9252 RPS6KA5; ribosomal protein S6 kinase, 90kDa, polypeptide 5 
       8986 RPS6KA4; ribosomal protein S6 kinase, 90kDa, polypeptide 4 
       994 CDC25B; cell division cycle 25B 
       4772 NFATC1; nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1
       4775 NFATC3; nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 3
       3725 JUN; jun proto-oncogene
       3727 JUND; jun D proto-oncogene
       1386 ATF2; activating transcription factor 2 
       7157 TP53; tumor protein p53
       1649 DDIT3; DNA-damage-inducible transcript 3
       4149 MAX; MYC associated factor X
       4208 MEF2C; myocyte enhancer factor 2C
       3315 HSPB1; heat shock 27kDa protein 1
       207 AKT1; v-akt murine thymoma viral oncogene homolog 1 
       208 AKT2; v-akt murine thymoma viral oncogene homolog 2 
       10000 AKT3; v-akt murine thymoma viral oncogene homolog 3 
       5494 PPM1A; protein phosphatase, Mg2+/Mn2+ dependent, 1A 
       5801 PTPRR; protein tyrosine phosphatase, receptor type, R 
       84867 PTPN5; protein tyrosine phosphatase, non-receptor type 5 (striatum-enriched) 
       5778 PTPN7; protein tyrosine phosphatase, non-receptor type 7 
       1843 DUSP1; dual specificity phosphatase 1 
       1846 DUSP4; dual specificity phosphatase 4 
       1844 DUSP2; dual specificity phosphatase 2 
       1849 DUSP7; dual specificity phosphatase 7 
       1850 DUSP8; dual specificity phosphatase 8 
       1847 DUSP5; dual specificity phosphatase 5 
       1848 DUSP6; dual specificity phosphatase 6 
       1852 DUSP9; dual specificity phosphatase 9 
       11221 DUSP10; dual specificity phosphatase 10 
       80824 DUSP16; dual specificity phosphatase 16 
       1845 DUSP3; dual specificity phosphatase 3 
       5536 PPP5C; protein phosphatase 5, catalytic subunit 
       100506012 PPP5D1; PPP5 tetratricopeptide repeat domain containing 1
       5495 PPM1B; protein phosphatase, Mg2+/Mn2+ dependent, 1B 
       3312 HSPA8; heat shock 70kDa protein 8
       3303 HSPA1A; heat shock 70kDa protein 1A
       3306 HSPA2; heat shock 70kDa protein 2
       3305 HSPA1L; heat shock 70kDa protein 1-like
       3304 HSPA1B; heat shock 70kDa protein 1B
       3310 HSPA6; heat shock 70kDa protein 6 (HSP70B')
       2122 MECOM; MDS1 and EVI1 complex locus
       5607 MAP2K5; mitogen-activated protein kinase kinase 5 
       5598 MAPK7; mitogen-activated protein kinase 7 
       3164 NR4A1; nuclear receptor subfamily 4, group A, member 1
       9020 MAP3K14; mitogen-activated protein kinase kinase kinase 14 
       1147 CHUK; conserved helix-loop-helix ubiquitous kinase 
       3551 IKBKB; inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta 
       8517 IKBKG; inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma
       51701 NLK; nemo-like kinase 
       4790 NFKB1; nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
       4791 NFKB2; nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100)
       5970 RELA; v-rel avian reticuloendotheliosis viral oncogene homolog A
       5971 RELB; v-rel avian reticuloendotheliosis viral oncogene homolog B
K04344 CACNA1A; voltage-dependent calcium channel P/Q type alpha-1A
K04849 CACNA1B; voltage-dependent calcium channel N type alpha-1B
K04850 CACNA1C; voltage-dependent calcium channel L type alpha-1C
K04851 CACNA1D; voltage-dependent calcium channel L type alpha-1D
K04852 CACNA1E; voltage-dependent calcium channel R type alpha-1E
K04853 CACNA1F; voltage-dependent calcium channel L type alpha-1F
K04854 CACNA1G; voltage-dependent calcium channel T type alpha-1G
K04855 CACNA1H; voltage-dependent calcium channel T type alpha-1H
K04856 CACNA1I; voltage-dependent calcium channel T type alpha-1I
K04857 CACNA1S; voltage-dependent calcium channel L type alpha-1S
K04858 CACNA2D1; voltage-dependent calcium channel alpha-2/delta-1
K04859 CACNA2D2; voltage-dependent calcium channel alpha-2/delta-2
K04860 CACNA2D3; voltage-dependent calcium channel alpha-2/delta-3
K04861 CACNA2D4; voltage-dependent calcium channel alpha-2/delta-4
K04862 CACNB1; voltage-dependent calcium channel beta-1
K04863 CACNB2; voltage-dependent calcium channel beta-2
K04864 CACNB3; voltage-dependent calcium channel beta-3
K04865 CACNB4; voltage-dependent calcium channel beta-4
K04866 CACNG1; voltage-dependent calcium channel gamma-1
K04867 CACNG2; voltage-dependent calcium channel gamma-2
K04868 CACNG3; voltage-dependent calcium channel gamma-3
K04869 CACNG4; voltage-dependent calcium channel gamma-4
K04870 CACNG5; voltage-dependent calcium channel gamma-5
K04871 CACNG6; voltage-dependent calcium channel gamma-6
K04872 CACNG7; voltage-dependent calcium channel gamma-7
K04873 CACNG8; voltage-dependent calcium channel gamma-8
K04345 PKA; protein kinase A [EC:2.7.11.11]
K04345 PKA; protein kinase A [EC:2.7.11.11]
K04345 PKA; protein kinase A [EC:2.7.11.11]
K04345 PKA; protein kinase A [EC:2.7.11.11]
K02677 CPKC; classical protein kinase C [EC:2.7.11.13]
K02677 CPKC; classical protein kinase C [EC:2.7.11.13]
K02677 CPKC; classical protein kinase C [EC:2.7.11.13]
K04346 GNA12; guanine nucleotide-binding protein subunit alpha-12
K04347 GNG12; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-12
K04347 GNG12; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-12
K04348 PPP3C; serine/threonine-protein phosphatase 2B catalytic subunit [EC:3.1.3.16]
K04348 PPP3C; serine/threonine-protein phosphatase 2B catalytic subunit [EC:3.1.3.16]
K04348 PPP3C; serine/threonine-protein phosphatase 2B catalytic subunit [EC:3.1.3.16]
K06268 PPP3R; serine/threonine-protein phosphatase 2B regulatory subunit
K06268 PPP3R; serine/threonine-protein phosphatase 2B regulatory subunit
K04349 RASGRF1; Ras-specific guanine nucleotide-releasing factor 1
K12326 RASGRF2; Ras-specific guanine nucleotide-releasing factor 2
K04350 RASGRP1; RAS guanyl-releasing protein 1
K12361 RASGRP2; RAS guanyl-releasing protein 2
K12362 RASGRP3; RAS guanyl-releasing protein 3
K12363 RASGRP4; RAS guanyl-releasing protein 4
K08018 RAPGEF2; Rap guanine nucleotide exchange factor 2
K08052 NF1; neurofibromin 1
K04352 RASA1; Ras GTPase-activating protein 1
K08053 RASA2; Ras GTPase-activating protein 2
K04353 RAP1A; Ras-related protein Rap-1A
K07836 RAP1B; Ras-related protein Rap-1B
K02582 NGFB; nerve growth factor, beta
K04355 BDNF; brain-derived neurotrophic factor
K04356 NTF3; neurotrophin 3
K12457 NTF4; neurotrophin 4
K04357 EGF; epidermal growth factor
K04358 FGF; fibroblast growth factor
K04358 FGF; fibroblast growth factor
K04358 FGF; fibroblast growth factor
K04358 FGF; fibroblast growth factor
K04358 FGF; fibroblast growth factor
K04358 FGF; fibroblast growth factor
K04358 FGF; fibroblast growth factor
K04358 FGF; fibroblast growth factor
K04358 FGF; fibroblast growth factor
K04358 FGF; fibroblast growth factor
K04358 FGF; fibroblast growth factor
K04358 FGF; fibroblast growth factor
K04358 FGF; fibroblast growth factor
K04358 FGF; fibroblast growth factor
K04358 FGF; fibroblast growth factor
K04358 FGF; fibroblast growth factor
K04358 FGF; fibroblast growth factor
K04358 FGF; fibroblast growth factor
K04358 FGF; fibroblast growth factor
K04358 FGF; fibroblast growth factor
K04358 FGF; fibroblast growth factor
K04358 FGF; fibroblast growth factor
K04359 PDGFA; platelet-derived growth factor subunit A
K17386 PDGFB; platelet-derived growth factor subunit B
K03176 NTRK1; neurotrophic tyrosine kinase receptor type 1 [EC:2.7.10.1]
K04360 NTRK2; neurotrophic tyrosine kinase receptor type 2 [EC:2.7.10.1]
K04361 EGFR; epidermal growth factor receptor [EC:2.7.10.1]
K04362 FGFR1; fibroblast growth factor receptor 1 [EC:2.7.10.1]
K05093 FGFR2; fibroblast growth factor receptor 2 [EC:2.7.10.1]
K05094 FGFR3; fibroblast growth factor receptor 3 [EC:2.7.10.1]
K05095 FGFR4; fibroblast growth factor receptor 4 [EC:2.7.10.1]
K04363 PDGFRA; platelet-derived growth factor receptor alpha [EC:2.7.10.1]
K05089 PDGFRB; platelet-derived growth factor receptor beta [EC:2.7.10.1]
K04364 GRB2; growth factor receptor-binding protein 2
K03099 SOS; son of sevenless
K03099 SOS; son of sevenless
K02833 HRAS; GTPase HRas
K07827 KRAS; GTPase KRas
K07828 NRAS; GTPase NRas
K07829 RRAS; Ras-related protein R-Ras
K07830 RRAS2; Ras-related protein R-Ras2
K07831 MRAS; Ras-related protein M-Ras
K04365 BRAF; B-Raf proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1]
K04366 RAF1; RAF proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1]
K04367 MOS; proto-oncogene serine/threonine-protein kinase mos [EC:2.7.11.1]
K04368 MAP2K1; mitogen-activated protein kinase kinase 1 [EC:2.7.12.2]
K04369 MAP2K2; mitogen-activated protein kinase kinase 2 [EC:2.7.12.2]
K04370 MP1; mitogen-activated protein kinase kinase 1 interacting protein 1
K04371 MAPK1_3; mitogen-activated protein kinase 1/3 [EC:2.7.11.24]
K04371 MAPK1_3; mitogen-activated protein kinase 1/3 [EC:2.7.11.24]
K04372 MKNK; MAP kinase interacting serine/threonine kinase [EC:2.7.11.1]
K04372 MKNK; MAP kinase interacting serine/threonine kinase [EC:2.7.11.1]
K04373 RPS6KA; p90 ribosomal S6 kinase [EC:2.7.11.1]
K04373 RPS6KA; p90 ribosomal S6 kinase [EC:2.7.11.1]
K04373 RPS6KA; p90 ribosomal S6 kinase [EC:2.7.11.1]
K04373 RPS6KA; p90 ribosomal S6 kinase [EC:2.7.11.1]
K04374 ATF4; cyclic AMP-dependent transcription factor ATF-4
K04375 ELK1; ETS domain-containing protein Elk-1
K04376 ELK4; ETS domain-containing protein Elk-4
K04377 MYC; Myc proto-oncogene protein
K04378 SRF; serum response factor
K04379 FOS; proto-oncogene protein c-fos
K04380 MAPT; microtubule-associated protein tau
K04381 STMN1; stathmin
K16342 PLA2G4; cytosolic phospholipase A2 [EC:3.1.1.4]
K16342 PLA2G4; cytosolic phospholipase A2 [EC:3.1.1.4]
K16342 PLA2G4; cytosolic phospholipase A2 [EC:3.1.1.4]
K16342 PLA2G4; cytosolic phospholipase A2 [EC:3.1.1.4]
K16342 PLA2G4; cytosolic phospholipase A2 [EC:3.1.1.4]
K16342 PLA2G4; cytosolic phospholipase A2 [EC:3.1.1.4]
K16342 PLA2G4; cytosolic phospholipase A2 [EC:3.1.1.4]
K03156 TNFA; tumor necrosis factor superfamily, member 2
K04383 IL1A; interleukin 1 alpha
K04519 IL1B; interleukin 1 beta
K13375 TGFB1; transforming growth factor beta-1
K13376 TGFB2; transforming growth factor beta-2
K13377 TGFB3; transforming growth factor beta-3
K03158 TNFRSF1A; tumor necrosis factor receptor superfamily member 1A
K04386 IL1R1; interleukin 1 receptor type I
K04387 IL1R2; interleukin 1 receptor type II
K04674 TGFBR1; TGF-beta receptor type-1 [EC:2.7.11.30]
K04388 TGFBR2; TGF-beta receptor type-2 [EC:2.7.11.30]
K04389 TNFSF6; tumor necrosis factor ligand superfamily member 6
K04390 TNFRSF6; tumor necrosis factor receptor superfamily member 6
K04391 CD14; CD14 antigen
K04392 RAC1; Ras-related C3 botulinum toxin substrate 1
K07860 RAC2; Ras-related C3 botulinum toxin substrate 2
K07861 RAC3; Ras-related C3 botulinum toxin substrate 3
K04393 CDC42; cell division control protein 42
K02187 CASP3; caspase 3 [EC:3.4.22.56]
K03173 TRAF2; TNF receptor-associated factor 2
K02308 DAXX; death-associated protein 6
K03175 TRAF6; TNF receptor-associated factor 6
K04402 GADD45; growth arrest and DNA-damage-inducible protein
K04402 GADD45; growth arrest and DNA-damage-inducible protein
K04402 GADD45; growth arrest and DNA-damage-inducible protein
K04403 MAP3K7IP1; TAK1-binding protein 1
K04404 MAP3K7IP2; TAK1-binding protein 2
K04405 ECSIT; evolutionarily conserved signaling intermediate in Toll pathway
K04406 MAP4K3; mitogen-activated protein kinase kinase kinase kinase 3 [EC:2.7.11.1]
K04407 MAP4K4; mitogen-activated protein kinase kinase kinase kinase 4 [EC:2.7.11.1]
K04408 MAP4K1; mitogen-activated protein kinase kinase kinase kinase 1 [EC:2.7.11.1]
K04409 PAK1; p21-activated kinase 1 [EC:2.7.11.1]
K04410 PAK2; p21-activated kinase 2 [EC:2.7.11.1]
K04411 STK4; serine/threonine kinase 4
K04412 STK3; serine/threonine kinase 3
K04414 MAP4K2; mitogen-activated protein kinase kinase kinase kinase 2 [EC:2.7.11.1]
K04415 MAP3K8; mitogen-activated protein kinase kinase kinase 8 [EC:2.7.11.25]
K04416 MAP3K1; mitogen-activated protein kinase kinase kinase 1 [EC:2.7.11.25]
K04419 MAP3K11; mitogen-activated protein kinase kinase kinase 11 [EC:2.7.11.25]
K04420 MAP3K2; mitogen-activated protein kinase kinase kinase 2 [EC:2.7.11.25]
K04421 MAP3K3; mitogen-activated protein kinase kinase kinase 3 [EC:2.7.11.25]
K04422 MAP3K13; mitogen-activated protein kinase kinase kinase 13 [EC:2.7.11.25]
K04423 MAP3K12; mitogen-activated protein kinase kinase kinase 12 [EC:2.7.11.25]
K04424 ZAK; sterile alpha motif and leucine zipper containing kinase AZK [EC:2.7.11.25]
K04425 MAP3K6; mitogen-activated protein kinase kinase kinase 6 [EC:2.7.11.25]
K04426 MAP3K5; mitogen-activated protein kinase kinase kinase 5 [EC:2.7.11.25]
K04427 MAP3K7; mitogen-activated protein kinase kinase kinase 7 [EC:2.7.11.25]
K04428 MAP3K4; mitogen-activated protein kinase kinase kinase 4 [EC:2.7.11.25]
K04429 TAO; thousand and one amino acid protein kinase [EC:2.7.11.1]
K04429 TAO; thousand and one amino acid protein kinase [EC:2.7.11.1]
K04429 TAO; thousand and one amino acid protein kinase [EC:2.7.11.1]
K04430 MAP2K4; mitogen-activated protein kinase kinase 4 [EC:2.7.12.2]
K04431 MAP2K7; mitogen-activated protein kinase kinase 7 [EC:2.7.12.2]
K04432 MAP2K3; mitogen-activated protein kinase kinase 3 [EC:2.7.12.2]
K04433 MAP2K6; mitogen-activated protein kinase kinase 6 [EC:2.7.12.2]
K04434 MAPK8IP1; mitogen-activated protein kinase 8 interacting protein 1
K04435 MAPK8IP2; mitogen-activated protein kinase 8 interacting protein 2
K04436 MAPK8IP3; mitogen-activated protein kinase 8 interacting protein 3
K04437 FLNA; filamin
K04437 FLNA; filamin
K04437 FLNA; filamin
K04438 CRK; proto-oncogene C-crk
K04438 CRK; proto-oncogene C-crk
K04439 ARRB; beta-arrestin
K04439 ARRB; beta-arrestin
K04440 JNK; c-Jun N-terminal kinase [EC:2.7.11.24]
K04440 JNK; c-Jun N-terminal kinase [EC:2.7.11.24]
K04440 JNK; c-Jun N-terminal kinase [EC:2.7.11.24]
K04441 P38; p38 MAP kinase [EC:2.7.11.24]
K04441 P38; p38 MAP kinase [EC:2.7.11.24]
K04441 P38; p38 MAP kinase [EC:2.7.11.24]
K04441 P38; p38 MAP kinase [EC:2.7.11.24]
K04442 MAPKAPK5; mitogen-activated protein kinase-activated protein kinase 5 [EC:2.7.11.1]
K04443 MAPKAPK2; mitogen-activated protein kinase-activated protein kinase 2 [EC:2.7.11.1]
K04444 MAPKAPK3; mitogen-activated protein kinase-activated protein kinase 3 [EC:2.7.11.1]
K04445 MSK1; ribosomal protein S6 kinase alpha-5 [EC:2.7.11.1]
K16510 MSK2; ribosomal protein S6 kinase alpha-4 [EC:2.7.11.1]
K05866 CDC25B; M-phase inducer phosphatase 2 [EC:3.1.3.48]
K04446 NFATC1; nuclear factor of activated T-cells, cytoplasmic 1
K17333 NFATC3; nuclear factor of activated T-cells, cytoplasmic 3
K04448 JUN; transcription factor AP-1
K04449 JUND; transcription factor jun-D
K04450 ATF2; cyclic AMP-dependent transcription factor ATF-2
K04451 TP53; tumor protein p53
K04452 DDIT3; DNA damage-inducible transcript 3
K04453 MAX; Max protein
K04454 MEF2C; MADS-box transcription enhancer factor 2C
K04455 HSPB1; heat shock protein beta-1
K04456 AKT; RAC serine/threonine-protein kinase [EC:2.7.11.1]
K04456 AKT; RAC serine/threonine-protein kinase [EC:2.7.11.1]
K04456 AKT; RAC serine/threonine-protein kinase [EC:2.7.11.1]
K04457 PPM1A; protein phosphatase 1A [EC:3.1.3.16]
K04458 PTPRR; receptor-type tyrosine-protein phosphatase R [EC:3.1.3.48]
K18018 PTPN5; tyrosine-protein phosphatase non-receptor type 5 [EC:3.1.3.48]
K18019 PTPN7; tyrosine-protein phosphatase non-receptor type 7 [EC:3.1.3.48]
K04459 DUSP; dual specificity MAP kinase phosphatase [EC:3.1.3.16 3.1.3.48]
K04459 DUSP; dual specificity MAP kinase phosphatase [EC:3.1.3.16 3.1.3.48]
K04459 DUSP; dual specificity MAP kinase phosphatase [EC:3.1.3.16 3.1.3.48]
K04459 DUSP; dual specificity MAP kinase phosphatase [EC:3.1.3.16 3.1.3.48]
K04459 DUSP; dual specificity MAP kinase phosphatase [EC:3.1.3.16 3.1.3.48]
K04459 DUSP; dual specificity MAP kinase phosphatase [EC:3.1.3.16 3.1.3.48]
K04459 DUSP; dual specificity MAP kinase phosphatase [EC:3.1.3.16 3.1.3.48]
K04459 DUSP; dual specificity MAP kinase phosphatase [EC:3.1.3.16 3.1.3.48]
K04459 DUSP; dual specificity MAP kinase phosphatase [EC:3.1.3.16 3.1.3.48]
K04459 DUSP; dual specificity MAP kinase phosphatase [EC:3.1.3.16 3.1.3.48]
K17614 DUSP3; dual specificity phosphatase 3 [EC:3.1.3.16 3.1.3.48]
K04460 PPP5C; serine/threonine-protein phosphatase 5 [EC:3.1.3.16]
K04460 PPP5C; serine/threonine-protein phosphatase 5 [EC:3.1.3.16]
K04461 PPM1B; protein phosphatase 1B [EC:3.1.3.16]
K03283 HSPA1_8; heat shock 70kDa protein 1/8
K03283 HSPA1_8; heat shock 70kDa protein 1/8
K03283 HSPA1_8; heat shock 70kDa protein 1/8
K03283 HSPA1_8; heat shock 70kDa protein 1/8
K03283 HSPA1_8; heat shock 70kDa protein 1/8
K03283 HSPA1_8; heat shock 70kDa protein 1/8
K04462 EVI1; ecotropic virus integration site 1 protein
K04463 MAP2K5; mitogen-activated protein kinase kinase 5 [EC:2.7.12.2]
K04464 MAPK7; mitogen-activated protein kinase 7 [EC:2.7.11.24]
K04465 NR4A1; nuclear receptor subfamily 4 group A member 1
K04466 MAP3K14; mitogen-activated protein kinase kinase kinase 14 [EC:2.7.11.25]
K04467 IKBKA; inhibitor of nuclear factor kappa-B kinase subunit alpha [EC:2.7.11.10]
K07209 IKBKB; inhibitor of nuclear factor kappa-B kinase subunit beta [EC:2.7.11.10]
K07210 IKBKG; inhibitor of nuclear factor kappa-B kinase subunit gamma
K04468 NLK; nemo like kinase [EC:2.7.11.24]
K02580 NFKB1; nuclear factor NF-kappa-B p105 subunit
K04469 NFKB2; nuclear factor of kappa light polypeptide gene enhancer in B-cells 2
K04735 RELA; transcription factor p65
K09253 RELB; transcription factor RelB
     04013 MAPK signaling pathway - fly
     04011 MAPK signaling pathway - yeast
     04012 ErbB signaling pathway [PATH:hsa04012]
     04310 Wnt signaling pathway [PATH:hsa04310]
     04330 Notch signaling pathway [PATH:hsa04330]
     04340 Hedgehog signaling pathway [PATH:hsa04340]
     04350 TGF-beta signaling pathway [PATH:hsa04350]
       8646 CHRD; chordin
       9241 NOG; noggin
       7057 THBS1; thrombospondin 1
       1634 DCN; decorin
       10637 LEFTY1; left-right determination factor 1
       7044 LEFTY2; left-right determination factor 2
       10468 FST; follistatin
       650 BMP2; bone morphogenetic protein 2
       652 BMP4; bone morphogenetic protein 4
       653 BMP5; bone morphogenetic protein 5
       654 BMP6; bone morphogenetic protein 6
       655 BMP7; bone morphogenetic protein 7
       656 BMP8B; bone morphogenetic protein 8b
       353500 BMP8A; bone morphogenetic protein 8a
       151449 GDF7; growth differentiation factor 7
       8200 GDF5; growth differentiation factor 5
       392255 GDF6; growth differentiation factor 6
       268 AMH; anti-Mullerian hormone
       7040 TGFB1; transforming growth factor, beta 1
       7042 TGFB2; transforming growth factor, beta 2
       7043 TGFB3; transforming growth factor, beta 3
       3624 INHBA; inhibin, beta A
       3625 INHBB; inhibin, beta B
       3626 INHBC; inhibin, beta C
       83729 INHBE; inhibin, beta E
       4838 NODAL; nodal growth differentiation factor
       659 BMPR2; bone morphogenetic protein receptor, type II (serine/threonine kinase) 
       269 AMHR2; anti-Mullerian hormone receptor, type II 
       7048 TGFBR2; transforming growth factor, beta receptor II (70/80kDa) 
       92 ACVR2A; activin A receptor, type IIA 
       93 ACVR2B; activin A receptor, type IIB 
       657 BMPR1A; bone morphogenetic protein receptor, type IA 
       658 BMPR1B; bone morphogenetic protein receptor, type IB 
       90 ACVR1; activin A receptor, type I 
       7046 TGFBR1; transforming growth factor, beta receptor 1 
       91 ACVR1B; activin A receptor, type IB 
       25805 BAMBI; BMP and activin membrane-bound inhibitor
       4086 SMAD1; SMAD family member 1
       4090 SMAD5; SMAD family member 5
       4093 SMAD9; SMAD family member 9
       4087 SMAD2; SMAD family member 2
       4088 SMAD3; SMAD family member 3
       4089 SMAD4; SMAD family member 4
       4091 SMAD6; SMAD family member 6
       4092 SMAD7; SMAD family member 7
       57154 SMURF1; SMAD specific E3 ubiquitin protein ligase 1
       64750 SMURF2; SMAD specific E3 ubiquitin protein ligase 2
       9372 ZFYVE9; zinc finger, FYVE domain containing 9
       9765 ZFYVE16; zinc finger, FYVE domain containing 16
       3397 ID1; inhibitor of DNA binding 1, dominant negative helix-loop-helix protein
       3398 ID2; inhibitor of DNA binding 2, dominant negative helix-loop-helix protein
       3399 ID3; inhibitor of DNA binding 3, dominant negative helix-loop-helix protein
       3400 ID4; inhibitor of DNA binding 4, dominant negative helix-loop-helix protein
       5933 RBL1; retinoblastoma-like 1
       1874 E2F4; E2F transcription factor 4, p107/p130-binding
       1875 E2F5; E2F transcription factor 5, p130-binding
       7027 TFDP1; transcription factor Dp-1
       1387 CREBBP; CREB binding protein 
       2033 EP300; E1A binding protein p300 
       6667 SP1; Sp1 transcription factor
       4609 MYC; v-myc avian myelocytomatosis viral oncogene homolog
       1030 CDKN2B; cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)
       5308 PITX2; paired-like homeodomain 2
       9978 RBX1; ring-box 1, E3 ubiquitin protein ligase
       8454 CUL1; cullin 1
       6500 SKP1; S-phase kinase-associated protein 1 
       5594 MAPK1; mitogen-activated protein kinase 1 
       5595 MAPK3; mitogen-activated protein kinase 3 
       3458 IFNG; interferon, gamma
       7124 TNF; tumor necrosis factor
       387 RHOA; ras homolog family member A
       6093 ROCK1; Rho-associated, coiled-coil containing protein kinase 1 
       5519 PPP2R1B; protein phosphatase 2, regulatory subunit A, beta 
       5518 PPP2R1A; protein phosphatase 2, regulatory subunit A, alpha 
       5515 PPP2CA; protein phosphatase 2, catalytic subunit, alpha isozyme 
       5516 PPP2CB; protein phosphatase 2, catalytic subunit, beta isozyme 
       6198 RPS6KB1; ribosomal protein S6 kinase, 70kDa, polypeptide 1 
       6199 RPS6KB2; ribosomal protein S6 kinase, 70kDa, polypeptide 2 
       130399 ACVR1C; activin A receptor, type IC 
       4052 LTBP1; latent transforming growth factor beta binding protein 1
K04657 CHRD; chordin
K04658 NOG; noggin
K16857 THBS1; thrombospondin 1
K04660 DCN; decorin
K04668 LEFTY; left-right determination factor
K04668 LEFTY; left-right determination factor
K04661 FST; follistatin
K04662 BMP2_4; bone morphogenetic protein 2/4
K04662 BMP2_4; bone morphogenetic protein 2/4
K04663 BMP5; bone morphogenetic protein 5
K16620 BMP6; bone morphogenetic protein 6
K16621 BMP7; bone morphogenetic protein 7
K16622 BMP8; bone morphogenetic protein 8
K16622 BMP8; bone morphogenetic protein 8
K04664 GDF5_6_7; growth differentiation factor 5/6/7
K04664 GDF5_6_7; growth differentiation factor 5/6/7
K04664 GDF5_6_7; growth differentiation factor 5/6/7
K04665 AMH; anti-mullerian hormone
K13375 TGFB1; transforming growth factor beta-1
K13376 TGFB2; transforming growth factor beta-2
K13377 TGFB3; transforming growth factor beta-3
K04667 INHB; inhibin, beta
K04667 INHB; inhibin, beta
K04667 INHB; inhibin, beta
K04667 INHB; inhibin, beta
K04666 NODAL; nodal
K04671 BMPR2; bone morphogenetic protein receptor type-2 [EC:2.7.11.30]
K04672 AMHR2; anti-mullerian hormone receptor type-2 [EC:2.7.11.30]
K04388 TGFBR2; TGF-beta receptor type-2 [EC:2.7.11.30]
K04670 ACVR2A; activin receptor type-2A [EC:2.7.11.30]
K13596 ACVR2B; activin receptor type-2B [EC:2.7.11.30]
K04673 BMPR1A; bone morphogenetic protein receptor type-1A [EC:2.7.11.30]
K13578 BMPR1B; bone morphogenetic protein receptor type-1B [EC:2.7.11.30]
K04675 ACVR1; activin receptor type-1 [EC:2.7.11.30]
K04674 TGFBR1; TGF-beta receptor type-1 [EC:2.7.11.30]
K13567 ACVR1B; activin receptor type-1B [EC:2.7.11.30]
K10162 BAMBI; BMP and activin membrane-bound inhibitor
K04676 SMAD1; mothers against decapentaplegic homolog 1
K16790 SMAD5; mothers against decapentaplegic homolog 5
K16791 SMAD9; mothers against decapentaplegic homolog 9
K04500 SMAD2_3; mothers against decapentaplegic homolog 2/3
K04500 SMAD2_3; mothers against decapentaplegic homolog 2/3
K04501 SMAD4; mothers against decapentaplegic homolog 4
K04677 SMAD6_7; mothers against decapentaplegic homolog 6/7
K04677 SMAD6_7; mothers against decapentaplegic homolog 6/7
K04678 SMURF; E3 ubiquitin ligase SMURF1/2 [EC:6.3.2.19]
K04678 SMURF; E3 ubiquitin ligase SMURF1/2 [EC:6.3.2.19]
K04679 MADHIP; MAD, mothers against decapentaplegic interacting protein
K04679 MADHIP; MAD, mothers against decapentaplegic interacting protein
K04680 ID1; DNA-binding protein inhibitor ID1
K17693 ID2; DNA-binding protein inhibitor ID2
K17694 ID3; DNA-binding protein inhibitor ID3
K17695 ID4; DNA-binding protein inhibitor ID4
K04681 RBL1; retinoblastoma-like protein 1
K04682 E2F4_5; transcription factor E2F4/5
K04682 E2F4_5; transcription factor E2F4/5
K04683 TFDP1; transcription factor Dp-1
K04498 EP300; E1A/CREB-binding protein [EC:2.3.1.48]
K04498 EP300; E1A/CREB-binding protein [EC:2.3.1.48]
K04684 SP1; transcription factor Sp1
K04377 MYC; Myc proto-oncogene protein
K04685 CDKN2B; cyclin-dependent kinase inhibitor 2B
K04686 PITX2; paired-like homeodomain transcription factor 2
K03868 RBX1; RING-box protein 1
K03347 CUL1; cullin 1
K03094 SKP1; S-phase kinase-associated protein 1
K04371 MAPK1_3; mitogen-activated protein kinase 1/3 [EC:2.7.11.24]
K04371 MAPK1_3; mitogen-activated protein kinase 1/3 [EC:2.7.11.24]
K04687 IFNG; interferon gamma
K03156 TNFA; tumor necrosis factor superfamily, member 2
K04513 RHOA; Ras homolog gene family, member A
K04514 ROCK1; Rho-associated protein kinase 1 [EC:2.7.11.1]
K03456 PPP2R1; serine/threonine-protein phosphatase 2A regulatory subunit A
K03456 PPP2R1; serine/threonine-protein phosphatase 2A regulatory subunit A
K04382 PPP2C; serine/threonine-protein phosphatase 2A catalytic subunit [EC:3.1.3.16]
K04382 PPP2C; serine/threonine-protein phosphatase 2A catalytic subunit [EC:3.1.3.16]
K04688 RPS6KB; p70 ribosomal S6 kinase [EC:2.7.11.1]
K04688 RPS6KB; p70 ribosomal S6 kinase [EC:2.7.11.1]
K13568 ACVR1C; activin receptor type-1C [EC:2.7.11.30]
K08023 LTBP; latent transforming growth factor beta binding protein
     04390 Hippo signaling pathway [PATH:hsa04390]
     04391 Hippo signaling pathway -fly
     04370 VEGF signaling pathway [PATH:hsa04370]
     04630 Jak-STAT signaling pathway [PATH:hsa04630]
     04064 NF-kappa B signaling pathway [PATH:hsa04064]
       3932 LCK; lymphocyte-specific protein tyrosine kinase 
       7535 ZAP70; zeta-chain (TCR) associated protein kinase 70kDa 
       27040 LAT; linker for activation of T cells
       5335 PLCG1; phospholipase C, gamma 1 
       5588 PRKCQ; protein kinase C, theta 
       6850 SYK; spleen tyrosine kinase 
       4067 LYN; v-yes-1 Yamaguchi sarcoma viral related oncogene homolog 
       29760 BLNK; B-cell linker
       695 BTK; Bruton agammaglobulinemia tyrosine kinase 
       5336 PLCG2; phospholipase C, gamma 2 (phosphatidylinositol-specific) 
       84433 CARD11; caspase recruitment domain family, member 11
       8915 BCL10; B-cell CLL/lymphoma 10
       10892 MALT1; mucosa associated lymphoid tissue lymphoma translocation gene 1 
       3553 IL1B; interleukin 1, beta
       3554 IL1R1; interleukin 1 receptor, type I
       4615 MYD88; myeloid differentiation primary response 88
       3654 IRAK1; interleukin-1 receptor-associated kinase 1 
       51135 IRAK4; interleukin-1 receptor-associated kinase 4 
       7189 TRAF6; TNF receptor-associated factor 6, E3 ubiquitin protein ligase
       7124 TNF; tumor necrosis factor
       7132 TNFRSF1A; tumor necrosis factor receptor superfamily, member 1A
       8737 RIPK1; receptor (TNFRSF)-interacting serine-threonine kinase 1 
       8717 TRADD; TNFRSF1A-associated via death domain
       7186 TRAF2; TNF receptor-associated factor 2
       7188 TRAF5; TNF receptor-associated factor 5
       329 BIRC2; baculoviral IAP repeat containing 2
       330 BIRC3; baculoviral IAP repeat containing 3
       23586 DDX58; DEAD (Asp-Glu-Ala-Asp) box polypeptide 58 
       7706 TRIM25; tripartite motif containing 25 
       3929 LBP; lipopolysaccharide binding protein
       929 CD14; CD14 molecule
       7099 TLR4; toll-like receptor 4
       23643 LY96; lymphocyte antigen 96
       114609 TIRAP; toll-interleukin 1 receptor (TIR) domain containing adaptor protein
       353376 TICAM2; toll-like receptor adaptor molecule 2
       148022 TICAM1; toll-like receptor adaptor molecule 1
       959 CD40LG; CD40 ligand
       958 CD40; CD40 molecule, TNF receptor superfamily member 5
       7187 TRAF3; TNF receptor-associated factor 3
       8600 TNFSF11; tumor necrosis factor (ligand) superfamily, member 11
       8792 TNFRSF11A; tumor necrosis factor receptor superfamily, member 11a, NFKB activator
       4049 LTA; lymphotoxin alpha
       4050 LTB; lymphotoxin beta (TNF superfamily, member 3)
       8740 TNFSF14; tumor necrosis factor (ligand) superfamily, member 14
       4055 LTBR; lymphotoxin beta receptor (TNFR superfamily, member 3)
       9020 MAP3K14; mitogen-activated protein kinase kinase kinase 14 
       6885 MAP3K7; mitogen-activated protein kinase kinase kinase 7 
       10454 TAB1; TGF-beta activated kinase 1/MAP3K7 binding protein 1
       23118 TAB2; TGF-beta activated kinase 1/MAP3K7 binding protein 2
       257397 TAB3; TGF-beta activated kinase 1/MAP3K7 binding protein 3
       10673 TNFSF13B; tumor necrosis factor (ligand) superfamily, member 13b
       115650 TNFRSF13C; tumor necrosis factor receptor superfamily, member 13C
       8517 IKBKG; inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma
       1147 CHUK; conserved helix-loop-helix ubiquitous kinase 
       3551 IKBKB; inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta 
       51588 PIAS4; protein inhibitor of activated STAT, 4
       7329 UBE2I; ubiquitin-conjugating enzyme E2I 
       472 ATM; ataxia telangiectasia mutated 
       55367 PIDD1; p53-induced death domain protein 1
       23085 ERC1; ELKS/RAB6-interacting/CAST family member 1
       4792 NFKBIA; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha
       4790 NFKB1; nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
       5970 RELA; v-rel avian reticuloendotheliosis viral oncogene homolog A
       8837 CFLAR; CASP8 and FADD-like apoptosis regulator
       331 XIAP; X-linked inhibitor of apoptosis
       598 BCL2L1; BCL2-like 1
       596 BCL2; B-cell CLL/lymphoma 2
       7185 TRAF1; TNF receptor-associated factor 1
       597 BCL2A1; BCL2-related protein A1
       4791 NFKB2; nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100)
       3576 CXCL8; chemokine (C-X-C motif) ligand 8
       7128 TNFAIP3; tumor necrosis factor, alpha-induced protein 3 
       5743 PTGS2; prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) 
       6351 CCL4; chemokine (C-C motif) ligand 4
       9560 CCL4L2; chemokine (C-C motif) ligand 4-like 2
       388372 CCL4L1; chemokine (C-C motif) ligand 4-like 1
       7412 VCAM1; vascular cell adhesion molecule 1
       5328 PLAU; plasminogen activator, urokinase 
       1457 CSNK2A1; casein kinase 2, alpha 1 polypeptide 
       1459 CSNK2A2; casein kinase 2, alpha prime polypeptide 
       1460 CSNK2B; casein kinase 2, beta polypeptide 
       5971 RELB; v-rel avian reticuloendotheliosis viral oncogene homolog B
       6357 CCL13; chemokine (C-C motif) ligand 13
       6363 CCL19; chemokine (C-C motif) ligand 19
       6366 CCL21; chemokine (C-C motif) ligand 21
       6387 CXCL12; chemokine (C-X-C motif) ligand 12
       3383 ICAM1; intercellular adhesion molecule 1
       142 PARP1; poly (ADP-ribose) polymerase 1 
       2920 CXCL2; chemokine (C-X-C motif) ligand 2
       4616 GADD45B; growth arrest and DNA-damage-inducible, beta
       5579 PRKCB; protein kinase C, beta 
K05856 LCK; lymphocyte cell-specific protein tyrosine kinase [EC:2.7.10.2]
K07360 ZAP70; tyrosine-protein kinase ZAP-70 [EC:2.7.10.2]
K07362 LAT; linker for activation of T cells
K01116 PLCG1; phosphatidylinositol phospholipase C, gamma-1 [EC:3.1.4.11]
K18052 PRKCQ; novel protein kinase C theta type [EC:2.7.11.13]
K05855 SYK; spleen tyrosine kinase [EC:2.7.10.2]
K05854 LYN; tyrosine-protein kinase Lyn [EC:2.7.10.2]
K07371 BLNK; B-cell linker protein
K07370 BTK; Bruton agammaglobulinemia tyrosine kinase [EC:2.7.10.2]
K05859 PLCG2; phosphatidylinositol phospholipase C, gamma-2 [EC:3.1.4.11]
K07367 CARD11; caspase recruitment domain-containing protein 11
K07368 BCL10; B-cell CLL/lymphoma 10
K07369 MALT1; mucosa-associated lymphoid tissue lymphoma translocation protein 1 [EC:3.4.22.-]
K04519 IL1B; interleukin 1 beta
K04386 IL1R1; interleukin 1 receptor type I
K04729 MYD88; myeloid differentiation primary response protein MyD88
K04730 IRAK1; interleukin-1 receptor-associated kinase 1 [EC:2.7.11.1]
K04733 IRAK4; interleukin-1 receptor-associated kinase 4 [EC:2.7.11.1]
K03175 TRAF6; TNF receptor-associated factor 6
K03156 TNFA; tumor necrosis factor superfamily, member 2
K03158 TNFRSF1A; tumor necrosis factor receptor superfamily member 1A
K02861 RIPK1; receptor-interacting serine/threonine-protein kinase 1 [EC:2.7.11.1]
K03171 TRADD; tumor necrosis factor receptor type 1-associated DEATH domain protein
K03173 TRAF2; TNF receptor-associated factor 2
K09849 TRAF5; TNF receptor-associated factor 5
K16060 BIRC2_3; baculoviral IAP repeat-containing protein 2/3
K16060 BIRC2_3; baculoviral IAP repeat-containing protein 2/3
K12646 DDX58; ATP-dependent RNA helicase DDX58 [EC:3.6.3.14]
K10652 TRIM25; tripartite motif-containing protein 25 [EC:6.3.2.19]
K05399 LBP; lipopolysaccharide-binding protein
K04391 CD14; CD14 antigen
K10160 TLR4; toll-like receptor 4
K05400 LY96; lymphocyte antigen 96
K05403 TIRAP; toll-interleukin 1 receptor (TIR) domain-containing adaptor protein
K05409 TIRP; TRIF-related adaptor molecule
K05842 TRIF; toll-like receptor adapter molecule 1
K03161 TNFSF5; tumor necrosis factor ligand superfamily member 5
K03160 TNFRSF5; tumor necrosis factor receptor superfamily member 5
K03174 TRAF3; TNF receptor-associated factor 3
K05473 TNFSF11; tumor necrosis factor ligand superfamily member 11
K05147 TNFRSF11A; tumor necrosis factor receptor superfamily member 11A
K05468 LTA; lymphotoxin alpha (TNF superfamily, member 1)
K03157 LTB; lymphotoxin beta (TNF superfamily, member 3)
K05477 TNFSF14; tumor necrosis factor ligand superfamily member 14
K03159 TNFRSF3; lymphotoxin beta receptor TNFR superfamily member 3
K04466 MAP3K14; mitogen-activated protein kinase kinase kinase 14 [EC:2.7.11.25]
K04427 MAP3K7; mitogen-activated protein kinase kinase kinase 7 [EC:2.7.11.25]
K04403 MAP3K7IP1; TAK1-binding protein 1
K04404 MAP3K7IP2; TAK1-binding protein 2
K12793 MAP3K7IP3; TAK1-binding protein 3
K05476 TNFSF13B; tumor necrosis factor ligand superfamily member 13B
K05151 TNFRSF13C; tumor necrosis factor receptor superfamily member 13C
K07210 IKBKG; inhibitor of nuclear factor kappa-B kinase subunit gamma
K04467 IKBKA; inhibitor of nuclear factor kappa-B kinase subunit alpha [EC:2.7.11.10]
K07209 IKBKB; inhibitor of nuclear factor kappa-B kinase subunit beta [EC:2.7.11.10]
K16065 PIAS4; E3 SUMO-protein ligase PIAS4 [EC:6.3.2.-]
K10577 UBE2I; ubiquitin-conjugating enzyme E2 I [EC:6.3.2.19]
K04728 ATM; ataxia telangiectasia mutated family protein [EC:2.7.11.1]
K10130 LRDD; leucine-rich repeats and death domain-containing protein
K16072 ERC1; ELKS/RAB6-interacting/CAST family member 1
K04734 NFKBIA; NF-kappa-B inhibitor alpha
K02580 NFKB1; nuclear factor NF-kappa-B p105 subunit
K04735 RELA; transcription factor p65
K04724 CFLAR; CASP8 and FADD-like apoptosis regulator
K04725 XIAP; E3 ubiquitin-protein ligase XIAP
K04570 BCL2L1; BCL2-like 1 (apoptosis regulator Bcl-X)
K02161 BCL2; apoptosis regulator BCL-2
K03172 TRAF1; TNF receptor-associated factor 1
K02162 BCL2A1; hematopoietic BCL2-related protein A1
K04469 NFKB2; nuclear factor of kappa light polypeptide gene enhancer in B-cells 2
K10030 IL8; interleukin 8
K11859 TNFAIP3; tumor necrosis factor, alpha-induced protein 3 [EC:3.4.19.12 6.3.2.19]
K11987 PTGS2; prostaglandin-endoperoxide synthase 2 [EC:1.14.99.1]
K12964 CCL4; C-C motif chemokine 4
K12964 CCL4; C-C motif chemokine 4
K12964 CCL4; C-C motif chemokine 4
K06527 VCAM1; vascular cell adhesion molecule 1
K01348 PLAU; urokinase plasminogen activator [EC:3.4.21.73]
K03097 CSNK2A; casein kinase II subunit alpha [EC:2.7.11.1]
K03097 CSNK2A; casein kinase II subunit alpha [EC:2.7.11.1]
K03115 CSNK2B; casein kinase II subunit beta
K09253 RELB; transcription factor RelB
K16595 CCL13; C-C motif chemokine 13
K05512 CCL19; C-C motif chemokine 19
K16062 CCL21; C-C motif chemokine 21
K10031 CXCL12; C-X-C motif chemokine 12
K06490 ICAM1; intercellular adhesion molecule 1
K10798 PARP; poly [ADP-ribose] polymerase [EC:2.4.2.30]
K05505 CXCL1_2_3; C-X-C motif chemokine 1/2/3
K04402 GADD45; growth arrest and DNA-damage-inducible protein
K02677 CPKC; classical protein kinase C [EC:2.7.11.13]
     04668 TNF signaling pathway [PATH:hsa04668]
       7124 TNF; tumor necrosis factor
       7132 TNFRSF1A; tumor necrosis factor receptor superfamily, member 1A
       9530 BAG4; BCL2-associated athanogene 4
       8717 TRADD; TNFRSF1A-associated via death domain
       7186 TRAF2; TNF receptor-associated factor 2
       7188 TRAF5; TNF receptor-associated factor 5
       8737 RIPK1; receptor (TNFRSF)-interacting serine-threonine kinase 1 
       329 BIRC2; baculoviral IAP repeat containing 2
       330 BIRC3; baculoviral IAP repeat containing 3
       6885 MAP3K7; mitogen-activated protein kinase kinase kinase 7 
       10454 TAB1; TGF-beta activated kinase 1/MAP3K7 binding protein 1
       23118 TAB2; TGF-beta activated kinase 1/MAP3K7 binding protein 2
       257397 TAB3; TGF-beta activated kinase 1/MAP3K7 binding protein 3
       6416 MAP2K4; mitogen-activated protein kinase kinase 4 
       5609 MAP2K7; mitogen-activated protein kinase kinase 7 
       5599 MAPK8; mitogen-activated protein kinase 8 
       5602 MAPK10; mitogen-activated protein kinase 10 
       5601 MAPK9; mitogen-activated protein kinase 9 
       3725 JUN; jun proto-oncogene
       83737 ITCH; itchy E3 ubiquitin protein ligase
       8837 CFLAR; CASP8 and FADD-like apoptosis regulator
       5606 MAP2K3; mitogen-activated protein kinase kinase 3 
       5608 MAP2K6; mitogen-activated protein kinase kinase 6 
       5600 MAPK11; mitogen-activated protein kinase 11 
       6300 MAPK12; mitogen-activated protein kinase 12 
       5603 MAPK13; mitogen-activated protein kinase 13 
       1432 MAPK14; mitogen-activated protein kinase 14 
       1051 CEBPB; CCAAT/enhancer binding protein (C/EBP), beta
       4217 MAP3K5; mitogen-activated protein kinase kinase kinase 5 
       9020 MAP3K14; mitogen-activated protein kinase kinase kinase 14 
       8517 IKBKG; inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma
       3551 IKBKB; inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta 
       1147 CHUK; conserved helix-loop-helix ubiquitous kinase 
       4792 NFKBIA; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha
       5970 RELA; v-rel avian reticuloendotheliosis viral oncogene homolog A
       4790 NFKB1; nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
       1326 MAP3K8; mitogen-activated protein kinase kinase kinase 8 
       5604 MAP2K1; mitogen-activated protein kinase kinase 1 
       5594 MAPK1; mitogen-activated protein kinase 1 
       5595 MAPK3; mitogen-activated protein kinase 3 
       9252 RPS6KA5; ribosomal protein S6 kinase, 90kDa, polypeptide 5 
       8986 RPS6KA4; ribosomal protein S6 kinase, 90kDa, polypeptide 4 
       1385 CREB1; cAMP responsive element binding protein 1
       10488 CREB3; cAMP responsive element binding protein 3
       90993 CREB3L1; cAMP responsive element binding protein 3-like 1
       64764 CREB3L2; cAMP responsive element binding protein 3-like 2
       84699 CREB3L3; cAMP responsive element binding protein 3-like 3
       148327 CREB3L4; cAMP responsive element binding protein 3-like 4
       1386 ATF2; activating transcription factor 2 
       468 ATF4; activating transcription factor 4
       9586 CREB5; cAMP responsive element binding protein 5
       1388 ATF6B; activating transcription factor 6 beta
       11035 RIPK3; receptor-interacting serine-threonine kinase 3 
       197259 MLKL; mixed lineage kinase domain-like
       192111 PGAM5; phosphoglycerate mutase family member 5 
       10059 DNM1L; dynamin 1-like 
       8772 FADD; Fas (TNFRSF6)-associated via death domain
       841 CASP8; caspase 8, apoptosis-related cysteine peptidase 
       843 CASP10; caspase 10, apoptosis-related cysteine peptidase 
       840 CASP7; caspase 7, apoptosis-related cysteine peptidase 
       836 CASP3; caspase 3, apoptosis-related cysteine peptidase 
       6347 CCL2; chemokine (C-C motif) ligand 2
       6352 CCL5; chemokine (C-C motif) ligand 5
       6364 CCL20; chemokine (C-C motif) ligand 20
       2919 CXCL1; chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha)
       2920 CXCL2; chemokine (C-X-C motif) ligand 2
       2921 CXCL3; chemokine (C-X-C motif) ligand 3
       3627 CXCL10; chemokine (C-X-C motif) ligand 10
       6376 CX3CL1; chemokine (C-X3-C motif) ligand 1
       1435 CSF1; colony stimulating factor 1 (macrophage) 
       1437 CSF2; colony stimulating factor 2 (granulocyte-macrophage)
       355 FAS; Fas cell surface death receptor
       8809 IL18R1; interleukin 18 receptor 1
       3553 IL1B; interleukin 1, beta
       3569 IL6; interleukin 6
       3600 IL15; interleukin 15
       3976 LIF; leukemia inhibitory factor
       4049 LTA; lymphotoxin alpha
       602 BCL3; B-cell CLL/lymphoma 3
       9021 SOCS3; suppressor of cytokine signaling 3
       7128 TNFAIP3; tumor necrosis factor, alpha-induced protein 3 
       7185 TRAF1; TNF receptor-associated factor 1
       2353 FOS; FBJ murine osteosarcoma viral oncogene homolog
       3726 JUNB; jun B proto-oncogene
       4314 MMP3; matrix metallopeptidase 3 (stromelysin 1, progelatinase) 
       4318 MMP9; matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) 
       4323 MMP14; matrix metallopeptidase 14 (membrane-inserted) 
       1906 EDN1; endothelin 1
       64127 NOD2; nucleotide-binding oligomerization domain containing 2
       3383 ICAM1; intercellular adhesion molecule 1
       6401 SELE; selectin E
       7412 VCAM1; vascular cell adhesion molecule 1
       5743 PTGS2; prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) 
       7133 TNFRSF1B; tumor necrosis factor receptor superfamily, member 1B
       7187 TRAF3; TNF receptor-associated factor 3
       5290 PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha 
       5293 PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta 
       5291 PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta 
       5294 PIK3CG; phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma 
       5295 PIK3R1; phosphoinositide-3-kinase, regulatory subunit 1 (alpha)
       23533 PIK3R5; phosphoinositide-3-kinase, regulatory subunit 5
       5296 PIK3R2; phosphoinositide-3-kinase, regulatory subunit 2 (beta)
       8503 PIK3R3; phosphoinositide-3-kinase, regulatory subunit 3 (gamma)
       207 AKT1; v-akt murine thymoma viral oncogene homolog 1 
       208 AKT2; v-akt murine thymoma viral oncogene homolog 2 
       10000 AKT3; v-akt murine thymoma viral oncogene homolog 3 
       9863 MAGI2; membrane associated guanylate kinase, WW and PDZ domain containing 2
       182 JAG1; jagged 1
       6374 CXCL5; chemokine (C-X-C motif) ligand 5
       7424 VEGFC; vascular endothelial growth factor C
K03156 TNFA; tumor necrosis factor superfamily, member 2
K03158 TNFRSF1A; tumor necrosis factor receptor superfamily member 1A
K09558 BAG4; BCL2-associated athanogene 4
K03171 TRADD; tumor necrosis factor receptor type 1-associated DEATH domain protein
K03173 TRAF2; TNF receptor-associated factor 2
K09849 TRAF5; TNF receptor-associated factor 5
K02861 RIPK1; receptor-interacting serine/threonine-protein kinase 1 [EC:2.7.11.1]
K16060 BIRC2_3; baculoviral IAP repeat-containing protein 2/3
K16060 BIRC2_3; baculoviral IAP repeat-containing protein 2/3
K04427 MAP3K7; mitogen-activated protein kinase kinase kinase 7 [EC:2.7.11.25]
K04403 MAP3K7IP1; TAK1-binding protein 1
K04404 MAP3K7IP2; TAK1-binding protein 2
K12793 MAP3K7IP3; TAK1-binding protein 3
K04430 MAP2K4; mitogen-activated protein kinase kinase 4 [EC:2.7.12.2]
K04431 MAP2K7; mitogen-activated protein kinase kinase 7 [EC:2.7.12.2]
K04440 JNK; c-Jun N-terminal kinase [EC:2.7.11.24]
K04440 JNK; c-Jun N-terminal kinase [EC:2.7.11.24]
K04440 JNK; c-Jun N-terminal kinase [EC:2.7.11.24]
K04448 JUN; transcription factor AP-1
K05632 AIP4; atrophin-1 interacting protein 4 [EC:6.3.2.19]
K04724 CFLAR; CASP8 and FADD-like apoptosis regulator
K04432 MAP2K3; mitogen-activated protein kinase kinase 3 [EC:2.7.12.2]
K04433 MAP2K6; mitogen-activated protein kinase kinase 6 [EC:2.7.12.2]
K04441 P38; p38 MAP kinase [EC:2.7.11.24]
K04441 P38; p38 MAP kinase [EC:2.7.11.24]
K04441 P38; p38 MAP kinase [EC:2.7.11.24]
K04441 P38; p38 MAP kinase [EC:2.7.11.24]
K10048 CEBPB; CCAAT/enhancer binding protein (C/EBP), beta
K04426 MAP3K5; mitogen-activated protein kinase kinase kinase 5 [EC:2.7.11.25]
K04466 MAP3K14; mitogen-activated protein kinase kinase kinase 14 [EC:2.7.11.25]
K07210 IKBKG; inhibitor of nuclear factor kappa-B kinase subunit gamma
K07209 IKBKB; inhibitor of nuclear factor kappa-B kinase subunit beta [EC:2.7.11.10]
K04467 IKBKA; inhibitor of nuclear factor kappa-B kinase subunit alpha [EC:2.7.11.10]
K04734 NFKBIA; NF-kappa-B inhibitor alpha
K04735 RELA; transcription factor p65
K02580 NFKB1; nuclear factor NF-kappa-B p105 subunit
K04415 MAP3K8; mitogen-activated protein kinase kinase kinase 8 [EC:2.7.11.25]
K04368 MAP2K1; mitogen-activated protein kinase kinase 1 [EC:2.7.12.2]
K04371 MAPK1_3; mitogen-activated protein kinase 1/3 [EC:2.7.11.24]
K04371 MAPK1_3; mitogen-activated protein kinase 1/3 [EC:2.7.11.24]
K04445 MSK1; ribosomal protein S6 kinase alpha-5 [EC:2.7.11.1]
K16510 MSK2; ribosomal protein S6 kinase alpha-4 [EC:2.7.11.1]
K05870 CREB1; cyclic AMP-responsive element-binding protein 1
K09048 CREB3; cyclic AMP-responsive element-binding protein 3
K09048 CREB3; cyclic AMP-responsive element-binding protein 3
K09048 CREB3; cyclic AMP-responsive element-binding protein 3
K09048 CREB3; cyclic AMP-responsive element-binding protein 3
K09048 CREB3; cyclic AMP-responsive element-binding protein 3
K04450 ATF2; cyclic AMP-dependent transcription factor ATF-2
K04374 ATF4; cyclic AMP-dependent transcription factor ATF-4
K09047 CREB5; cyclic AMP-responsive element-binding protein 5
K09049 ATF6B; cyclic AMP-dependent transcription factor ATF-6 beta
K08847 RIPK3; receptor-interacting serine/threonine-protein kinase 3 [EC:2.7.11.1]
K08849 MLKL; mixed lineage kinase domain-like [EC:2.7.11.1]
K15637 PGAM5; serine/threonine-protein phosphatase PGAM5 [EC:3.1.3.16]
K17065 DNM1L; dynamin 1-like protein [EC:3.6.5.5]
K02373 FADD; FAS-associated death domain protein
K04398 CASP8; caspase 8 [EC:3.4.22.61]
K04400 CASP10; caspase 10 [EC:3.4.22.63]
K04397 CASP7; caspase 7 [EC:3.4.22.60]
K02187 CASP3; caspase 3 [EC:3.4.22.56]
K14624 CCL2; C-C motif chemokine 2
K12499 CCL5; C-C motif chemokine 5
K14625 CCL20; C-C motif chemokine 20
K05505 CXCL1_2_3; C-X-C motif chemokine 1/2/3
K05505 CXCL1_2_3; C-X-C motif chemokine 1/2/3
K05505 CXCL1_2_3; C-X-C motif chemokine 1/2/3
K12671 CXCL10; C-X-C motif chemokine 10
K05508 CX3CL1; C-X3-C motif chemokine 1
K05453 CSF1; macrophage colony-stimulating factor 1
K05427 CSF2; granulocyte-macrophage colony-stimulating factor
K04390 TNFRSF6; tumor necrosis factor receptor superfamily member 6
K05173 IL18R1; interleukin 18 receptor 1
K04519 IL1B; interleukin 1 beta
K05405 IL6; interleukin 6
K05433 IL15; interleukin 15
K05419 LIF; leukemia inhibitory factor
K05468 LTA; lymphotoxin alpha (TNF superfamily, member 1)
K09258 BCL3; B-cell CLL/lymphoma protein 3
K04696 SOCS3; suppressor of cytokine signaling 3
K11859 TNFAIP3; tumor necrosis factor, alpha-induced protein 3 [EC:3.4.19.12 6.3.2.19]
K03172 TRAF1; TNF receptor-associated factor 1
K04379 FOS; proto-oncogene protein c-fos
K09028 JUNB; transcription factor jun-B
K01394 MMP3; matrix metalloproteinase-3 (stromelysin 1, progelatinase) [EC:3.4.24.17]
K01403 MMP9; matrix metalloproteinase-9 (gelatinase B) [EC:3.4.24.35]
K07763 MMP14; matrix metalloproteinase-14 (membrane-inserted) [EC:3.4.24.80]
K16366 EDN1; endothelin-1
K10165 NOD2; nucleotide-binding oligomerization domain-containing protein 2
K06490 ICAM1; intercellular adhesion molecule 1
K06494 SELE; selectin, endothelial cell
K06527 VCAM1; vascular cell adhesion molecule 1
K11987 PTGS2; prostaglandin-endoperoxide synthase 2 [EC:1.14.99.1]
K05141 TNFRSF1B; tumor necrosis factor receptor superfamily member 1B
K03174 TRAF3; TNF receptor-associated factor 3
K00922 PIK3C; phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
K00922 PIK3C; phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
K00922 PIK3C; phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
K00922 PIK3C; phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
K02649 PIK3R; phosphoinositide-3-kinase, regulatory subunit
K02649 PIK3R; phosphoinositide-3-kinase, regulatory subunit
K02649 PIK3R; phosphoinositide-3-kinase, regulatory subunit
K02649 PIK3R; phosphoinositide-3-kinase, regulatory subunit
K04456 AKT; RAC serine/threonine-protein kinase [EC:2.7.11.1]
K04456 AKT; RAC serine/threonine-protein kinase [EC:2.7.11.1]
K04456 AKT; RAC serine/threonine-protein kinase [EC:2.7.11.1]
K05629 AIP1; atrophin-1 interacting protein 1
K06052 JAGGED; jagged
K05506 CXCL5_6; C-X-C motif chemokine 5/6
K05449 VEGFC_D; vascular endothelial growth factor C/D
     04066 HIF-1 signaling pathway [PATH:hsa04066]
     04068 FoxO signaling pathway [PATH:hsa04068]
     04020 Calcium signaling pathway [PATH:hsa04020]
     04070 Phosphatidylinositol signaling system [PATH:hsa04070]
     04022 cGMP - PKG signaling pathway [PATH:hsa04022]
     04151 PI3K-Akt signaling pathway [PATH:hsa04151]
     04152 AMPK signaling pathway [PATH:hsa04152]
     04150 mTOR signaling pathway [PATH:hsa04150]
       3630 INS; insulin
       3479 IGF1; insulin-like growth factor 1 (somatomedin C)
       3667 IRS1; insulin receptor substrate 1
       5295 PIK3R1; phosphoinositide-3-kinase, regulatory subunit 1 (alpha)
       23533 PIK3R5; phosphoinositide-3-kinase, regulatory subunit 5
       5296 PIK3R2; phosphoinositide-3-kinase, regulatory subunit 2 (beta)
       8503 PIK3R3; phosphoinositide-3-kinase, regulatory subunit 3 (gamma)
       5290 PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha 
       5293 PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta 
       5291 PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta 
       5294 PIK3CG; phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma 
       5728 PTEN; phosphatase and tensin homolog 
       5170 PDPK1; 3-phosphoinositide dependent protein kinase 1 
       207 AKT1; v-akt murine thymoma viral oncogene homolog 1 
       208 AKT2; v-akt murine thymoma viral oncogene homolog 2 
       10000 AKT3; v-akt murine thymoma viral oncogene homolog 3 
       84335 AKT1S1; AKT1 substrate 1 (proline-rich)
       7248 TSC1; tuberous sclerosis 1
       7249 TSC2; tuberous sclerosis 2
       6009 RHEB; Ras homolog enriched in brain
       64223 MLST8; MTOR associated protein, LST8 homolog (S. cerevisiae)
       10670 RRAGA; Ras-related GTP binding A
       10325 RRAGB; Ras-related GTP binding B
       64121 RRAGC; Ras-related GTP binding C
       58528 RRAGD; Ras-related GTP binding D
       2475 MTOR; mechanistic target of rapamycin (serine/threonine kinase) 
       57521 RPTOR; regulatory associated protein of MTOR, complex 1
       253260 RICTOR; RPTOR independent companion of MTOR, complex 2
       3091 HIF1A; hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
       7422 VEGFA; vascular endothelial growth factor A
       6198 RPS6KB1; ribosomal protein S6 kinase, 70kDa, polypeptide 1 
       6199 RPS6KB2; ribosomal protein S6 kinase, 70kDa, polypeptide 2 
       1975 EIF4B; eukaryotic translation initiation factor 4B
       6194 RPS6; ribosomal protein S6
       1978 EIF4EBP1; eukaryotic translation initiation factor 4E binding protein 1
       1977 EIF4E; eukaryotic translation initiation factor 4E
       9470 EIF4E2; eukaryotic translation initiation factor 4E family member 2
       253314 EIF4E1B; eukaryotic translation initiation factor 4E family member 1B
       25989 ULK3; unc-51 like kinase 3 
       8408 ULK1; unc-51 like autophagy activating kinase 1 
       9706 ULK2; unc-51 like autophagy activating kinase 2 
       5594 MAPK1; mitogen-activated protein kinase 1 
       5595 MAPK3; mitogen-activated protein kinase 3 
       6197 RPS6KA3; ribosomal protein S6 kinase, 90kDa, polypeptide 3 
       6195 RPS6KA1; ribosomal protein S6 kinase, 90kDa, polypeptide 1 
       6196 RPS6KA2; ribosomal protein S6 kinase, 90kDa, polypeptide 2 
       27330 RPS6KA6; ribosomal protein S6 kinase, 90kDa, polypeptide 6 
       54541 DDIT4; DNA-damage-inducible transcript 4
       7124 TNF; tumor necrosis factor
       3551 IKBKB; inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta 
       6794 STK11; serine/threonine kinase 11 
       92335 STRADA; STE20-related kinase adaptor alpha
       51719 CAB39; calcium binding protein 39
       81617 CAB39L; calcium binding protein 39-like
       5562 PRKAA1; protein kinase, AMP-activated, alpha 1 catalytic subunit 
       5563 PRKAA2; protein kinase, AMP-activated, alpha 2 catalytic subunit 
       673 BRAF; v-raf murine sarcoma viral oncogene homolog B 
       5578 PRKCA; protein kinase C, alpha 
       5579 PRKCB; protein kinase C, beta 
       5582 PRKCG; protein kinase C, gamma 
K04526 INS; insulin
K05459 IGF1; insulin-like growth factor 1
K16172 IRS1; insulin receptor substrate 1
K02649 PIK3R; phosphoinositide-3-kinase, regulatory subunit
K02649 PIK3R; phosphoinositide-3-kinase, regulatory subunit
K02649 PIK3R; phosphoinositide-3-kinase, regulatory subunit
K02649 PIK3R; phosphoinositide-3-kinase, regulatory subunit
K00922 PIK3C; phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
K00922 PIK3C; phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
K00922 PIK3C; phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
K00922 PIK3C; phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
K01110 PTEN; phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN [EC:3.1.3.16 3.1.3.48 3.1.3.67]
K06276 PDPK1; 3-phosphoinositide dependent protein kinase-1 [EC:2.7.11.1]
K04456 AKT; RAC serine/threonine-protein kinase [EC:2.7.11.1]
K04456 AKT; RAC serine/threonine-protein kinase [EC:2.7.11.1]
K04456 AKT; RAC serine/threonine-protein kinase [EC:2.7.11.1]
K16184 AKT1S1; proline-rich AKT1 substrate 1
K07206 TSC1; tuberous sclerosis 1
K07207 TSC2; tuberous sclerosis 2
K07208 RHEB; Ras homolog enriched in brain
K08266 GBL; G protein beta subunit-like
K16185 RRAGA_B; Ras-related GTP-binding protein A/B
K16185 RRAGA_B; Ras-related GTP-binding protein A/B
K16186 RRAGC_D; Ras-related GTP-binding protein C/D
K16186 RRAGC_D; Ras-related GTP-binding protein C/D
K07203 FRAP; FKBP12-rapamycin complex-associated protein
K07204 RAPTOR; regulatory associated protein of mTOR
K08267 RICTOR; rapamycin-insensitive companion of mTOR
K08268 HIF1A; hypoxia-inducible factor 1 alpha
K05448 VEGFA; vascular endothelial growth factor A
K04688 RPS6KB; p70 ribosomal S6 kinase [EC:2.7.11.1]
K04688 RPS6KB; p70 ribosomal S6 kinase [EC:2.7.11.1]
K03258 EIF4B; translation initiation factor 4B
K02991 RP-S6e; small subunit ribosomal protein S6e
K07205 EIF4EBP1; eukaryotic translation initiation factor 4E binding protein 1
K03259 EIF4E; translation initiation factor 4E
K03259 EIF4E; translation initiation factor 4E
K03259 EIF4E; translation initiation factor 4E
K08269 ULK1_2_3; serine/threonine-protein kinase ULK/ATG1 [EC:2.7.11.1]
K08269 ULK1_2_3; serine/threonine-protein kinase ULK/ATG1 [EC:2.7.11.1]
K08269 ULK1_2_3; serine/threonine-protein kinase ULK/ATG1 [EC:2.7.11.1]
K04371 MAPK1_3; mitogen-activated protein kinase 1/3 [EC:2.7.11.24]
K04371 MAPK1_3; mitogen-activated protein kinase 1/3 [EC:2.7.11.24]
K04373 RPS6KA; p90 ribosomal S6 kinase [EC:2.7.11.1]
K04373 RPS6KA; p90 ribosomal S6 kinase [EC:2.7.11.1]
K04373 RPS6KA; p90 ribosomal S6 kinase [EC:2.7.11.1]
K04373 RPS6KA; p90 ribosomal S6 kinase [EC:2.7.11.1]
K08270 DDIT4; DNA-damage-inducible transcript 4
K03156 TNFA; tumor necrosis factor superfamily, member 2
K07209 IKBKB; inhibitor of nuclear factor kappa-B kinase subunit beta [EC:2.7.11.10]
K07298 STK11; serine/threonine-protein kinase 11
K08271 STRADA; STE20-related kinase adapter protein alpha
K08272 CAB39; calcium binding protein 39
K08272 CAB39; calcium binding protein 39
K07198 PRKAA; 5'-AMP-activated protein kinase, catalytic alpha subunit [EC:2.7.11.11]
K07198 PRKAA; 5'-AMP-activated protein kinase, catalytic alpha subunit [EC:2.7.11.11]
K04365 BRAF; B-Raf proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1]
K02677 CPKC; classical protein kinase C [EC:2.7.11.13]
K02677 CPKC; classical protein kinase C [EC:2.7.11.13]
K02677 CPKC; classical protein kinase C [EC:2.7.11.13]
     04075 Plant hormone signal transduction
 
   Signaling molecules and interaction
     04030 G protein-coupled receptors [BR:hsa04030]
     01020 Enzyme-linked receptors [BR:hsa01020]
     04050 Cytokine receptors [BR:hsa04050]
     03310 Nuclear receptors [BR:hsa03310]
     04040 Ion channels [BR:hsa04040]
     04031 GTP-binding proteins [BR:hsa04031]
     04080 Neuroactive ligand-receptor interaction [PATH:hsa04080]
     04060 Cytokine-cytokine receptor interaction [PATH:hsa04060]
       2919 CXCL1; chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha)
       2920 CXCL2; chemokine (C-X-C motif) ligand 2
       2921 CXCL3; chemokine (C-X-C motif) ligand 3
       6374 CXCL5; chemokine (C-X-C motif) ligand 5
       6372 CXCL6; chemokine (C-X-C motif) ligand 6
       5473 PPBP; pro-platelet basic protein (chemokine (C-X-C motif) ligand 7)
       3576 CXCL8; chemokine (C-X-C motif) ligand 8
       4283 CXCL9; chemokine (C-X-C motif) ligand 9
       3627 CXCL10; chemokine (C-X-C motif) ligand 10
       6373 CXCL11; chemokine (C-X-C motif) ligand 11
       6387 CXCL12; chemokine (C-X-C motif) ligand 12
       10563 CXCL13; chemokine (C-X-C motif) ligand 13
       58191 CXCL16; chemokine (C-X-C motif) ligand 16
       5196 PF4; platelet factor 4
       5197 PF4V1; platelet factor 4 variant 1
       9547 CXCL14; chemokine (C-X-C motif) ligand 14
       6375 XCL1; chemokine (C motif) ligand 1
       6846 XCL2; chemokine (C motif) ligand 2
       6376 CX3CL1; chemokine (C-X3-C motif) ligand 1
       6346 CCL1; chemokine (C-C motif) ligand 1
       6358 CCL14; chemokine (C-C motif) ligand 14
       6360 CCL16; chemokine (C-C motif) ligand 16
       6361 CCL17; chemokine (C-C motif) ligand 17
       6362 CCL18; chemokine (C-C motif) ligand 18 (pulmonary and activation-regulated)
       6367 CCL22; chemokine (C-C motif) ligand 22
       6369 CCL24; chemokine (C-C motif) ligand 24
       10344 CCL26; chemokine (C-C motif) ligand 26
       6364 CCL20; chemokine (C-C motif) ligand 20
       6370 CCL25; chemokine (C-C motif) ligand 25
       6363 CCL19; chemokine (C-C motif) ligand 19
       6366 CCL21; chemokine (C-C motif) ligand 21
       6347 CCL2; chemokine (C-C motif) ligand 2
       6351 CCL4; chemokine (C-C motif) ligand 4
       9560 CCL4L2; chemokine (C-C motif) ligand 4-like 2
       388372 CCL4L1; chemokine (C-C motif) ligand 4-like 1
       6348 CCL3; chemokine (C-C motif) ligand 3
       6349 CCL3L1; chemokine (C-C motif) ligand 3-like 1
       414062 CCL3L3; chemokine (C-C motif) ligand 3-like 3
       6357 CCL13; chemokine (C-C motif) ligand 13
       6354 CCL7; chemokine (C-C motif) ligand 7
       6352 CCL5; chemokine (C-C motif) ligand 5
       6359 CCL15; chemokine (C-C motif) ligand 15
       6368 CCL23; chemokine (C-C motif) ligand 23
       6355 CCL8; chemokine (C-C motif) ligand 8
       6356 CCL11; chemokine (C-C motif) ligand 11
       56477 CCL28; chemokine (C-C motif) ligand 28
       10850 CCL27; chemokine (C-C motif) ligand 27
       3569 IL6; interleukin 6
       3589 IL11; interleukin 11
       5008 OSM; oncostatin M
       3976 LIF; leukemia inhibitory factor
       1270 CNTF; ciliary neurotrophic factor
       23529 CLCF1; cardiotrophin-like cytokine factor 1
       1489 CTF1; cardiotrophin 1
       1440 CSF3; colony stimulating factor 3 (granulocyte)
       3952 LEP; leptin
       3565 IL4; interleukin 4
       3596 IL13; interleukin 13
       3592 IL12A; interleukin 12A
       3593 IL12B; interleukin 12B
       51561 IL23A; interleukin 23, alpha subunit p19
       1437 CSF2; colony stimulating factor 2 (granulocyte-macrophage)
       3562 IL3; interleukin 3
       3567 IL5; interleukin 5
       3558 IL2; interleukin 2
       3574 IL7; interleukin 7
       3578 IL9; interleukin 9
       3600 IL15; interleukin 15
       59067 IL21; interleukin 21
       85480 TSLP; thymic stromal lymphopoietin
       2056 EPO; erythropoietin
       2688 GH1; growth hormone 1
       2689 GH2; growth hormone 2
       1442 CSH1; chorionic somatomammotropin hormone 1 (placental lactogen)
       1443 CSH2; chorionic somatomammotropin hormone 2
       5617 PRL; prolactin
       7173 TPO; thyroid peroxidase 
       56034 PDGFC; platelet derived growth factor C
       80310 PDGFD; platelet derived growth factor D
       5154 PDGFA; platelet-derived growth factor alpha polypeptide
       5155 PDGFB; platelet-derived growth factor beta polypeptide
       7422 VEGFA; vascular endothelial growth factor A
       7423 VEGFB; vascular endothelial growth factor B
       7424 VEGFC; vascular endothelial growth factor C
       2277 FIGF; c-fos induced growth factor (vascular endothelial growth factor D)
       3082 HGF; hepatocyte growth factor (hepapoietin A; scatter factor)
       1950 EGF; epidermal growth factor
       1435 CSF1; colony stimulating factor 1 (macrophage) 
       4254 KITLG; KIT ligand
       2323 FLT3LG; fms-related tyrosine kinase 3 ligand
       3439 IFNA1; interferon, alpha 1
       3440 IFNA2; interferon, alpha 2
       3441 IFNA4; interferon, alpha 4
       3442 IFNA5; interferon, alpha 5
       3443 IFNA6; interferon, alpha 6
       3444 IFNA7; interferon, alpha 7
       3445 IFNA8; interferon, alpha 8
       3446 IFNA10; interferon, alpha 10
       3447 IFNA13; interferon, alpha 13
       3448 IFNA14; interferon, alpha 14
       3449 IFNA16; interferon, alpha 16
       3451 IFNA17; interferon, alpha 17
       3452 IFNA21; interferon, alpha 21
       3456 IFNB1; interferon, beta 1, fibroblast
       3467 IFNW1; interferon, omega 1
       56832 IFNK; interferon, kappa
       338376 IFNE; interferon, epsilon
       3458 IFNG; interferon, gamma
       3586 IL10; interleukin 10
       29949 IL19; interleukin 19
       50604 IL20; interleukin 20
       11009 IL24; interleukin 24
       50616 IL22; interleukin 22
       282616 IFNL2; interferon, lambda 2
       282617 IFNL3; interferon, lambda 3
       282618 IFNL1; interferon, lambda 1
       55801 IL26; interleukin 26
       9966 TNFSF15; tumor necrosis factor (ligand) superfamily, member 15
       8743 TNFSF10; tumor necrosis factor (ligand) superfamily, member 10
       8600 TNFSF11; tumor necrosis factor (ligand) superfamily, member 11
       8742 TNFSF12; tumor necrosis factor (ligand) superfamily, member 12
       7124 TNF; tumor necrosis factor
       4049 LTA; lymphotoxin alpha
       4050 LTB; lymphotoxin beta (TNF superfamily, member 3)
       8740 TNFSF14; tumor necrosis factor (ligand) superfamily, member 14
       356 FASLG; Fas ligand (TNF superfamily, member 6)
       959 CD40LG; CD40 ligand
       970 CD70; CD70 molecule
       944 TNFSF8; tumor necrosis factor (ligand) superfamily, member 8
       8744 TNFSF9; tumor necrosis factor (ligand) superfamily, member 9
       7292 TNFSF4; tumor necrosis factor (ligand) superfamily, member 4
       8995 TNFSF18; tumor necrosis factor (ligand) superfamily, member 18
       8741 TNFSF13; tumor necrosis factor (ligand) superfamily, member 13
       10673 TNFSF13B; tumor necrosis factor (ligand) superfamily, member 13b
       1896 EDA; ectodysplasin A
       7040 TGFB1; transforming growth factor, beta 1
       7042 TGFB2; transforming growth factor, beta 2
       7043 TGFB3; transforming growth factor, beta 3
       3624 INHBA; inhibin, beta A
       3625 INHBB; inhibin, beta B
       3626 INHBC; inhibin, beta C
       83729 INHBE; inhibin, beta E
       268 AMH; anti-Mullerian hormone
       650 BMP2; bone morphogenetic protein 2
       652 BMP4; bone morphogenetic protein 4
       655 BMP7; bone morphogenetic protein 7
       151449 GDF7; growth differentiation factor 7
       8200 GDF5; growth differentiation factor 5
       392255 GDF6; growth differentiation factor 6
       3605 IL17A; interleukin 17A
       27190 IL17B; interleukin 17B
       64806 IL25; interleukin 25
       3552 IL1A; interleukin 1, alpha
       3553 IL1B; interleukin 1, beta
       3606 IL18; interleukin 18
       3579 CXCR2; chemokine (C-X-C motif) receptor 2
       3577 CXCR1; chemokine (C-X-C motif) receptor 1
       2833 CXCR3; chemokine (C-X-C motif) receptor 3
       7852 CXCR4; chemokine (C-X-C motif) receptor 4
       643 CXCR5; chemokine (C-X-C motif) receptor 5
       10663 CXCR6; chemokine (C-X-C motif) receptor 6
       57007 ACKR3; atypical chemokine receptor 3
       2829 XCR1; chemokine (C motif) receptor 1
       1524 CX3CR1; chemokine (C-X3-C motif) receptor 1
       1237 CCR8; chemokine (C-C motif) receptor 8
       1235 CCR6; chemokine (C-C motif) receptor 6
       10803 CCR9; chemokine (C-C motif) receptor 9
       1233 CCR4; chemokine (C-C motif) receptor 4
       1236 CCR7; chemokine (C-C motif) receptor 7
       729230 CCR2; chemokine (C-C motif) receptor 2
       1234 CCR5; chemokine (C-C motif) receptor 5 (gene/pseudogene)
       1230 CCR1; chemokine (C-C motif) receptor 1
       1232 CCR3; chemokine (C-C motif) receptor 3
       2826 CCR10; chemokine (C-C motif) receptor 10
       3570 IL6R; interleukin 6 receptor
       3572 IL6ST; interleukin 6 signal transducer
       3590 IL11RA; interleukin 11 receptor, alpha
       3977 LIFR; leukemia inhibitory factor receptor alpha
       9180 OSMR; oncostatin M receptor
       1271 CNTFR; ciliary neurotrophic factor receptor
       1441 CSF3R; colony stimulating factor 3 receptor (granulocyte)
       3953 LEPR; leptin receptor
       3566 IL4R; interleukin 4 receptor
       3597 IL13RA1; interleukin 13 receptor, alpha 1
       3594 IL12RB1; interleukin 12 receptor, beta 1
       3595 IL12RB2; interleukin 12 receptor, beta 2
       149233 IL23R; interleukin 23 receptor
       1438 CSF2RA; colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage)
       1439 CSF2RB; colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage)
       3563 IL3RA; interleukin 3 receptor, alpha (low affinity)
       3568 IL5RA; interleukin 5 receptor, alpha
       3559 IL2RA; interleukin 2 receptor, alpha
       3560 IL2RB; interleukin 2 receptor, beta
       3561 IL2RG; interleukin 2 receptor, gamma
       3575 IL7R; interleukin 7 receptor
       3581 IL9R; interleukin 9 receptor
       3601 IL15RA; interleukin 15 receptor, alpha
       50615 IL21R; interleukin 21 receptor
       64109 CRLF2; cytokine receptor-like factor 2
       2057 EPOR; erythropoietin receptor
       2690 GHR; growth hormone receptor
       5618 PRLR; prolactin receptor
       4352 MPL; myeloproliferative leukemia virus oncogene
       5156 PDGFRA; platelet-derived growth factor receptor, alpha polypeptide 
       5159 PDGFRB; platelet-derived growth factor receptor, beta polypeptide 
       2321 FLT1; fms-related tyrosine kinase 1 
       3791 KDR; kinase insert domain receptor (a type III receptor tyrosine kinase) 
       2324 FLT4; fms-related tyrosine kinase 4 
       4233 MET; met proto-oncogene 
       1956 EGFR; epidermal growth factor receptor 
       1436 CSF1R; colony stimulating factor 1 receptor 
       3815 KIT; v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog 
       2322 FLT3; fms-related tyrosine kinase 3 
       3454 IFNAR1; interferon (alpha, beta and omega) receptor 1
       3455 IFNAR2; interferon (alpha, beta and omega) receptor 2
       3459 IFNGR1; interferon gamma receptor 1
       3460 IFNGR2; interferon gamma receptor 2 (interferon gamma transducer 1)
       3587 IL10RA; interleukin 10 receptor, alpha
       3588 IL10RB; interleukin 10 receptor, beta
       53832 IL20RA; interleukin 20 receptor, alpha
       53833 IL20RB; interleukin 20 receptor beta
       58985 IL22RA1; interleukin 22 receptor, alpha 1
       116379 IL22RA2; interleukin 22 receptor, alpha 2
       163702 IFNLR1; interferon, lambda receptor 1
       8797 TNFRSF10A; tumor necrosis factor receptor superfamily, member 10a
       8795 TNFRSF10B; tumor necrosis factor receptor superfamily, member 10b
       8794 TNFRSF10C; tumor necrosis factor receptor superfamily, member 10c, decoy without an intracellular domain
       8793 TNFRSF10D; tumor necrosis factor receptor superfamily, member 10d, decoy with truncated death domain
       4982 TNFRSF11B; tumor necrosis factor receptor superfamily, member 11b
       8792 TNFRSF11A; tumor necrosis factor receptor superfamily, member 11a, NFKB activator
       8718 TNFRSF25; tumor necrosis factor receptor superfamily, member 25
       51330 TNFRSF12A; tumor necrosis factor receptor superfamily, member 12A
       27242 TNFRSF21; tumor necrosis factor receptor superfamily, member 21
       4804 NGFR; nerve growth factor receptor
       7133 TNFRSF1B; tumor necrosis factor receptor superfamily, member 1B
       7132 TNFRSF1A; tumor necrosis factor receptor superfamily, member 1A
       4055 LTBR; lymphotoxin beta receptor (TNFR superfamily, member 3)
       8764 TNFRSF14; tumor necrosis factor receptor superfamily, member 14
       8771 TNFRSF6B; tumor necrosis factor receptor superfamily, member 6b, decoy
       355 FAS; Fas cell surface death receptor
       958 CD40; CD40 molecule, TNF receptor superfamily member 5
       939 CD27; CD27 molecule
       943 TNFRSF8; tumor necrosis factor receptor superfamily, member 8
       3604 TNFRSF9; tumor necrosis factor receptor superfamily, member 9
       7293 TNFRSF4; tumor necrosis factor receptor superfamily, member 4
       8784 TNFRSF18; tumor necrosis factor receptor superfamily, member 18
       608 TNFRSF17; tumor necrosis factor receptor superfamily, member 17
       23495 TNFRSF13B; tumor necrosis factor receptor superfamily, member 13B
       115650 TNFRSF13C; tumor necrosis factor receptor superfamily, member 13C
       10913 EDAR; ectodysplasin A receptor
       60401 EDA2R; ectodysplasin A2 receptor
       55504 TNFRSF19; tumor necrosis factor receptor superfamily, member 19
       84957 RELT; RELT tumor necrosis factor receptor
       7048 TGFBR2; transforming growth factor, beta receptor II (70/80kDa) 
       7046 TGFBR1; transforming growth factor, beta receptor 1 
       92 ACVR2A; activin A receptor, type IIA 
       93 ACVR2B; activin A receptor, type IIB 
       90 ACVR1; activin A receptor, type I 
       91 ACVR1B; activin A receptor, type IB 
       269 AMHR2; anti-Mullerian hormone receptor, type II 
       659 BMPR2; bone morphogenetic protein receptor, type II (serine/threonine kinase) 
       657 BMPR1A; bone morphogenetic protein receptor, type IA 
       658 BMPR1B; bone morphogenetic protein receptor, type IB 
       23765 IL17RA; interleukin 17 receptor A
       55540 IL17RB; interleukin 17 receptor B
       3554 IL1R1; interleukin 1 receptor, type I
       3556 IL1RAP; interleukin 1 receptor accessory protein
       7850 IL1R2; interleukin 1 receptor, type II
       8809 IL18R1; interleukin 18 receptor 1
       8807 IL18RAP; interleukin 18 receptor accessory protein
       80301 PLEKHO2; pleckstrin homology domain containing, family O member 2
K05505 CXCL1_2_3; C-X-C motif chemokine 1/2/3
K05505 CXCL1_2_3; C-X-C motif chemokine 1/2/3
K05505 CXCL1_2_3; C-X-C motif chemokine 1/2/3
K05506 CXCL5_6; C-X-C motif chemokine 5/6
K05506 CXCL5_6; C-X-C motif chemokine 5/6
K10029 PPBP; platelet basic protein
K10030 IL8; interleukin 8
K05416 CXCL9; C-X-C motif chemokine 9
K12671 CXCL10; C-X-C motif chemokine 10
K12672 CXCL11; C-X-C motif chemokine 11
K10031 CXCL12; C-X-C motif chemokine 12
K10032 CXCL13; C-X-C motif chemokine 13
K10035 CXCL16; C-X-C motif chemokine 16
K05407 PF4; platelet factor 4
K05407 PF4; platelet factor 4
K10033 CXCL14; C-X-C motif chemokine 14
K05507 XCL; C motif chemokine 1/2
K05507 XCL; C motif chemokine 1/2
K05508 CX3CL1; C-X3-C motif chemokine 1
K05514 CCLX; C-C motif chemokine, other
K05514 CCLX; C-C motif chemokine, other
K05514 CCLX; C-C motif chemokine, other
K05514 CCLX; C-C motif chemokine, other
K05514 CCLX; C-C motif chemokine, other
K05514 CCLX; C-C motif chemokine, other
K05514 CCLX; C-C motif chemokine, other
K05514 CCLX; C-C motif chemokine, other
K14625 CCL20; C-C motif chemokine 20
K13072 CCL25; C-C motif chemokine 25
K05512 CCL19; C-C motif chemokine 19
K16062 CCL21; C-C motif chemokine 21
K14624 CCL2; C-C motif chemokine 2
K12964 CCL4; C-C motif chemokine 4
K12964 CCL4; C-C motif chemokine 4
K12964 CCL4; C-C motif chemokine 4
K05408 CCL3; C-C motif chemokine 3
K05408 CCL3; C-C motif chemokine 3
K05408 CCL3; C-C motif chemokine 3
K16595 CCL13; C-C motif chemokine 13
K05509 CCL7; C-C motif chemokine 7
K12499 CCL5; C-C motif chemokine 5
K05511 CCL15_23; C-C motif chemokine 15/23
K05511 CCL15_23; C-C motif chemokine 15/23
K16596 CCL8; C-C motif chemokine 8
K16597 CCL11; C-C motif chemokine 11
K05513 CCL28; C-C motif chemokine 28
K16598 CCL27; C-C motif chemokine 27
K05405 IL6; interleukin 6
K05417 IL11; interleukin 11
K05418 OSM; oncostatin M
K05419 LIF; leukemia inhibitory factor
K05420 CNTF; ciliary neurotrophic factor
K05421 BSF3; B-cell stimulating factor 3
K05422 CTF1; cardiotrophin 1
K05423 CSF3; granulocyte colony-stimulating factor
K05424 LEP; leptin
K05430 IL4; interleukin 4
K05435 IL13; interleukin 13
K05406 IL12A; interleukin 12A
K05425 IL12B; interleukin 12B
K05426 IL23A; interleukin 23, alpha subunit p19
K05427 CSF2; granulocyte-macrophage colony-stimulating factor
K04736 IL3; interleukin 3
K05428 IL5; interleukin 5
K05429 IL2; interleukin 2
K05431 IL7; interleukin 7
K05432 IL9; interleukin 9
K05433 IL15; interleukin 15
K05434 IL21; interleukin 21
K05436 TSLP; thymic stromal lymphopoietin
K05437 EPO; erythropoietin
K05438 GH; growth hormone
K05438 GH; growth hormone
K05438 GH; growth hormone
K05438 GH; growth hormone
K05439 PRL; prolactin
K00431 TPO; thyroid peroxidase [EC:1.11.1.8]
K05450 PDGFC_D; platelet derived growth factor C/D
K05450 PDGFC_D; platelet derived growth factor C/D
K04359 PDGFA; platelet-derived growth factor subunit A
K17386 PDGFB; platelet-derived growth factor subunit B
K05448 VEGFA; vascular endothelial growth factor A
K16858 VEGFB; vascular endothelial growth factor B
K05449 VEGFC_D; vascular endothelial growth factor C/D
K05449 VEGFC_D; vascular endothelial growth factor C/D
K05460 HGF; hepatocyte growth factor
K04357 EGF; epidermal growth factor
K05453 CSF1; macrophage colony-stimulating factor 1
K05461 KITLG; KIT ligand
K05454 FLT3LG; fms-related tyrosine kinase 3 ligand
K05414 IFNA; interferon alpha
K05414 IFNA; interferon alpha
K05414 IFNA; interferon alpha
K05414 IFNA; interferon alpha
K05414 IFNA; interferon alpha
K05414 IFNA; interferon alpha
K05414 IFNA; interferon alpha
K05414 IFNA; interferon alpha
K05414 IFNA; interferon alpha
K05414 IFNA; interferon alpha
K05414 IFNA; interferon alpha
K05414 IFNA; interferon alpha
K05414 IFNA; interferon alpha
K05415 IFNB; interferon beta
K05440 IFNW1; interferon, omega 1
K05441 IFNK; interferon, kappa
K05442 IFNT1; interferon, tau-1
K04687 IFNG; interferon gamma
K05443 IL10; interleukin 10
K05444 IL19_20_24; interleukin 19/20/24
K05444 IL19_20_24; interleukin 19/20/24
K05444 IL19_20_24; interleukin 19/20/24
K05445 IL22; interleukin 22
K05447 IL28_29; interleukin 28/29 (interferon, lambda)
K05447 IL28_29; interleukin 28/29 (interferon, lambda)
K05447 IL28_29; interleukin 28/29 (interferon, lambda)
K05446 IL26; interleukin 26
K05478 TNFSF15; tumor necrosis factor ligand superfamily member 15
K04721 TNFSF10; tumor necrosis factor ligand superfamily member 10
K05473 TNFSF11; tumor necrosis factor ligand superfamily member 11
K05474 TNFSF12; tumor necrosis factor ligand superfamily member 12
K03156 TNFA; tumor necrosis factor superfamily, member 2
K05468 LTA; lymphotoxin alpha (TNF superfamily, member 1)
K03157 LTB; lymphotoxin beta (TNF superfamily, member 3)
K05477 TNFSF14; tumor necrosis factor ligand superfamily member 14
K04389 TNFSF6; tumor necrosis factor ligand superfamily member 6
K03161 TNFSF5; tumor necrosis factor ligand superfamily member 5
K05470 TNFSF7; tumor necrosis factor ligand superfamily member 7
K05471 TNFSF8; tumor necrosis factor ligand superfamily member 8
K05472 TNFSF9; tumor necrosis factor ligand superfamily member 9
K05469 TNFSF4; tumor necrosis factor ligand superfamily member 4
K05479 TNFSF18; tumor necrosis factor ligand superfamily member 18
K05475 TNFSF13; tumor necrosis factor ligand superfamily member 13
K05476 TNFSF13B; tumor necrosis factor ligand superfamily member 13B
K05480 EDA; ectodysplasin-A
K13375 TGFB1; transforming growth factor beta-1
K13376 TGFB2; transforming growth factor beta-2
K13377 TGFB3; transforming growth factor beta-3
K04667 INHB; inhibin, beta
K04667 INHB; inhibin, beta
K04667 INHB; inhibin, beta
K04667 INHB; inhibin, beta
K04665 AMH; anti-mullerian hormone
K04662 BMP2_4; bone morphogenetic protein 2/4
K04662 BMP2_4; bone morphogenetic protein 2/4
K16621 BMP7; bone morphogenetic protein 7
K04664 GDF5_6_7; growth differentiation factor 5/6/7
K04664 GDF5_6_7; growth differentiation factor 5/6/7
K04664 GDF5_6_7; growth differentiation factor 5/6/7
K05489 IL17; interleukin 17
K05490 IL17B; interleukin 17B
K05493 IL17E; interleukin 17E
K04383 IL1A; interleukin 1 alpha
K04519 IL1B; interleukin 1 beta
K05482 IL18; interleukin 18
K05050 IL8RB; interleukin 8 receptor beta
K04175 IL8RA; interleukin 8 receptor alpha
K04188 CXCR3; C-X-C chemokine receptor type 3
K04189 CXCR4; C-X-C chemokine receptor type 4
K04190 CXCR5; C-X-C chemokine receptor type 5
K04191 CXCR6; C-X-C chemokine receptor type 6
K04304 CXCR7; C-X-C chemokine receptor type 7
K04193 XCR1; XC chemokine receptor 1
K04192 CX3CR1; CX3C chemokine receptor 1
K04183 CCR8; C-C chemokine receptor type 8
K04181 CCR6; C-C chemokine receptor type 6
K04184 CCR9; C-C chemokine receptor type 9
K04179 CCR4; C-C chemokine receptor type 4
K04182 CCR7; C-C chemokine receptor type 7
K04177 CCR2; C-C chemokine receptor type 2
K04180 CCR5; C-C chemokine receptor type 5
K04176 CCR1; C-C chemokine receptor type 1
K04178 CCR3; C-C chemokine receptor type 3
K04185 CCR10; C-C chemokine receptor type 10
K05055 IL6R; interleukin 6 receptor
K05060 IL6ST; interleukin 6 signal transducer
K05056 IL11RA; interleukin 11 receptor alpha
K05058 LIFR; leukemia inhibitory factor receptor
K05057 OSMR; oncostatin M receptor
K05059 CNTFR; ciliary neurotrophic factor receptor
K05061 CSF3R; granulocyte colony-stimulating factor receptor
K05062 LEPR; leptin receptor
K05071 IL4R; interleukin 4 receptor
K05076 IL13RA1; interleukin 13 receptor alpha-1
K05063 IL12RB1; interleukin 12 receptor beta-1
K05064 IL12RB2; interleukin 12 receptor beta-2
K05065 IL23R; interleukin 23 receptor
K05066 CSF2RA; granulocyte-macrophage colony-stimulating factor receptor alpha
K04738 CSF2RB; cytokine receptor common subunit beta
K04737 IL3RA; interleukin 3 receptor alpha
K05067 IL5RA; interleukin 5 receptor alpha
K05068 IL2RA; interleukin 2 receptor alpha
K05069 IL2RB; interleukin 2 receptor beta
K05070 IL2RG; interleukin 2 receptor gamma
K05072 IL7R; interleukin 7 receptor
K05073 IL9R; interleukin 9 receptor
K05074 IL15RA; interleukin 15 receptor alpha
K05075 IL21R; interleukin 21 receptor
K05078 TSLPR; thymic stromal-derived lymphopoietin receptor
K05079 EPOR; erythropoietin receptor
K05080 GHR; growth hormone receptor
K05081 PRLR; prolactin receptor
K05082 TPOR; thrombopoietin receptor
K04363 PDGFRA; platelet-derived growth factor receptor alpha [EC:2.7.10.1]
K05089 PDGFRB; platelet-derived growth factor receptor beta [EC:2.7.10.1]
K05096 FLT1; FMS-like tyrosine kinase 1 [EC:2.7.10.1]
K05098 KDR; kinase insert domain protein receptor [EC:2.7.10.1]
K05097 FLT4; FMS-like tyrosine kinase 4 [EC:2.7.10.1]
K05099 MET; proto-oncogene tyrosine-protein kinase Met [EC:2.7.10.1]
K04361 EGFR; epidermal growth factor receptor [EC:2.7.10.1]
K05090 CSF1R; macrophage colony-stimulating factor 1 receptor [EC:2.7.10.1]
K05091 KIT; proto-oncogene tyrosine-protein kinase Kit [EC:2.7.10.1]
K05092 FLT3; fms-related tyrosine kinase 3 [EC:2.7.10.1]
K05130 IFNAR1; interferon receptor 1
K05131 IFNAR2; interferon receptor 2
K05132 IFNGR1; interferon gamma receptor 1
K05133 IFNGR2; interferon gamma receptor 2
K05134 IL10RA; interleukin 10 receptor alpha
K05135 IL10RB; interleukin 10 receptor beta
K05136 IL20RA; interleukin 20 receptor alpha
K05137 IL20RB; interleukin 20 receptor beta
K05138 IL22RA1; interleukin 22 receptor alpha 1
K05139 IL22RA2; interleukin 22 receptor alpha 2
K05140 IL28RA; interleukin 28 receptor alpha
K04722 TNFRSF10; tumor necrosis factor receptor superfamily member 10
K04722 TNFRSF10; tumor necrosis factor receptor superfamily member 10
K04722 TNFRSF10; tumor necrosis factor receptor superfamily member 10
K04722 TNFRSF10; tumor necrosis factor receptor superfamily member 10
K05148 TNFRSF11B; tumor necrosis factor receptor superfamily member 11B
K05147 TNFRSF11A; tumor necrosis factor receptor superfamily member 11A
K05160 TNFRSF25; tumor necrosis factor receptor superfamily member 25
K05149 TNFRSF12A; tumor necrosis factor receptor superfamily member 12A
K05157 TNFRSF21; tumor necrosis factor receptor superfamily member 21
K02583 NGFR; nerve growth factor receptor (TNFR superfamily member 16)
K05141 TNFRSF1B; tumor necrosis factor receptor superfamily member 1B
K03158 TNFRSF1A; tumor necrosis factor receptor superfamily member 1A
K03159 TNFRSF3; lymphotoxin beta receptor TNFR superfamily member 3
K05152 TNFRSF14; tumor necrosis factor receptor superfamily member 14
K05143 TNFRSF6B; tumor necrosis factor receptor superfamily member 6B
K04390 TNFRSF6; tumor necrosis factor receptor superfamily member 6
K03160 TNFRSF5; tumor necrosis factor receptor superfamily member 5
K05144 TNFRSF7; tumor necrosis factor receptor superfamily member 7
K05145 TNFRSF8; tumor necrosis factor receptor superfamily member 8
K05146 TNFRSF9; tumor necrosis factor receptor superfamily member 9
K05142 TNFRSF4; tumor necrosis factor receptor superfamily member 4
K05154 TNFRSF18; tumor necrosis factor receptor superfamily member 18
K05153 TNFRSF17; tumor necrosis factor receptor superfamily member 17
K05150 TNFRSF13B; tumor necrosis factor receptor superfamily member 13B
K05151 TNFRSF13C; tumor necrosis factor receptor superfamily member 13C
K05162 EDAR; tumor necrosis factor receptor superfamily member EDAR
K05163 EDA2R; tumor necrosis factor receptor superfamily member 27
K05155 TNFRSF19; tumor necrosis factor receptor superfamily member 19
K05156 TNFRSF19L; tumor necrosis factor receptor superfamily member 19-like
K04388 TGFBR2; TGF-beta receptor type-2 [EC:2.7.11.30]
K04674 TGFBR1; TGF-beta receptor type-1 [EC:2.7.11.30]
K04670 ACVR2A; activin receptor type-2A [EC:2.7.11.30]
K13596 ACVR2B; activin receptor type-2B [EC:2.7.11.30]
K04675 ACVR1; activin receptor type-1 [EC:2.7.11.30]
K13567 ACVR1B; activin receptor type-1B [EC:2.7.11.30]
K04672 AMHR2; anti-mullerian hormone receptor type-2 [EC:2.7.11.30]
K04671 BMPR2; bone morphogenetic protein receptor type-2 [EC:2.7.11.30]
K04673 BMPR1A; bone morphogenetic protein receptor type-1A [EC:2.7.11.30]
K13578 BMPR1B; bone morphogenetic protein receptor type-1B [EC:2.7.11.30]
K05164 IL17R; interleukin 17 receptor
K05165 IL17RB; interleukin 17 receptor B
K04386 IL1R1; interleukin 1 receptor type I
K04723 IL1RAP; interleukin 1 receptor accessory protein
K04387 IL1R2; interleukin 1 receptor type II
K05173 IL18R1; interleukin 18 receptor 1
K05174 IL18RAP; interleukin 18 receptor accessory protein
 
     04052 Cytokines [BR:hsa04052]
     04512 ECM-receptor interaction [PATH:hsa04512]
     04514 Cell adhesion molecules (CAMs) [PATH:hsa04514]
     04516 Cell adhesion molecules and their ligands [BR:hsa04516]
     04090 CD Molecules [BR:hsa04090]
     04091 Lectins [BR:hsa04091]
     02042 Bacterial toxins [BR:hsa02042]
 
 Cellular Processes
 
   Transport and catabolism
 
   Cell motility
 
   Cell growth and death
     04110 Cell cycle [PATH:hsa04110]
     04111 Cell cycle - yeast
     04112 Cell cycle - Caulobacter
     04113 Meiosis - yeast
     04114 Oocyte meiosis [PATH:hsa04114]
     04210 Apoptosis [PATH:hsa04210]
       356 FASLG; Fas ligand (TNF superfamily, member 6)
       355 FAS; Fas cell surface death receptor
       8743 TNFSF10; tumor necrosis factor (ligand) superfamily, member 10
       8797 TNFRSF10A; tumor necrosis factor receptor superfamily, member 10a
       8795 TNFRSF10B; tumor necrosis factor receptor superfamily, member 10b
       8794 TNFRSF10C; tumor necrosis factor receptor superfamily, member 10c, decoy without an intracellular domain
       8793 TNFRSF10D; tumor necrosis factor receptor superfamily, member 10d, decoy with truncated death domain
       7124 TNF; tumor necrosis factor
       7132 TNFRSF1A; tumor necrosis factor receptor superfamily, member 1A
       3552 IL1A; interleukin 1, alpha
       3553 IL1B; interleukin 1, beta
       3554 IL1R1; interleukin 1 receptor, type I
       3556 IL1RAP; interleukin 1 receptor accessory protein
       8772 FADD; Fas (TNFRSF6)-associated via death domain
       8717 TRADD; TNFRSF1A-associated via death domain
       8837 CFLAR; CASP8 and FADD-like apoptosis regulator
       843 CASP10; caspase 10, apoptosis-related cysteine peptidase 
       841 CASP8; caspase 8, apoptosis-related cysteine peptidase 
       836 CASP3; caspase 3, apoptosis-related cysteine peptidase 
       840 CASP7; caspase 7, apoptosis-related cysteine peptidase 
       839 CASP6; caspase 6, apoptosis-related cysteine peptidase 
       329 BIRC2; baculoviral IAP repeat containing 2
       330 BIRC3; baculoviral IAP repeat containing 3
       331 XIAP; X-linked inhibitor of apoptosis
       79444 BIRC7; baculoviral IAP repeat containing 7
       112401 BIRC8; baculoviral IAP repeat containing 8
       637 BID; BH3 interacting domain death agonist
       596 BCL2; B-cell CLL/lymphoma 2
       598 BCL2L1; BCL2-like 1
       54205 CYCS; cytochrome c, somatic
       317 APAF1; apoptotic peptidase activating factor 1
       842 CASP9; caspase 9, apoptosis-related cysteine peptidase 
       1676 DFFA; DNA fragmentation factor, 45kDa, alpha polypeptide
       1677 DFFB; DNA fragmentation factor, 40kDa, beta polypeptide (caspase-activated DNase)
       9131 AIFM1; apoptosis-inducing factor, mitochondrion-associated, 1
       2021 ENDOG; endonuclease G
       472 ATM; ataxia telangiectasia mutated 
       7157 TP53; tumor protein p53
       8737 RIPK1; receptor (TNFRSF)-interacting serine-threonine kinase 1 
       7186 TRAF2; TNF receptor-associated factor 2
       4615 MYD88; myeloid differentiation primary response 88
       3654 IRAK1; interleukin-1 receptor-associated kinase 1 
       3656 IRAK2; interleukin-1 receptor-associated kinase 2
       11213 IRAK3; interleukin-1 receptor-associated kinase 3 
       51135 IRAK4; interleukin-1 receptor-associated kinase 4 
       9020 MAP3K14; mitogen-activated protein kinase kinase kinase 14 
       1147 CHUK; conserved helix-loop-helix ubiquitous kinase 
       3551 IKBKB; inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta 
       8517 IKBKG; inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma
       4792 NFKBIA; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha
       4790 NFKB1; nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
       5970 RELA; v-rel avian reticuloendotheliosis viral oncogene homolog A
       4803 NGF; nerve growth factor (beta polypeptide)
       4914 NTRK1; neurotrophic tyrosine kinase, receptor, type 1 
       3562 IL3; interleukin 3
       3563 IL3RA; interleukin 3 receptor, alpha (low affinity)
       1439 CSF2RB; colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage)
       5290 PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha 
       5293 PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta 
       5291 PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta 
       5294 PIK3CG; phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma 
       5295 PIK3R1; phosphoinositide-3-kinase, regulatory subunit 1 (alpha)
       23533 PIK3R5; phosphoinositide-3-kinase, regulatory subunit 5
       5296 PIK3R2; phosphoinositide-3-kinase, regulatory subunit 2 (beta)
       8503 PIK3R3; phosphoinositide-3-kinase, regulatory subunit 3 (gamma)
       207 AKT1; v-akt murine thymoma viral oncogene homolog 1 
       208 AKT2; v-akt murine thymoma viral oncogene homolog 2 
       10000 AKT3; v-akt murine thymoma viral oncogene homolog 3 
       5573 PRKAR1A; protein kinase, cAMP-dependent, regulatory, type I, alpha 
       5576 PRKAR2A; protein kinase, cAMP-dependent, regulatory, type II, alpha 
       5577 PRKAR2B; protein kinase, cAMP-dependent, regulatory, type II, beta 
       5575 PRKAR1B; protein kinase, cAMP-dependent, regulatory, type I, beta 
       5566 PRKACA; protein kinase, cAMP-dependent, catalytic, alpha 
       5567 PRKACB; protein kinase, cAMP-dependent, catalytic, beta 
       5568 PRKACG; protein kinase, cAMP-dependent, catalytic, gamma 
       5613 PRKX; protein kinase, X-linked 
       572 BAD; BCL2-associated agonist of cell death
       581 BAX; BCL2-associated X protein
       5530 PPP3CA; protein phosphatase 3, catalytic subunit, alpha isozyme 
       5532 PPP3CB; protein phosphatase 3, catalytic subunit, beta isozyme 
       5533 PPP3CC; protein phosphatase 3, catalytic subunit, gamma isozyme 
       5534 PPP3R1; protein phosphatase 3, regulatory subunit B, alpha 
       5535 PPP3R2; protein phosphatase 3, regulatory subunit B, beta 
       823 CAPN1; calpain 1, (mu/I) large subunit 
       824 CAPN2; calpain 2, (m/II) large subunit 
       100506742 CASP12; caspase 12 (gene/pseudogene)
K04389 TNFSF6; tumor necrosis factor ligand superfamily member 6
K04390 TNFRSF6; tumor necrosis factor receptor superfamily member 6
K04721 TNFSF10; tumor necrosis factor ligand superfamily member 10
K04722 TNFRSF10; tumor necrosis factor receptor superfamily member 10
K04722 TNFRSF10; tumor necrosis factor receptor superfamily member 10
K04722 TNFRSF10; tumor necrosis factor receptor superfamily member 10
K04722 TNFRSF10; tumor necrosis factor receptor superfamily member 10
K03156 TNFA; tumor necrosis factor superfamily, member 2
K03158 TNFRSF1A; tumor necrosis factor receptor superfamily member 1A
K04383 IL1A; interleukin 1 alpha
K04519 IL1B; interleukin 1 beta
K04386 IL1R1; interleukin 1 receptor type I
K04723 IL1RAP; interleukin 1 receptor accessory protein
K02373 FADD; FAS-associated death domain protein
K03171 TRADD; tumor necrosis factor receptor type 1-associated DEATH domain protein
K04724 CFLAR; CASP8 and FADD-like apoptosis regulator
K04400 CASP10; caspase 10 [EC:3.4.22.63]
K04398 CASP8; caspase 8 [EC:3.4.22.61]
K02187 CASP3; caspase 3 [EC:3.4.22.56]
K04397 CASP7; caspase 7 [EC:3.4.22.60]
K04396 CASP6; caspase 6 [EC:3.4.22.59]
K16060 BIRC2_3; baculoviral IAP repeat-containing protein 2/3
K16060 BIRC2_3; baculoviral IAP repeat-containing protein 2/3
K04725 XIAP; E3 ubiquitin-protein ligase XIAP
K16061 BIRC7_8; baculoviral IAP repeat-containing protein 7/8
K16061 BIRC7_8; baculoviral IAP repeat-containing protein 7/8
K04726 BID; BH3 interacting domain death agonist
K02161 BCL2; apoptosis regulator BCL-2
K04570 BCL2L1; BCL2-like 1 (apoptosis regulator Bcl-X)
K08738 CYC; cytochrome c
K02084 APAF1; apoptotic protease-activating factor
K04399 CASP9; caspase 9 [EC:3.4.22.62]
K02310 DFFA; DNA fragmentation factor, 45 kD, alpha subunit
K02311 DFFB; DNA fragmentation factor, 40 kD, beta subunit [EC:3.-.-.-]
K04727 PDCD8; programmed cell death 8 (apoptosis-inducing factor) [EC:1.-.-.-]
K01173 ENDOG; endonuclease G, mitochondrial
K04728 ATM; ataxia telangiectasia mutated family protein [EC:2.7.11.1]
K04451 TP53; tumor protein p53
K02861 RIPK1; receptor-interacting serine/threonine-protein kinase 1 [EC:2.7.11.1]
K03173 TRAF2; TNF receptor-associated factor 2
K04729 MYD88; myeloid differentiation primary response protein MyD88
K04730 IRAK1; interleukin-1 receptor-associated kinase 1 [EC:2.7.11.1]
K04731 IRAK2; interleukin-1 receptor-associated kinase 2 [EC:2.7.11.1]
K04732 IRAK3; interleukin-1 receptor-associated kinase 3 [EC:2.7.11.1]
K04733 IRAK4; interleukin-1 receptor-associated kinase 4 [EC:2.7.11.1]
K04466 MAP3K14; mitogen-activated protein kinase kinase kinase 14 [EC:2.7.11.25]
K04467 IKBKA; inhibitor of nuclear factor kappa-B kinase subunit alpha [EC:2.7.11.10]
K07209 IKBKB; inhibitor of nuclear factor kappa-B kinase subunit beta [EC:2.7.11.10]
K07210 IKBKG; inhibitor of nuclear factor kappa-B kinase subunit gamma
K04734 NFKBIA; NF-kappa-B inhibitor alpha
K02580 NFKB1; nuclear factor NF-kappa-B p105 subunit
K04735 RELA; transcription factor p65
K02582 NGFB; nerve growth factor, beta
K03176 NTRK1; neurotrophic tyrosine kinase receptor type 1 [EC:2.7.10.1]
K04736 IL3; interleukin 3
K04737 IL3RA; interleukin 3 receptor alpha
K04738 CSF2RB; cytokine receptor common subunit beta
K00922 PIK3C; phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
K00922 PIK3C; phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
K00922 PIK3C; phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
K00922 PIK3C; phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
K02649 PIK3R; phosphoinositide-3-kinase, regulatory subunit
K02649 PIK3R; phosphoinositide-3-kinase, regulatory subunit
K02649 PIK3R; phosphoinositide-3-kinase, regulatory subunit
K02649 PIK3R; phosphoinositide-3-kinase, regulatory subunit
K04456 AKT; RAC serine/threonine-protein kinase [EC:2.7.11.1]
K04456 AKT; RAC serine/threonine-protein kinase [EC:2.7.11.1]
K04456 AKT; RAC serine/threonine-protein kinase [EC:2.7.11.1]
K04739 PRKAR; cAMP-dependent protein kinase regulator
K04739 PRKAR; cAMP-dependent protein kinase regulator
K04739 PRKAR; cAMP-dependent protein kinase regulator
K04739 PRKAR; cAMP-dependent protein kinase regulator
K04345 PKA; protein kinase A [EC:2.7.11.11]
K04345 PKA; protein kinase A [EC:2.7.11.11]
K04345 PKA; protein kinase A [EC:2.7.11.11]
K04345 PKA; protein kinase A [EC:2.7.11.11]
K02158 BAD; BCL2-antagonist of cell death
K02159 BAX; apoptosis regulator BAX
K04348 PPP3C; serine/threonine-protein phosphatase 2B catalytic subunit [EC:3.1.3.16]
K04348 PPP3C; serine/threonine-protein phosphatase 2B catalytic subunit [EC:3.1.3.16]
K04348 PPP3C; serine/threonine-protein phosphatase 2B catalytic subunit [EC:3.1.3.16]
K06268 PPP3R; serine/threonine-protein phosphatase 2B regulatory subunit
K06268 PPP3R; serine/threonine-protein phosphatase 2B regulatory subunit
K01367 CAPN1; calpain-1 [EC:3.4.22.52]
K03853 CAPN2; calpain-2 [EC:3.4.22.53]
K04741 CASP12; caspase 12 [EC:3.4.22.-]
     04115 p53 signaling pathway [PATH:hsa04115]
 
   Cell communication
 
 Organismal Systems
 
   Immune system
     04640 Hematopoietic cell lineage [PATH:hsa04640]
       4254 KITLG; KIT ligand
       3574 IL7; interleukin 7
       3565 IL4; interleukin 4
       1437 CSF2; colony stimulating factor 2 (granulocyte-macrophage)
       2323 FLT3LG; fms-related tyrosine kinase 3 ligand
       3567 IL5; interleukin 5
       1440 CSF3; colony stimulating factor 3 (granulocyte)
       3562 IL3; interleukin 3
       3569 IL6; interleukin 6
       3589 IL11; interleukin 11
       3552 IL1A; interleukin 1, alpha
       3553 IL1B; interleukin 1, beta
       7124 TNF; tumor necrosis factor
       1435 CSF1; colony stimulating factor 1 (macrophage) 
       2056 EPO; erythropoietin
       7173 TPO; thyroid peroxidase 
       7066 THPO; thrombopoietin
       947 CD34; CD34 molecule
       2322 FLT3; fms-related tyrosine kinase 3 
       1791 DNTT; DNA nucleotidylexotransferase 
       960 CD44; CD44 molecule (Indian blood group)
       3815 KIT; v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog 
       3559 IL2RA; interleukin 2 receptor, alpha
       3575 IL7R; interleukin 7 receptor
       7037 TFRC; transferrin receptor
       924 CD7; CD7 molecule
       914 CD2; CD2 molecule
       921 CD5; CD5 molecule
       909 CD1A; CD1a molecule
       910 CD1B; CD1b molecule
       911 CD1C; CD1c molecule
       912 CD1D; CD1d molecule
       913 CD1E; CD1e molecule
       920 CD4; CD4 molecule
       925 CD8A; CD8a molecule
       926 CD8B; CD8b molecule
       915 CD3D; CD3d molecule, delta (CD3-TCR complex)
       916 CD3E; CD3e molecule, epsilon (CD3-TCR complex)
       917 CD3G; CD3g molecule, gamma (CD3-TCR complex)
       4311 MME; membrane metallo-endopeptidase 
       928 CD9; CD9 molecule
       930 CD19; CD19 molecule
       933 CD22; CD22 molecule
       100133941 CD24; CD24 molecule
       931 MS4A1; membrane-spanning 4-domains, subfamily A, member 1
       1380 CR2; complement component (3d/Epstein Barr virus) receptor 2
       951 CD37; CD37 molecule
       2208 FCER2; Fc fragment of IgE, low affinity II, receptor for (CD23)
       1378 CR1; complement component (3b/4b) receptor 1 (Knops blood group)
       1438 CSF2RA; colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage)
       3563 IL3RA; interleukin 3 receptor, alpha (low affinity)
       945 CD33; CD33 molecule
       3566 IL4R; interleukin 4 receptor
       3570 IL6R; interleukin 6 receptor
       2209 FCGR1A; Fc fragment of IgG, high affinity Ia, receptor (CD64)
       1436 CSF1R; colony stimulating factor 1 receptor 
       290 ANPEP; alanyl (membrane) aminopeptidase 
       3684 ITGAM; integrin, alpha M (complement component 3 receptor 3 subunit)
       929 CD14; CD14 molecule
       3581 IL9R; interleukin 9 receptor
       3554 IL1R1; interleukin 1 receptor, type I
       7850 IL1R2; interleukin 1 receptor, type II
       1441 CSF3R; colony stimulating factor 3 receptor (granulocyte)
       3568 IL5RA; interleukin 5 receptor, alpha
       2057 EPOR; erythropoietin receptor
       948 CD36; CD36 molecule (thrombospondin receptor)
       1604 CD55; CD55 molecule, decay accelerating factor for complement (Cromer blood group)
       966 CD59; CD59 molecule, complement regulatory protein
       3590 IL11RA; interleukin 11 receptor, alpha
       3690 ITGB3; integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)
       3674 ITGA2B; integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41)
       2815 GP9; glycoprotein IX (platelet)
       2811 GP1BA; glycoprotein Ib (platelet), alpha polypeptide
       2812 GP1BB; glycoprotein Ib (platelet), beta polypeptide
       2814 GP5; glycoprotein V (platelet)
       3672 ITGA1; integrin, alpha 1
       3673 ITGA2; integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor)
       3675 ITGA3; integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor)
       3676 ITGA4; integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor)
       3678 ITGA5; integrin, alpha 5 (fibronectin receptor, alpha polypeptide)
       3655 ITGA6; integrin, alpha 6
       2993 GYPA; glycophorin A (MNS blood group)
       3122 HLA-DRA; major histocompatibility complex, class II, DR alpha
       3123 HLA-DRB1; major histocompatibility complex, class II, DR beta 1
       3125 HLA-DRB3; major histocompatibility complex, class II, DR beta 3
       3126 HLA-DRB4; major histocompatibility complex, class II, DR beta 4
       3127 HLA-DRB5; major histocompatibility complex, class II, DR beta 5
       952 CD38; CD38 molecule 
K05461 KITLG; KIT ligand
K05431 IL7; interleukin 7
K05430 IL4; interleukin 4
K05427 CSF2; granulocyte-macrophage colony-stimulating factor
K05454 FLT3LG; fms-related tyrosine kinase 3 ligand
K05428 IL5; interleukin 5
K05423 CSF3; granulocyte colony-stimulating factor
K04736 IL3; interleukin 3
K05405 IL6; interleukin 6
K05417 IL11; interleukin 11
K04383 IL1A; interleukin 1 alpha
K04519 IL1B; interleukin 1 beta
K03156 TNFA; tumor necrosis factor superfamily, member 2
K05453 CSF1; macrophage colony-stimulating factor 1
K05437 EPO; erythropoietin
K00431 TPO; thyroid peroxidase [EC:1.11.1.8]
K06854 THPO; thrombopoietin
K06474 CD34; CD34 antigen
K05092 FLT3; fms-related tyrosine kinase 3 [EC:2.7.10.1]
K00977 E2.7.7.31; DNA nucleotidylexotransferase [EC:2.7.7.31]
K06256 CD44; CD44 antigen
K05091 KIT; proto-oncogene tyrosine-protein kinase Kit [EC:2.7.10.1]
K05068 IL2RA; interleukin 2 receptor alpha
K05072 IL7R; interleukin 7 receptor
K06503 TFRC; transferrin receptor
K06457 CD7; CD7 antigen
K06449 CD2; CD2 antigen
K06455 CD5; CD5 antigen
K06448 CD1; CD1 antigen
K06448 CD1; CD1 antigen
K06448 CD1; CD1 antigen
K06448 CD1; CD1 antigen
K06448 CD1; CD1 antigen
K06454 CD4; CD4 antigen
K06458 CD8A; CD8A antigen, alpha polypeptide
K06459 CD8B; CD8B antigen, beta polypeptide
K06450 CD3D; T-cell surface glycoprotein CD3 delta chain
K06451 CD3E; T-cell surface glycoprotein CD3 epsilon chain
K06452 CD3G; T-cell surface glycoprotein CD3 gamma chain
K01389 MME; neprilysin [EC:3.4.24.11]
K06460 CD9; CD9 antigen
K06465 CD19; CD19 antigen
K06467 CD22; CD22 antigen
K06469 CD24; CD24 antigen
K06466 MS4A1; membrane-spanning 4-domains, subfamily A, member 1
K04012 CR2; complement receptor type 2
K06475 CD37; CD37 antigen
K06468 FCER2; Fc receptor, IgE, low affinity II
K04011 CR1; complement component (3b/4b) receptor 1
K05066 CSF2RA; granulocyte-macrophage colony-stimulating factor receptor alpha
K04737 IL3RA; interleukin 3 receptor alpha
K06473 CD33; CD33 antigen
K05071 IL4R; interleukin 4 receptor
K05055 IL6R; interleukin 6 receptor
K06498 FCGR1A; high affinity immunoglobulin gamma Fc receptor I
K05090 CSF1R; macrophage colony-stimulating factor 1 receptor [EC:2.7.10.1]
K11140 ANPEP; aminopeptidase N [EC:3.4.11.2]
K06461 ITGAM; integrin alpha M
K04391 CD14; CD14 antigen
K05073 IL9R; interleukin 9 receptor
K04386 IL1R1; interleukin 1 receptor type I
K04387 IL1R2; interleukin 1 receptor type II
K05061 CSF3R; granulocyte colony-stimulating factor receptor
K05067 IL5RA; interleukin 5 receptor alpha
K05079 EPOR; erythropoietin receptor
K06259 CD36; CD36 antigen
K04006 DAF; decay accelerating factor
K04008 CD59; CD59 antigen
K05056 IL11RA; interleukin 11 receptor alpha
K06493 ITGB3; integrin beta 3
K06476 ITGA2B; integrin alpha 2B
K06263 GP9; platelet glycoprotein IX
K06261 GP1BA; platelet glycoprotein Ib alpha chain
K06262 GP1BB; platelet glycoprotein Ib beta chain
K06260 GP5; platelet glycoprotein V
K06480 ITGA1; integrin alpha 1
K06481 ITGA2; integrin alpha 2
K06482 ITGA3; integrin alpha 3
K06483 ITGA4; integrin alpha 4
K06484 ITGA5; integrin alpha 5
K06485 ITGA6; integrin alpha 6
K06575 GYPA_B; glycophorin
K06752 MHC2; major histocompatibility complex, class II
K06752 MHC2; major histocompatibility complex, class II
K06752 MHC2; major histocompatibility complex, class II
K06752 MHC2; major histocompatibility complex, class II
K06752 MHC2; major histocompatibility complex, class II
K01242 CD38; ADP-ribosyl cyclase 1 [EC:3.2.2.6 2.4.99.20]
     04610 Complement and coagulation cascades [PATH:hsa04610]
     04611 Platelet activation [PATH:hsa04611]
     04620 Toll-like receptor signaling pathway [PATH:hsa04620]
       7096 TLR1; toll-like receptor 1
       7097 TLR2; toll-like receptor 2
       10333 TLR6; toll-like receptor 6
       3929 LBP; lipopolysaccharide binding protein
       929 CD14; CD14 molecule
       23643 LY96; lymphocyte antigen 96
       7098 TLR3; toll-like receptor 3
       7099 TLR4; toll-like receptor 4
       7100 TLR5; toll-like receptor 5
       51284 TLR7; toll-like receptor 7
       51311 TLR8; toll-like receptor 8
       1513 CTSK; cathepsin K 
       54106 TLR9; toll-like receptor 9
       5879 RAC1; ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)
       5290 PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha 
       5293 PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta 
       5291 PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta 
       5294 PIK3CG; phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma 
       5295 PIK3R1; phosphoinositide-3-kinase, regulatory subunit 1 (alpha)
       23533 PIK3R5; phosphoinositide-3-kinase, regulatory subunit 5
       5296 PIK3R2; phosphoinositide-3-kinase, regulatory subunit 2 (beta)
       8503 PIK3R3; phosphoinositide-3-kinase, regulatory subunit 3 (gamma)
       207 AKT1; v-akt murine thymoma viral oncogene homolog 1 
       208 AKT2; v-akt murine thymoma viral oncogene homolog 2 
       10000 AKT3; v-akt murine thymoma viral oncogene homolog 3 
       54472 TOLLIP; toll interacting protein
       4615 MYD88; myeloid differentiation primary response 88
       114609 TIRAP; toll-interleukin 1 receptor (TIR) domain containing adaptor protein
       8772 FADD; Fas (TNFRSF6)-associated via death domain
       841 CASP8; caspase 8, apoptosis-related cysteine peptidase 
       51135 IRAK4; interleukin-1 receptor-associated kinase 4 
       3654 IRAK1; interleukin-1 receptor-associated kinase 1 
       7189 TRAF6; TNF receptor-associated factor 6, E3 ubiquitin protein ligase
       10454 TAB1; TGF-beta activated kinase 1/MAP3K7 binding protein 1
       23118 TAB2; TGF-beta activated kinase 1/MAP3K7 binding protein 2
       6885 MAP3K7; mitogen-activated protein kinase kinase kinase 7 
       8517 IKBKG; inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma
       1147 CHUK; conserved helix-loop-helix ubiquitous kinase 
       3551 IKBKB; inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta 
       4792 NFKBIA; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha
       4790 NFKB1; nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
       5970 RELA; v-rel avian reticuloendotheliosis viral oncogene homolog A
       1326 MAP3K8; mitogen-activated protein kinase kinase kinase 8 
       5604 MAP2K1; mitogen-activated protein kinase kinase 1 
       5605 MAP2K2; mitogen-activated protein kinase kinase 2 
       5594 MAPK1; mitogen-activated protein kinase 1 
       5595 MAPK3; mitogen-activated protein kinase 3 
       5606 MAP2K3; mitogen-activated protein kinase kinase 3 
       5608 MAP2K6; mitogen-activated protein kinase kinase 6 
       6416 MAP2K4; mitogen-activated protein kinase kinase 4 
       5609 MAP2K7; mitogen-activated protein kinase kinase 7 
       5600 MAPK11; mitogen-activated protein kinase 11 
       6300 MAPK12; mitogen-activated protein kinase 12 
       5603 MAPK13; mitogen-activated protein kinase 13 
       1432 MAPK14; mitogen-activated protein kinase 14 
       5599 MAPK8; mitogen-activated protein kinase 8 
       5602 MAPK10; mitogen-activated protein kinase 10 
       5601 MAPK9; mitogen-activated protein kinase 9 
       3725 JUN; jun proto-oncogene
       2353 FOS; FBJ murine osteosarcoma viral oncogene homolog
       7124 TNF; tumor necrosis factor
       3553 IL1B; interleukin 1, beta
       3569 IL6; interleukin 6
       3592 IL12A; interleukin 12A
       3593 IL12B; interleukin 12B
       3576 CXCL8; chemokine (C-X-C motif) ligand 8
       6352 CCL5; chemokine (C-C motif) ligand 5
       6348 CCL3; chemokine (C-C motif) ligand 3
       6349 CCL3L1; chemokine (C-C motif) ligand 3-like 1
       414062 CCL3L3; chemokine (C-C motif) ligand 3-like 3
       6351 CCL4; chemokine (C-C motif) ligand 4
       9560 CCL4L2; chemokine (C-C motif) ligand 4-like 2
       388372 CCL4L1; chemokine (C-C motif) ligand 4-like 1
       353376 TICAM2; toll-like receptor adaptor molecule 2
       148022 TICAM1; toll-like receptor adaptor molecule 1
       8737 RIPK1; receptor (TNFRSF)-interacting serine-threonine kinase 1 
       3663 IRF5; interferon regulatory factor 5
       3665 IRF7; interferon regulatory factor 7
       6696 SPP1; secreted phosphoprotein 1
       9641 IKBKE; inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase epsilon 
       29110 TBK1; TANK-binding kinase 1 
       7187 TRAF3; TNF receptor-associated factor 3
       3661 IRF3; interferon regulatory factor 3
       958 CD40; CD40 molecule, TNF receptor superfamily member 5
       941 CD80; CD80 molecule
       942 CD86; CD86 molecule
       3439 IFNA1; interferon, alpha 1
       3440 IFNA2; interferon, alpha 2
       3441 IFNA4; interferon, alpha 4
       3442 IFNA5; interferon, alpha 5
       3443 IFNA6; interferon, alpha 6
       3444 IFNA7; interferon, alpha 7
       3445 IFNA8; interferon, alpha 8
       3446 IFNA10; interferon, alpha 10
       3447 IFNA13; interferon, alpha 13
       3448 IFNA14; interferon, alpha 14
       3449 IFNA16; interferon, alpha 16
       3451 IFNA17; interferon, alpha 17
       3452 IFNA21; interferon, alpha 21
       3456 IFNB1; interferon, beta 1, fibroblast
       3454 IFNAR1; interferon (alpha, beta and omega) receptor 1
       3455 IFNAR2; interferon (alpha, beta and omega) receptor 2
       6772 STAT1; signal transducer and activator of transcription 1, 91kDa
       3627 CXCL10; chemokine (C-X-C motif) ligand 10
       4283 CXCL9; chemokine (C-X-C motif) ligand 9
       6373 CXCL11; chemokine (C-X-C motif) ligand 11
K05398 TLR1; toll-like receptor 1
K10159 TLR2; toll-like receptor 2
K10169 TLR6; toll-like receptor 6
K05399 LBP; lipopolysaccharide-binding protein
K04391 CD14; CD14 antigen
K05400 LY96; lymphocyte antigen 96
K05401 TLR3; toll-like receptor 3
K10160 TLR4; toll-like receptor 4
K10168 TLR5; toll-like receptor 5
K05404 TLR7; toll-like receptor 7
K10170 TLR8; toll-like receptor 8
K01371 CTSK; cathepsin K [EC:3.4.22.38]
K10161 TLR9; toll-like receptor 9
K04392 RAC1; Ras-related C3 botulinum toxin substrate 1
K00922 PIK3C; phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
K00922 PIK3C; phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
K00922 PIK3C; phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
K00922 PIK3C; phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
K02649 PIK3R; phosphoinositide-3-kinase, regulatory subunit
K02649 PIK3R; phosphoinositide-3-kinase, regulatory subunit
K02649 PIK3R; phosphoinositide-3-kinase, regulatory subunit
K02649 PIK3R; phosphoinositide-3-kinase, regulatory subunit
K04456 AKT; RAC serine/threonine-protein kinase [EC:2.7.11.1]
K04456 AKT; RAC serine/threonine-protein kinase [EC:2.7.11.1]
K04456 AKT; RAC serine/threonine-protein kinase [EC:2.7.11.1]
K05402 TOLLIP; toll-interacting protein
K04729 MYD88; myeloid differentiation primary response protein MyD88
K05403 TIRAP; toll-interleukin 1 receptor (TIR) domain-containing adaptor protein
K02373 FADD; FAS-associated death domain protein
K04398 CASP8; caspase 8 [EC:3.4.22.61]
K04733 IRAK4; interleukin-1 receptor-associated kinase 4 [EC:2.7.11.1]
K04730 IRAK1; interleukin-1 receptor-associated kinase 1 [EC:2.7.11.1]
K03175 TRAF6; TNF receptor-associated factor 6
K04403 MAP3K7IP1; TAK1-binding protein 1
K04404 MAP3K7IP2; TAK1-binding protein 2
K04427 MAP3K7; mitogen-activated protein kinase kinase kinase 7 [EC:2.7.11.25]
K07210 IKBKG; inhibitor of nuclear factor kappa-B kinase subunit gamma
K04467 IKBKA; inhibitor of nuclear factor kappa-B kinase subunit alpha [EC:2.7.11.10]
K07209 IKBKB; inhibitor of nuclear factor kappa-B kinase subunit beta [EC:2.7.11.10]
K04734 NFKBIA; NF-kappa-B inhibitor alpha
K02580 NFKB1; nuclear factor NF-kappa-B p105 subunit
K04735 RELA; transcription factor p65
K04415 MAP3K8; mitogen-activated protein kinase kinase kinase 8 [EC:2.7.11.25]
K04368 MAP2K1; mitogen-activated protein kinase kinase 1 [EC:2.7.12.2]
K04369 MAP2K2; mitogen-activated protein kinase kinase 2 [EC:2.7.12.2]
K04371 MAPK1_3; mitogen-activated protein kinase 1/3 [EC:2.7.11.24]
K04371 MAPK1_3; mitogen-activated protein kinase 1/3 [EC:2.7.11.24]
K04432 MAP2K3; mitogen-activated protein kinase kinase 3 [EC:2.7.12.2]
K04433 MAP2K6; mitogen-activated protein kinase kinase 6 [EC:2.7.12.2]
K04430 MAP2K4; mitogen-activated protein kinase kinase 4 [EC:2.7.12.2]
K04431 MAP2K7; mitogen-activated protein kinase kinase 7 [EC:2.7.12.2]
K04441 P38; p38 MAP kinase [EC:2.7.11.24]
K04441 P38; p38 MAP kinase [EC:2.7.11.24]
K04441 P38; p38 MAP kinase [EC:2.7.11.24]
K04441 P38; p38 MAP kinase [EC:2.7.11.24]
K04440 JNK; c-Jun N-terminal kinase [EC:2.7.11.24]
K04440 JNK; c-Jun N-terminal kinase [EC:2.7.11.24]
K04440 JNK; c-Jun N-terminal kinase [EC:2.7.11.24]
K04448 JUN; transcription factor AP-1
K04379 FOS; proto-oncogene protein c-fos
K03156 TNFA; tumor necrosis factor superfamily, member 2
K04519 IL1B; interleukin 1 beta
K05405 IL6; interleukin 6
K05406 IL12A; interleukin 12A
K05425 IL12B; interleukin 12B
K10030 IL8; interleukin 8
K12499 CCL5; C-C motif chemokine 5
K05408 CCL3; C-C motif chemokine 3
K05408 CCL3; C-C motif chemokine 3
K05408 CCL3; C-C motif chemokine 3
K12964 CCL4; C-C motif chemokine 4
K12964 CCL4; C-C motif chemokine 4
K12964 CCL4; C-C motif chemokine 4
K05409 TIRP; TRIF-related adaptor molecule
K05842 TRIF; toll-like receptor adapter molecule 1
K02861 RIPK1; receptor-interacting serine/threonine-protein kinase 1 [EC:2.7.11.1]
K09446 IRF5; interferon regulatory factor 5
K09447 IRF7; interferon regulatory factor 7
K06250 SPP1; secreted phosphoprotein 1
K07211 IKBKE; inhibitor of nuclear factor kappa-B kinase subunit epsilon [EC:2.7.11.10]
K05410 TBK1; TANK-binding kinase 1 [EC:2.7.11.10]
K03174 TRAF3; TNF receptor-associated factor 3
K05411 IRF3; interferon regulatory factor 3
K03160 TNFRSF5; tumor necrosis factor receptor superfamily member 5
K05412 CD80; CD80 antigen
K05413 CD86; CD86 antigen
K05414 IFNA; interferon alpha
K05414 IFNA; interferon alpha
K05414 IFNA; interferon alpha
K05414 IFNA; interferon alpha
K05414 IFNA; interferon alpha
K05414 IFNA; interferon alpha
K05414 IFNA; interferon alpha
K05414 IFNA; interferon alpha
K05414 IFNA; interferon alpha
K05414 IFNA; interferon alpha
K05414 IFNA; interferon alpha
K05414 IFNA; interferon alpha
K05414 IFNA; interferon alpha
K05415 IFNB; interferon beta
K05130 IFNAR1; interferon receptor 1
K05131 IFNAR2; interferon receptor 2
K11220 STAT1; signal transducer and activator of transcription 1
K12671 CXCL10; C-X-C motif chemokine 10
K05416 CXCL9; C-X-C motif chemokine 9
K12672 CXCL11; C-X-C motif chemokine 11
     04621 NOD-like receptor signaling pathway [PATH:hsa04621]
       10392 NOD1; nucleotide-binding oligomerization domain containing 1
       64127 NOD2; nucleotide-binding oligomerization domain containing 2
       7205 TRIP6; thyroid hormone receptor interactor 6
       8767 RIPK2; receptor-interacting serine-threonine kinase 2 
       7189 TRAF6; TNF receptor-associated factor 6, E3 ubiquitin protein ligase
       8517 IKBKG; inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma
       1147 CHUK; conserved helix-loop-helix ubiquitous kinase 
       3551 IKBKB; inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta 
       4793 NFKBIB; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, beta
       4792 NFKBIA; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha
       4790 NFKB1; nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
       5970 RELA; v-rel avian reticuloendotheliosis viral oncogene homolog A
       3576 CXCL8; chemokine (C-X-C motif) ligand 8
       6347 CCL2; chemokine (C-C motif) ligand 2
       6352 CCL5; chemokine (C-C motif) ligand 5
       7124 TNF; tumor necrosis factor
       3569 IL6; interleukin 6
       6885 MAP3K7; mitogen-activated protein kinase kinase kinase 7 
       10454 TAB1; TGF-beta activated kinase 1/MAP3K7 binding protein 1
       23118 TAB2; TGF-beta activated kinase 1/MAP3K7 binding protein 2
       257397 TAB3; TGF-beta activated kinase 1/MAP3K7 binding protein 3
       5594 MAPK1; mitogen-activated protein kinase 1 
       5595 MAPK3; mitogen-activated protein kinase 3 
       5599 MAPK8; mitogen-activated protein kinase 8 
       5602 MAPK10; mitogen-activated protein kinase 10 
       5601 MAPK9; mitogen-activated protein kinase 9 
       5600 MAPK11; mitogen-activated protein kinase 11 
       6300 MAPK12; mitogen-activated protein kinase 12 
       5603 MAPK13; mitogen-activated protein kinase 13 
       1432 MAPK14; mitogen-activated protein kinase 14 
       64170 CARD9; caspase recruitment domain family, member 9
       841 CASP8; caspase 8, apoptosis-related cysteine peptidase 
       10910 SUGT1; SGT1, suppressor of G2 allele of SKP1 (S. cerevisiae)
       55914 ERBB2IP; erbb2 interacting protein
       84674 CARD6; caspase recruitment domain family, member 6
       329 BIRC2; baculoviral IAP repeat containing 2
       330 BIRC3; baculoviral IAP repeat containing 3
       7128 TNFAIP3; tumor necrosis factor, alpha-induced protein 3 
       22861 NLRP1; NLR family, pyrin domain containing 1
       29108 PYCARD; PYD and CARD domain containing
       834 CASP1; caspase 1, apoptosis-related cysteine peptidase 
       838 CASP5; caspase 5, apoptosis-related cysteine peptidase 
       114548 NLRP3; NLR family, pyrin domain containing 3
       22900 CARD8; caspase recruitment domain family, member 8
       260434 PYDC1; PYD (pyrin domain) containing 1
       4210 MEFV; Mediterranean fever
       9051 PSTPIP1; proline-serine-threonine phosphatase interacting protein 1
       3320 HSP90AA1; heat shock protein 90kDa alpha (cytosolic), class A member 1
       3326 HSP90AB1; heat shock protein 90kDa alpha (cytosolic), class B member 1
       7184 HSP90B1; heat shock protein 90kDa beta (Grp94), member 1
       58484 NLRC4; NLR family, CARD domain containing 4
       59082 CARD18; caspase recruitment domain family, member 18
       4671 NAIP; NLR family, apoptosis inhibitory protein
       3553 IL1B; interleukin 1, beta
       3606 IL18; interleukin 18
       2919 CXCL1; chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha)
       2920 CXCL2; chemokine (C-X-C motif) ligand 2
K08727 NOD1; nucleotide-binding oligomerization domain-containing protein 1
K10165 NOD2; nucleotide-binding oligomerization domain-containing protein 2
K12792 TRIP6; thyroid receptor-interacting protein 6
K08846 RIPK2; receptor-interacting serine/threonine-protein kinase 2 [EC:2.7.11.1]
K03175 TRAF6; TNF receptor-associated factor 6
K07210 IKBKG; inhibitor of nuclear factor kappa-B kinase subunit gamma
K04467 IKBKA; inhibitor of nuclear factor kappa-B kinase subunit alpha [EC:2.7.11.10]
K07209 IKBKB; inhibitor of nuclear factor kappa-B kinase subunit beta [EC:2.7.11.10]
K02581 NFKBIB; NF-kappa-B inhibitor beta
K04734 NFKBIA; NF-kappa-B inhibitor alpha
K02580 NFKB1; nuclear factor NF-kappa-B p105 subunit
K04735 RELA; transcription factor p65
K10030 IL8; interleukin 8
K14624 CCL2; C-C motif chemokine 2
K12499 CCL5; C-C motif chemokine 5
K03156 TNFA; tumor necrosis factor superfamily, member 2
K05405 IL6; interleukin 6
K04427 MAP3K7; mitogen-activated protein kinase kinase kinase 7 [EC:2.7.11.25]
K04403 MAP3K7IP1; TAK1-binding protein 1
K04404 MAP3K7IP2; TAK1-binding protein 2
K12793 MAP3K7IP3; TAK1-binding protein 3
K04371 MAPK1_3; mitogen-activated protein kinase 1/3 [EC:2.7.11.24]
K04371 MAPK1_3; mitogen-activated protein kinase 1/3 [EC:2.7.11.24]
K04440 JNK; c-Jun N-terminal kinase [EC:2.7.11.24]
K04440 JNK; c-Jun N-terminal kinase [EC:2.7.11.24]
K04440 JNK; c-Jun N-terminal kinase [EC:2.7.11.24]
K04441 P38; p38 MAP kinase [EC:2.7.11.24]
K04441 P38; p38 MAP kinase [EC:2.7.11.24]
K04441 P38; p38 MAP kinase [EC:2.7.11.24]
K04441 P38; p38 MAP kinase [EC:2.7.11.24]
K12794 CARD9; caspase recruitment domain-containing protein 9
K04398 CASP8; caspase 8 [EC:3.4.22.61]
K12795 SUGT1; suppressor of G2 allele of SKP1
K12796 ERBB2IP; erbb2-interacting protein
K12797 CARD6; caspase recruitment domain-containing protein 6
K16060 BIRC2_3; baculoviral IAP repeat-containing protein 2/3
K16060 BIRC2_3; baculoviral IAP repeat-containing protein 2/3
K11859 TNFAIP3; tumor necrosis factor, alpha-induced protein 3 [EC:3.4.19.12 6.3.2.19]
K12798 NLRP1; NACHT, LRR and PYD domains-containing protein 1
K12799 PYCARD; apoptosis-associated speck-like protein containing a CARD
K01370 CASP1; caspase 1 [EC:3.4.22.36]
K04395 CASP5; caspase 5 [EC:3.4.22.58]
K12800 NLRP3; NACHT, LRR and PYD domains-containing protein 3
K12801 CARD8; caspase recruitment domain-containing protein 8
K12802 PYDC1; pyrin domain-containing protein 1
K12803 MEFV; pyrin
K12804 PSTPIP1; proline-serine-threonine phosphatase interacting protein 1
K04079 htpG; molecular chaperone HtpG
K04079 htpG; molecular chaperone HtpG
K09487 HSP90B; heat shock protein 90kDa beta
K12805 NLRC4; NLR family CARD domain-containing protein 4
K12806 CARD18; caspase recruitment domain-containing protein 18
K12807 NAIP; baculoviral IAP repeat-containing protein 1
K04519 IL1B; interleukin 1 beta
K05482 IL18; interleukin 18
K05505 CXCL1_2_3; C-X-C motif chemokine 1/2/3
K05505 CXCL1_2_3; C-X-C motif chemokine 1/2/3
     04622 RIG-I-like receptor signaling pathway [PATH:hsa04622]
       23586 DDX58; DEAD (Asp-Glu-Ala-Asp) box polypeptide 58 
       64135 IFIH1; interferon induced with helicase C domain 1 
       57506 MAVS; mitochondrial antiviral signaling protein
       79132 DHX58; DEXH (Asp-Glu-X-His) box polypeptide 58 
       7187 TRAF3; TNF receptor-associated factor 3
       10010 TANK; TRAF family member-associated NFKB activator
       64343 AZI2; 5-azacytidine induced 2
       9755 TBKBP1; TBK1 binding protein 1
       8517 IKBKG; inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma
       29110 TBK1; TANK-binding kinase 1 
       9641 IKBKE; inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase epsilon 
       3661 IRF3; interferon regulatory factor 3
       3665 IRF7; interferon regulatory factor 7
       3439 IFNA1; interferon, alpha 1
       3440 IFNA2; interferon, alpha 2
       3441 IFNA4; interferon, alpha 4
       3442 IFNA5; interferon, alpha 5
       3443 IFNA6; interferon, alpha 6
       3444 IFNA7; interferon, alpha 7
       3445 IFNA8; interferon, alpha 8
       3446 IFNA10; interferon, alpha 10
       3447 IFNA13; interferon, alpha 13
       3448 IFNA14; interferon, alpha 14
       3449 IFNA16; interferon, alpha 16
       3451 IFNA17; interferon, alpha 17
       3452 IFNA21; interferon, alpha 21
       3456 IFNB1; interferon, beta 1, fibroblast
       3467 IFNW1; interferon, omega 1
       338376 IFNE; interferon, epsilon
       56832 IFNK; interferon, kappa
       8717 TRADD; TNFRSF1A-associated via death domain
       8772 FADD; Fas (TNFRSF6)-associated via death domain
       8737 RIPK1; receptor (TNFRSF)-interacting serine-threonine kinase 1 
       841 CASP8; caspase 8, apoptosis-related cysteine peptidase 
       843 CASP10; caspase 10, apoptosis-related cysteine peptidase 
       1147 CHUK; conserved helix-loop-helix ubiquitous kinase 
       3551 IKBKB; inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta 
       4793 NFKBIB; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, beta
       4792 NFKBIA; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha
       4790 NFKB1; nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
       5970 RELA; v-rel avian reticuloendotheliosis viral oncogene homolog A
       7186 TRAF2; TNF receptor-associated factor 2
       6885 MAP3K7; mitogen-activated protein kinase kinase kinase 7 
       7189 TRAF6; TNF receptor-associated factor 6, E3 ubiquitin protein ligase
       4214 MAP3K1; mitogen-activated protein kinase kinase kinase 1, E3 ubiquitin protein ligase 
       5599 MAPK8; mitogen-activated protein kinase 8 
       5602 MAPK10; mitogen-activated protein kinase 10 
       5601 MAPK9; mitogen-activated protein kinase 9 
       5600 MAPK11; mitogen-activated protein kinase 11 
       6300 MAPK12; mitogen-activated protein kinase 12 
       5603 MAPK13; mitogen-activated protein kinase 13 
       1432 MAPK14; mitogen-activated protein kinase 14 
       3576 CXCL8; chemokine (C-X-C motif) ligand 8
       7124 TNF; tumor necrosis factor
       3592 IL12A; interleukin 12A
       3593 IL12B; interleukin 12B
       3627 CXCL10; chemokine (C-X-C motif) ligand 10
       7706 TRIM25; tripartite motif containing 25 
       1540 CYLD; cylindromatosis (turban tumor syndrome) 
       54941 RNF125; ring finger protein 125, E3 ubiquitin protein ligase
       9636 ISG15; ISG15 ubiquitin-like modifier
       9474 ATG5; autophagy related 5
       9140 ATG12; autophagy related 12
       79671 NLRX1; NLR family member X1
       340061 TMEM173; transmembrane protein 173
       55593 OTUD5; OTU deubiquitinase 5 
       80143 SIKE1; suppressor of IKBKE 1
       1654 DDX3X; DEAD (Asp-Glu-Ala-Asp) box helicase 3, X-linked 
       5300 PIN1; peptidylprolyl cis/trans isomerase, NIMA-interacting 1 
       26007 DAK; dihydroxyacetone kinase 2 homolog (S. cerevisiae) 
K12646 DDX58; ATP-dependent RNA helicase DDX58 [EC:3.6.3.14]
K12647 IFIH1; interferon-induced helicase C domain-containing protein 1 [EC:3.6.4.13]
K12648 MAVS; mitochondrial antiviral-signaling protein
K12649 DHX58; ATP-dependent RNA helicase DHX58 [EC:3.6.3.14]
K03174 TRAF3; TNF receptor-associated factor 3
K12650 TANK; TRAF family member-associated NF-kappa-B activator
K12651 AZI2; 5-azacytidine-induced protein 2
K12652 TBKBP1; TANK-binding kinase 1-binding protein
K07210 IKBKG; inhibitor of nuclear factor kappa-B kinase subunit gamma
K05410 TBK1; TANK-binding kinase 1 [EC:2.7.11.10]
K07211 IKBKE; inhibitor of nuclear factor kappa-B kinase subunit epsilon [EC:2.7.11.10]
K05411 IRF3; interferon regulatory factor 3
K09447 IRF7; interferon regulatory factor 7
K05414 IFNA; interferon alpha
K05414 IFNA; interferon alpha
K05414 IFNA; interferon alpha
K05414 IFNA; interferon alpha
K05414 IFNA; interferon alpha
K05414 IFNA; interferon alpha
K05414 IFNA; interferon alpha
K05414 IFNA; interferon alpha
K05414 IFNA; interferon alpha
K05414 IFNA; interferon alpha
K05414 IFNA; interferon alpha
K05414 IFNA; interferon alpha
K05414 IFNA; interferon alpha
K05415 IFNB; interferon beta
K05440 IFNW1; interferon, omega 1
K05442 IFNT1; interferon, tau-1
K05441 IFNK; interferon, kappa
K03171 TRADD; tumor necrosis factor receptor type 1-associated DEATH domain protein
K02373 FADD; FAS-associated death domain protein
K02861 RIPK1; receptor-interacting serine/threonine-protein kinase 1 [EC:2.7.11.1]
K04398 CASP8; caspase 8 [EC:3.4.22.61]
K04400 CASP10; caspase 10 [EC:3.4.22.63]
K04467 IKBKA; inhibitor of nuclear factor kappa-B kinase subunit alpha [EC:2.7.11.10]
K07209 IKBKB; inhibitor of nuclear factor kappa-B kinase subunit beta [EC:2.7.11.10]
K02581 NFKBIB; NF-kappa-B inhibitor beta
K04734 NFKBIA; NF-kappa-B inhibitor alpha
K02580 NFKB1; nuclear factor NF-kappa-B p105 subunit
K04735 RELA; transcription factor p65
K03173 TRAF2; TNF receptor-associated factor 2
K04427 MAP3K7; mitogen-activated protein kinase kinase kinase 7 [EC:2.7.11.25]
K03175 TRAF6; TNF receptor-associated factor 6
K04416 MAP3K1; mitogen-activated protein kinase kinase kinase 1 [EC:2.7.11.25]
K04440 JNK; c-Jun N-terminal kinase [EC:2.7.11.24]
K04440 JNK; c-Jun N-terminal kinase [EC:2.7.11.24]
K04440 JNK; c-Jun N-terminal kinase [EC:2.7.11.24]
K04441 P38; p38 MAP kinase [EC:2.7.11.24]
K04441 P38; p38 MAP kinase [EC:2.7.11.24]
K04441 P38; p38 MAP kinase [EC:2.7.11.24]
K04441 P38; p38 MAP kinase [EC:2.7.11.24]
K10030 IL8; interleukin 8
K03156 TNFA; tumor necrosis factor superfamily, member 2
K05406 IL12A; interleukin 12A
K05425 IL12B; interleukin 12B
K12671 CXCL10; C-X-C motif chemokine 10
K10652 TRIM25; tripartite motif-containing protein 25 [EC:6.3.2.19]
K08601 CYLD; ubiquitin thioesterase CYLD [EC:3.1.2.15]
K12170 RNF125; E3 ubiquitin-protein ligase RNF125 [EC:6.3.2.19]
K12159 ISG15; ubiquitin cross-reactive protein
K08339 ATG5; autophagy-related protein 5
K08336 ATG12; ubiquitin-like protein ATG12
K12653 NLRX1; NLR family member X1
K12654 TMEM173; transmembrane protein 173
K12655 OTUD5; OTU domain-containing protein 5 [EC:3.4.19.12]
K12656 SIKE; suppressor of IKK-epsilon
K11594 DDX3X; ATP-dependent RNA helicase DDX3X [EC:3.6.4.13]
K09578 PIN1; peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 [EC:5.2.1.8]
K00863 E2.7.1.29; dihydroxyacetone kinase [EC:2.7.1.29]
     04623 Cytosolic DNA-sensing pathway [PATH:hsa04623]
     04650 Natural killer cell mediated cytotoxicity [PATH:hsa04650]
       3105 HLA-A; major histocompatibility complex, class I, A
       3106 HLA-B; major histocompatibility complex, class I, B
       3107 HLA-C; major histocompatibility complex, class I, C
       3134 HLA-F; major histocompatibility complex, class I, F
       3135 HLA-G; major histocompatibility complex, class I, G
       3133 HLA-E; major histocompatibility complex, class I, E
       3812 KIR3DL2; killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2
       3811 KIR3DL1; killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1
       115653 KIR3DL3; killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 3
       3803 KIR2DL2; killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 2
       3802 KIR2DL1; killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1
       3804 KIR2DL3; killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3
       3805 KIR2DL4; killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4
       57292 KIR2DL5A; killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 5A
       3821 KLRC1; killer cell lectin-like receptor subfamily C, member 1
       3822 KLRC2; killer cell lectin-like receptor subfamily C, member 2
       3823 KLRC3; killer cell lectin-like receptor subfamily C, member 3
       8302 KLRC4; killer cell lectin-like receptor subfamily C, member 4
       3824 KLRD1; killer cell lectin-like receptor subfamily D, member 1
       5777 PTPN6; protein tyrosine phosphatase, non-receptor type 6 
       5781 PTPN11; protein tyrosine phosphatase, non-receptor type 11 
       3383 ICAM1; intercellular adhesion molecule 1
       3384 ICAM2; intercellular adhesion molecule 2
       3683 ITGAL; integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide)
       3689 ITGB2; integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)
       2185 PTK2B; protein tyrosine kinase 2 beta 
       10451 VAV3; vav 3 guanine nucleotide exchange factor
       7409 VAV1; vav 1 guanine nucleotide exchange factor
       7410 VAV2; vav 2 guanine nucleotide exchange factor
       5879 RAC1; ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)
       5880 RAC2; ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2)
       5881 RAC3; ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3)
       5058 PAK1; p21 protein (Cdc42/Rac)-activated kinase 1 
       5604 MAP2K1; mitogen-activated protein kinase kinase 1 
       5605 MAP2K2; mitogen-activated protein kinase kinase 2 
       5594 MAPK1; mitogen-activated protein kinase 1 
       5595 MAPK3; mitogen-activated protein kinase 3 
       7124 TNF; tumor necrosis factor
       1437 CSF2; colony stimulating factor 2 (granulocyte-macrophage)
       3458 IFNG; interferon, gamma
       3806 KIR2DS1; killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 1
       3808 KIR2DS3; killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 3
       3809 KIR2DS4; killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4
       3810 KIR2DS5; killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 5
       100132285 KIR2DS2; killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 2
       9436 NCR2; natural cytotoxicity triggering receptor 2
       7305 TYROBP; TYRO protein tyrosine kinase binding protein
       3932 LCK; lymphocyte-specific protein tyrosine kinase 
       2214 FCGR3A; Fc fragment of IgG, low affinity IIIa, receptor (CD16a)
       2215 FCGR3B; Fc fragment of IgG, low affinity IIIb, receptor (CD16b)
       9437 NCR1; natural cytotoxicity triggering receptor 1
       259197 NCR3; natural cytotoxicity triggering receptor 3
       2207 FCER1G; Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide
       919 CD247; CD247 molecule
       7535 ZAP70; zeta-chain (TCR) associated protein kinase 70kDa 
       6850 SYK; spleen tyrosine kinase 
       3937 LCP2; lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa)
       27040 LAT; linker for activation of T cells
       5335 PLCG1; phospholipase C, gamma 1 
       5336 PLCG2; phospholipase C, gamma 2 (phosphatidylinositol-specific) 
       6452 SH3BP2; SH3-domain binding protein 2
       5290 PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha 
       5293 PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta 
       5291 PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta 
       5294 PIK3CG; phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma 
       5295 PIK3R1; phosphoinositide-3-kinase, regulatory subunit 1 (alpha)
       23533 PIK3R5; phosphoinositide-3-kinase, regulatory subunit 5
       5296 PIK3R2; phosphoinositide-3-kinase, regulatory subunit 2 (beta)
       8503 PIK3R3; phosphoinositide-3-kinase, regulatory subunit 3 (gamma)
       2534 FYN; FYN oncogene related to SRC, FGR, YES 
       6464 SHC1; SHC (Src homology 2 domain containing) transforming protein 1
       25759 SHC2; SHC (Src homology 2 domain containing) transforming protein 2
       53358 SHC3; SHC (Src homology 2 domain containing) transforming protein 3
       399694 SHC4; SHC (Src homology 2 domain containing) family, member 4
       2885 GRB2; growth factor receptor-bound protein 2
       6654 SOS1; son of sevenless homolog 1 (Drosophila)
       6655 SOS2; son of sevenless homolog 2 (Drosophila)
       3265 HRAS; Harvey rat sarcoma viral oncogene homolog
       3845 KRAS; Kirsten rat sarcoma viral oncogene homolog
       4893 NRAS; neuroblastoma RAS viral (v-ras) oncogene homolog
       369 ARAF; v-raf murine sarcoma 3611 viral oncogene homolog 
       673 BRAF; v-raf murine sarcoma viral oncogene homolog B 
       5894 RAF1; v-raf-1 murine leukemia viral oncogene homolog 1 
       4277 MICB; MHC class I polypeptide-related sequence B
       100507436 MICA; MHC class I polypeptide-related sequence A
       80329 ULBP1; UL16 binding protein 1
       80328 ULBP2; UL16 binding protein 2
       79465 ULBP3; UL16 binding protein 3
       353091 RAET1G; retinoic acid early transcript 1G
       154064 RAET1L; retinoic acid early transcript 1L
       135250 RAET1E; retinoic acid early transcript 1E
       22914 KLRK1; killer cell lectin-like receptor subfamily K, member 1
       100528032 KLRC4-KLRK1; KLRC4-KLRK1 readthrough
       10870 HCST; hematopoietic cell signal transducer
       962 CD48; CD48 molecule
       51744 CD244; CD244 molecule, natural killer cell receptor 2B4
       5530 PPP3CA; protein phosphatase 3, catalytic subunit, alpha isozyme 
       5532 PPP3CB; protein phosphatase 3, catalytic subunit, beta isozyme 
       5533 PPP3CC; protein phosphatase 3, catalytic subunit, gamma isozyme 
       5534 PPP3R1; protein phosphatase 3, regulatory subunit B, alpha 
       5535 PPP3R2; protein phosphatase 3, regulatory subunit B, beta 
       4772 NFATC1; nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1
       4773 NFATC2; nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2
       5578 PRKCA; protein kinase C, alpha 
       5579 PRKCB; protein kinase C, beta 
       5582 PRKCG; protein kinase C, gamma 
       117157 SH2D1B; SH2 domain containing 1B
       4068 SH2D1A; SH2 domain containing 1A
       3459 IFNGR1; interferon gamma receptor 1
       3460 IFNGR2; interferon gamma receptor 2 (interferon gamma transducer 1)
       3439 IFNA1; interferon, alpha 1
       3440 IFNA2; interferon, alpha 2
       3441 IFNA4; interferon, alpha 4
       3442 IFNA5; interferon, alpha 5
       3443 IFNA6; interferon, alpha 6
       3444 IFNA7; interferon, alpha 7
       3445 IFNA8; interferon, alpha 8
       3446 IFNA10; interferon, alpha 10
       3447 IFNA13; interferon, alpha 13
       3448 IFNA14; interferon, alpha 14
       3449 IFNA16; interferon, alpha 16
       3451 IFNA17; interferon, alpha 17
       3452 IFNA21; interferon, alpha 21
       3456 IFNB1; interferon, beta 1, fibroblast
       3454 IFNAR1; interferon (alpha, beta and omega) receptor 1
       3455 IFNAR2; interferon (alpha, beta and omega) receptor 2
       8743 TNFSF10; tumor necrosis factor (ligand) superfamily, member 10
       8797 TNFRSF10A; tumor necrosis factor receptor superfamily, member 10a
       8795 TNFRSF10B; tumor necrosis factor receptor superfamily, member 10b
       8794 TNFRSF10C; tumor necrosis factor receptor superfamily, member 10c, decoy without an intracellular domain
       8793 TNFRSF10D; tumor necrosis factor receptor superfamily, member 10d, decoy with truncated death domain
       356 FASLG; Fas ligand (TNF superfamily, member 6)
       355 FAS; Fas cell surface death receptor
       3002 GZMB; granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1) 
       5551 PRF1; perforin 1 (pore forming protein)
       836 CASP3; caspase 3, apoptosis-related cysteine peptidase 
       637 BID; BH3 interacting domain death agonist
K06751 MHC1; major histocompatibility complex, class I
K06751 MHC1; major histocompatibility complex, class I
K06751 MHC1; major histocompatibility complex, class I
K06751 MHC1; major histocompatibility complex, class I
K06751 MHC1; major histocompatibility complex, class I
K06751 MHC1; major histocompatibility complex, class I
K07980 KIR3DL; killer cell immunoglobulin-like receptor 3DL
K07980 KIR3DL; killer cell immunoglobulin-like receptor 3DL
K07980 KIR3DL; killer cell immunoglobulin-like receptor 3DL
K07981 KIR2DL; killer cell immunoglobulin-like receptor 2DL
K07981 KIR2DL; killer cell immunoglobulin-like receptor 2DL
K07981 KIR2DL; killer cell immunoglobulin-like receptor 2DL
K07981 KIR2DL; killer cell immunoglobulin-like receptor 2DL
K07981 KIR2DL; killer cell immunoglobulin-like receptor 2DL
K06541 KLRC; killer cell lectin-like receptor subfamily C
K06541 KLRC; killer cell lectin-like receptor subfamily C
K06541 KLRC; killer cell lectin-like receptor subfamily C
K06541 KLRC; killer cell lectin-like receptor subfamily C
K06516 KLRD1; killer cell lectin-like receptor subfamily D member 1
K05697 PTPN6; tyrosine-protein phosphatase non-receptor type 6 [EC:3.1.3.48]
K07293 PTPN11; tyrosine-protein phosphatase non-receptor type 11 [EC:3.1.3.48]
K06490 ICAM1; intercellular adhesion molecule 1
K06523 ICAM2; intercellular adhesion molecule 2
K05718 ITGAL; integrin alpha L
K06464 ITGB2; integrin beta 2
K05871 PTK2B; focal adhesion kinase 2 [EC:2.7.10.2]
K05730 VAV; guanine nucleotide exchange factor VAV
K05730 VAV; guanine nucleotide exchange factor VAV
K05730 VAV; guanine nucleotide exchange factor VAV
K04392 RAC1; Ras-related C3 botulinum toxin substrate 1
K07860 RAC2; Ras-related C3 botulinum toxin substrate 2
K07861 RAC3; Ras-related C3 botulinum toxin substrate 3
K04409 PAK1; p21-activated kinase 1 [EC:2.7.11.1]
K04368 MAP2K1; mitogen-activated protein kinase kinase 1 [EC:2.7.12.2]
K04369 MAP2K2; mitogen-activated protein kinase kinase 2 [EC:2.7.12.2]
K04371 MAPK1_3; mitogen-activated protein kinase 1/3 [EC:2.7.11.24]
K04371 MAPK1_3; mitogen-activated protein kinase 1/3 [EC:2.7.11.24]
K03156 TNFA; tumor necrosis factor superfamily, member 2
K05427 CSF2; granulocyte-macrophage colony-stimulating factor
K04687 IFNG; interferon gamma
K07982 KIR2DS; killer cell immunoglobulin-like receptor 2DS
K07982 KIR2DS; killer cell immunoglobulin-like receptor 2DS
K07982 KIR2DS; killer cell immunoglobulin-like receptor 2DS
K07982 KIR2DS; killer cell immunoglobulin-like receptor 2DS
K07982 KIR2DS; killer cell immunoglobulin-like receptor 2DS
K06742 NCR2; natural cytotoxicity triggering receptor 2
K07992 TYROBP; TYRO protein tyrosine kinase binding protein
K05856 LCK; lymphocyte cell-specific protein tyrosine kinase [EC:2.7.10.2]
K06463 FCGR3; low affinity immunoglobulin gamma Fc region receptor III
K06463 FCGR3; low affinity immunoglobulin gamma Fc region receptor III
K06741 NCR1; natural cytotoxicity triggering receptor 1
K06743 NCR3; natural cytotoxicity triggering receptor 3
K07983 FCER1G; Fc receptor, IgE, high affinity I, gamma polypeptide
K06453 CD3Z; CD3Z antigen, zeta polypeptide
K07360 ZAP70; tyrosine-protein kinase ZAP-70 [EC:2.7.10.2]
K05855 SYK; spleen tyrosine kinase [EC:2.7.10.2]
K07361 LCP2; lymphocyte cytosolic protein 2
K07362 LAT; linker for activation of T cells
K01116 PLCG1; phosphatidylinositol phospholipase C, gamma-1 [EC:3.1.4.11]
K05859 PLCG2; phosphatidylinositol phospholipase C, gamma-2 [EC:3.1.4.11]
K07984 SH3BP2; SH3-domain binding protein 2
K00922 PIK3C; phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
K00922 PIK3C; phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
K00922 PIK3C; phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
K00922 PIK3C; phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
K02649 PIK3R; phosphoinositide-3-kinase, regulatory subunit
K02649 PIK3R; phosphoinositide-3-kinase, regulatory subunit
K02649 PIK3R; phosphoinositide-3-kinase, regulatory subunit
K02649 PIK3R; phosphoinositide-3-kinase, regulatory subunit
K05703 FYN; tyrosine-protein kinase Fyn [EC:2.7.10.2]
K06279 SHC1; SHC- transforming protein 1
K17447 SHC2; SHC- transforming protein 2
K17448 SHC3; SHC- transforming protein 3
K17449 SHC4; SHC- transforming protein 4
K04364 GRB2; growth factor receptor-binding protein 2
K03099 SOS; son of sevenless
K03099 SOS; son of sevenless
K02833 HRAS; GTPase HRas
K07827 KRAS; GTPase KRas
K07828 NRAS; GTPase NRas
K08845 ARAF; A-Raf proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1]
K04365 BRAF; B-Raf proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1]
K04366 RAF1; RAF proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1]
K07985 MIC; MHC class I-related protein
K07985 MIC; MHC class I-related protein
K07986 ULBP; UL16 binding protein
K07986 ULBP; UL16 binding protein
K07986 ULBP; UL16 binding protein
K07987 RAET1; retinoic acid early transcript 1
K07987 RAET1; retinoic acid early transcript 1
K07987 RAET1; retinoic acid early transcript 1
K06728 KLRK1; killer cell lectin-like receptor subfamily K member 1
K06728 KLRK1; killer cell lectin-like receptor subfamily K member 1
K07988 HCST; hematopoietic cell signal transducer
K06479 CD48; CD48 antigen
K06582 CD244; natural killer cell receptor 2B4
K04348 PPP3C; serine/threonine-protein phosphatase 2B catalytic subunit [EC:3.1.3.16]
K04348 PPP3C; serine/threonine-protein phosphatase 2B catalytic subunit [EC:3.1.3.16]
K04348 PPP3C; serine/threonine-protein phosphatase 2B catalytic subunit [EC:3.1.3.16]
K06268 PPP3R; serine/threonine-protein phosphatase 2B regulatory subunit
K06268 PPP3R; serine/threonine-protein phosphatase 2B regulatory subunit
K04446 NFATC1; nuclear factor of activated T-cells, cytoplasmic 1
K17332 NFATC2; nuclear factor of activated T-cells, cytoplasmic 2
K02677 CPKC; classical protein kinase C [EC:2.7.11.13]
K02677 CPKC; classical protein kinase C [EC:2.7.11.13]
K02677 CPKC; classical protein kinase C [EC:2.7.11.13]
K07989 EAT2; EWS/FLI1 activated transcript 2
K07990 SH2D1A; SH2 domain protein 1A
K05132 IFNGR1; interferon gamma receptor 1
K05133 IFNGR2; interferon gamma receptor 2
K05414 IFNA; interferon alpha
K05414 IFNA; interferon alpha
K05414 IFNA; interferon alpha
K05414 IFNA; interferon alpha
K05414 IFNA; interferon alpha
K05414 IFNA; interferon alpha
K05414 IFNA; interferon alpha
K05414 IFNA; interferon alpha
K05414 IFNA; interferon alpha
K05414 IFNA; interferon alpha
K05414 IFNA; interferon alpha
K05414 IFNA; interferon alpha
K05414 IFNA; interferon alpha
K05415 IFNB; interferon beta
K05130 IFNAR1; interferon receptor 1
K05131 IFNAR2; interferon receptor 2
K04721 TNFSF10; tumor necrosis factor ligand superfamily member 10
K04722 TNFRSF10; tumor necrosis factor receptor superfamily member 10
K04722 TNFRSF10; tumor necrosis factor receptor superfamily member 10
K04722 TNFRSF10; tumor necrosis factor receptor superfamily member 10
K04722 TNFRSF10; tumor necrosis factor receptor superfamily member 10
K04389 TNFSF6; tumor necrosis factor ligand superfamily member 6
K04390 TNFRSF6; tumor necrosis factor receptor superfamily member 6
K01353 GZMB; granzyme B [EC:3.4.21.79]
K07818 PRF1; perforin 1
K02187 CASP3; caspase 3 [EC:3.4.22.56]
K04726 BID; BH3 interacting domain death agonist
     04612 Antigen processing and presentation [PATH:hsa04612]
       3458 IFNG; interferon, gamma
       7124 TNF; tumor necrosis factor
       5720 PSME1; proteasome (prosome, macropain) activator subunit 1 (PA28 alpha)
       5721 PSME2; proteasome (prosome, macropain) activator subunit 2 (PA28 beta)
       10197 PSME3; proteasome (prosome, macropain) activator subunit 3 (PA28 gamma; Ki)
       3312 HSPA8; heat shock 70kDa protein 8
       3303 HSPA1A; heat shock 70kDa protein 1A
       3306 HSPA2; heat shock 70kDa protein 2
       3305 HSPA1L; heat shock 70kDa protein 1-like
       3304 HSPA1B; heat shock 70kDa protein 1B
       3310 HSPA6; heat shock 70kDa protein 6 (HSP70B')
       3308 HSPA4; heat shock 70kDa protein 4
       3320 HSP90AA1; heat shock protein 90kDa alpha (cytosolic), class A member 1
       3326 HSP90AB1; heat shock protein 90kDa alpha (cytosolic), class B member 1
       3105 HLA-A; major histocompatibility complex, class I, A
       3106 HLA-B; major histocompatibility complex, class I, B
       3107 HLA-C; major histocompatibility complex, class I, C
       3134 HLA-F; major histocompatibility complex, class I, F
       3135 HLA-G; major histocompatibility complex, class I, G
       3133 HLA-E; major histocompatibility complex, class I, E
       821 CANX; calnexin
       567 B2M; beta-2-microglobulin
       2923 PDIA3; protein disulfide isomerase family A, member 3 
       811 CALR; calreticulin
       6892 TAPBP; TAP binding protein (tapasin)
       6890 TAP1; transporter 1, ATP-binding cassette, sub-family B (MDR/TAP)
       6891 TAP2; transporter 2, ATP-binding cassette, sub-family B (MDR/TAP)
       925 CD8A; CD8a molecule
       926 CD8B; CD8b molecule
       3812 KIR3DL2; killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2
       3811 KIR3DL1; killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1
       115653 KIR3DL3; killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 3
       3803 KIR2DL2; killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 2
       3802 KIR2DL1; killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1
       3804 KIR2DL3; killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3
       3805 KIR2DL4; killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4
       57292 KIR2DL5A; killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 5A
       3821 KLRC1; killer cell lectin-like receptor subfamily C, member 1
       3822 KLRC2; killer cell lectin-like receptor subfamily C, member 2
       3823 KLRC3; killer cell lectin-like receptor subfamily C, member 3
       8302 KLRC4; killer cell lectin-like receptor subfamily C, member 4
       3824 KLRD1; killer cell lectin-like receptor subfamily D, member 1
       3806 KIR2DS1; killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 1
       3808 KIR2DS3; killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 3
       3809 KIR2DS4; killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4
       3810 KIR2DS5; killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 5
       100132285 KIR2DS2; killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 2
       10437 IFI30; interferon, gamma-inducible protein 30
       5641 LGMN; legumain 
       1508 CTSB; cathepsin B 
       3108 HLA-DMA; major histocompatibility complex, class II, DM alpha
       3109 HLA-DMB; major histocompatibility complex, class II, DM beta
       3111 HLA-DOA; major histocompatibility complex, class II, DO alpha
       3112 HLA-DOB; major histocompatibility complex, class II, DO beta
       3113 HLA-DPA1; major histocompatibility complex, class II, DP alpha 1
       3115 HLA-DPB1; major histocompatibility complex, class II, DP beta 1
       3117 HLA-DQA1; major histocompatibility complex, class II, DQ alpha 1
       3118 HLA-DQA2; major histocompatibility complex, class II, DQ alpha 2
       3119 HLA-DQB1; major histocompatibility complex, class II, DQ beta 1
       3122 HLA-DRA; major histocompatibility complex, class II, DR alpha
       3123 HLA-DRB1; major histocompatibility complex, class II, DR beta 1
       3125 HLA-DRB3; major histocompatibility complex, class II, DR beta 3
       3126 HLA-DRB4; major histocompatibility complex, class II, DR beta 4
       3127 HLA-DRB5; major histocompatibility complex, class II, DR beta 5
       100509457 HLA class II histocompatibility antigen
       101060835 HLA class II histocompatibility antigen
       972 CD74; CD74 molecule, major histocompatibility complex, class II invariant chain
       1514 CTSL; cathepsin L 
       1520 CTSS; cathepsin S 
       920 CD4; CD4 molecule
       4261 CIITA; class II, major histocompatibility complex, transactivator
       5993 RFX5; regulatory factor X, 5 (influences HLA class II expression)
       8625 RFXANK; regulatory factor X-associated ankyrin-containing protein
       5994 RFXAP; regulatory factor X-associated protein
       1385 CREB1; cAMP responsive element binding protein 1
       4800 NFYA; nuclear transcription factor Y, alpha
       4801 NFYB; nuclear transcription factor Y, beta
       4802 NFYC; nuclear transcription factor Y, gamma
       3309 HSPA5; heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)
K04687 IFNG; interferon gamma
K03156 TNFA; tumor necrosis factor superfamily, member 2
K06696 PSME1; proteasome activator subunit 1 (PA28 alpha)
K06697 PSME2; proteasome activator subunit 2 (PA28 beta)
K06698 PSME3; proteasome activator subunit 3 (PA28 gamma)
K03283 HSPA1_8; heat shock 70kDa protein 1/8
K03283 HSPA1_8; heat shock 70kDa protein 1/8
K03283 HSPA1_8; heat shock 70kDa protein 1/8
K03283 HSPA1_8; heat shock 70kDa protein 1/8
K03283 HSPA1_8; heat shock 70kDa protein 1/8
K03283 HSPA1_8; heat shock 70kDa protein 1/8
K09489 HSPA4; heat shock 70kDa protein 4
K04079 htpG; molecular chaperone HtpG
K04079 htpG; molecular chaperone HtpG
K06751 MHC1; major histocompatibility complex, class I
K06751 MHC1; major histocompatibility complex, class I
K06751 MHC1; major histocompatibility complex, class I
K06751 MHC1; major histocompatibility complex, class I
K06751 MHC1; major histocompatibility complex, class I
K06751 MHC1; major histocompatibility complex, class I
K08054 CANX; calnexin
K08055 B2M; beta-2-microglobulin
K08056 PDIA3; protein disulfide isomerase family A, member 3 [EC:5.3.4.1]
K08057 CALR; calreticulin
K08058 TAPBP; TAP binding protein (tapasin)
K05653 ABCB2; ATP-binding cassette, subfamily B (MDR/TAP), member 2
K05654 ABCB3; ATP-binding cassette, subfamily B (MDR/TAP), member 3
K06458 CD8A; CD8A antigen, alpha polypeptide
K06459 CD8B; CD8B antigen, beta polypeptide
K07980 KIR3DL; killer cell immunoglobulin-like receptor 3DL
K07980 KIR3DL; killer cell immunoglobulin-like receptor 3DL
K07980 KIR3DL; killer cell immunoglobulin-like receptor 3DL
K07981 KIR2DL; killer cell immunoglobulin-like receptor 2DL
K07981 KIR2DL; killer cell immunoglobulin-like receptor 2DL
K07981 KIR2DL; killer cell immunoglobulin-like receptor 2DL
K07981 KIR2DL; killer cell immunoglobulin-like receptor 2DL
K07981 KIR2DL; killer cell immunoglobulin-like receptor 2DL
K06541 KLRC; killer cell lectin-like receptor subfamily C
K06541 KLRC; killer cell lectin-like receptor subfamily C
K06541 KLRC; killer cell lectin-like receptor subfamily C
K06541 KLRC; killer cell lectin-like receptor subfamily C
K06516 KLRD1; killer cell lectin-like receptor subfamily D member 1
K07982 KIR2DS; killer cell immunoglobulin-like receptor 2DS
K07982 KIR2DS; killer cell immunoglobulin-like receptor 2DS
K07982 KIR2DS; killer cell immunoglobulin-like receptor 2DS
K07982 KIR2DS; killer cell immunoglobulin-like receptor 2DS
K07982 KIR2DS; killer cell immunoglobulin-like receptor 2DS
K08059 IFI30; interferon, gamma-inducible protein 30
K01369 LGMN; legumain [EC:3.4.22.34]
K01363 CTSB; cathepsin B [EC:3.4.22.1]
K06752 MHC2; major histocompatibility complex, class II
K06752 MHC2; major histocompatibility complex, class II
K06752 MHC2; major histocompatibility complex, class II
K06752 MHC2; major histocompatibility complex, class II
K06752 MHC2; major histocompatibility complex, class II
K06752 MHC2; major histocompatibility complex, class II
K06752 MHC2; major histocompatibility complex, class II
K06752 MHC2; major histocompatibility complex, class II
K06752 MHC2; major histocompatibility complex, class II
K06752 MHC2; major histocompatibility complex, class II
K06752 MHC2; major histocompatibility complex, class II
K06752 MHC2; major histocompatibility complex, class II
K06752 MHC2; major histocompatibility complex, class II
K06752 MHC2; major histocompatibility complex, class II
K06752 MHC2; major histocompatibility complex, class II
K06752 MHC2; major histocompatibility complex, class II
K06505 CD74; CD74 antigen
K01365 CTSL; cathepsin L [EC:3.4.22.15]
K01368 CTSS; cathepsin S [EC:3.4.22.27]
K06454 CD4; CD4 antigen
K08060 CIITA; class II, major histocompatibility complex, transactivator
K08061 RFX5; regulatory factor X 5
K08062 RFXANK; regulatory factor X-associated ankyrin-containing protein
K08063 RFXAP; regulatory factor X-associated protein
K05870 CREB1; cyclic AMP-responsive element-binding protein 1
K08064 NFYA; nuclear transcription factor Y, alpha
K08065 NFYB; nuclear transcription Y subunit beta
K08066 NFYC; nuclear transcription factor Y, gamma
K09490 HSPA5; heat shock 70kDa protein 5
     04660 T cell receptor signaling pathway [PATH:hsa04660]
       915 CD3D; CD3d molecule, delta (CD3-TCR complex)
       916 CD3E; CD3e molecule, epsilon (CD3-TCR complex)
       917 CD3G; CD3g molecule, gamma (CD3-TCR complex)
       919 CD247; CD247 molecule
       920 CD4; CD4 molecule
       925 CD8A; CD8a molecule
       926 CD8B; CD8b molecule
       5788 PTPRC; protein tyrosine phosphatase, receptor type, C 
       3932 LCK; lymphocyte-specific protein tyrosine kinase 
       2534 FYN; FYN oncogene related to SRC, FGR, YES 
       7535 ZAP70; zeta-chain (TCR) associated protein kinase 70kDa 
       3937 LCP2; lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa)
       27040 LAT; linker for activation of T cells
       3702 ITK; IL2-inducible T-cell kinase 
       7006 TEC; tec protein tyrosine kinase 
       4690 NCK1; NCK adaptor protein 1
       8440 NCK2; NCK adaptor protein 2
       10451 VAV3; vav 3 guanine nucleotide exchange factor
       7409 VAV1; vav 1 guanine nucleotide exchange factor
       7410 VAV2; vav 2 guanine nucleotide exchange factor
       9402 GRAP2; GRB2-related adaptor protein 2
       2885 GRB2; growth factor receptor-bound protein 2
       5058 PAK1; p21 protein (Cdc42/Rac)-activated kinase 1 
       5062 PAK2; p21 protein (Cdc42/Rac)-activated kinase 2 
       5063 PAK3; p21 protein (Cdc42/Rac)-activated kinase 3 
       10298 PAK4; p21 protein (Cdc42/Rac)-activated kinase 4 
       56924 PAK6; p21 protein (Cdc42/Rac)-activated kinase 6 
       57144 PAK7; p21 protein (Cdc42/Rac)-activated kinase 7 
       387 RHOA; ras homolog family member A
       998 CDC42; cell division cycle 42
       1739 DLG1; discs, large homolog 1 (Drosophila)
       5600 MAPK11; mitogen-activated protein kinase 11 
       6300 MAPK12; mitogen-activated protein kinase 12 
       5603 MAPK13; mitogen-activated protein kinase 13 
       1432 MAPK14; mitogen-activated protein kinase 14 
       5335 PLCG1; phospholipase C, gamma 1 
       5530 PPP3CA; protein phosphatase 3, catalytic subunit, alpha isozyme 
       5532 PPP3CB; protein phosphatase 3, catalytic subunit, beta isozyme 
       5533 PPP3CC; protein phosphatase 3, catalytic subunit, gamma isozyme 
       5534 PPP3R1; protein phosphatase 3, regulatory subunit B, alpha 
       5535 PPP3R2; protein phosphatase 3, regulatory subunit B, beta 
       4772 NFATC1; nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1
       4773 NFATC2; nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2
       4775 NFATC3; nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 3
       6654 SOS1; son of sevenless homolog 1 (Drosophila)
       6655 SOS2; son of sevenless homolog 2 (Drosophila)
       10125 RASGRP1; RAS guanyl releasing protein 1 (calcium and DAG-regulated)
       3265 HRAS; Harvey rat sarcoma viral oncogene homolog
       3845 KRAS; Kirsten rat sarcoma viral oncogene homolog
       4893 NRAS; neuroblastoma RAS viral (v-ras) oncogene homolog
       5894 RAF1; v-raf-1 murine leukemia viral oncogene homolog 1 
       5604 MAP2K1; mitogen-activated protein kinase kinase 1 
       5605 MAP2K2; mitogen-activated protein kinase kinase 2 
       5594 MAPK1; mitogen-activated protein kinase 1 
       5595 MAPK3; mitogen-activated protein kinase 3 
       2353 FOS; FBJ murine osteosarcoma viral oncogene homolog
       3725 JUN; jun proto-oncogene
       5588 PRKCQ; protein kinase C, theta 
       84433 CARD11; caspase recruitment domain family, member 11
       8915 BCL10; B-cell CLL/lymphoma 10
       10892 MALT1; mucosa associated lymphoid tissue lymphoma translocation gene 1 
       6885 MAP3K7; mitogen-activated protein kinase kinase kinase 7 
       5609 MAP2K7; mitogen-activated protein kinase kinase 7 
       1147 CHUK; conserved helix-loop-helix ubiquitous kinase 
       3551 IKBKB; inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta 
       8517 IKBKG; inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma
       4790 NFKB1; nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
       5970 RELA; v-rel avian reticuloendotheliosis viral oncogene homolog A
       4792 NFKBIA; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha
       4793 NFKBIB; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, beta
       4794 NFKBIE; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon
       940 CD28; CD28 molecule
       29851 ICOS; inducible T-cell co-stimulator
       959 CD40LG; CD40 ligand
       5295 PIK3R1; phosphoinositide-3-kinase, regulatory subunit 1 (alpha)
       23533 PIK3R5; phosphoinositide-3-kinase, regulatory subunit 5
       5296 PIK3R2; phosphoinositide-3-kinase, regulatory subunit 2 (beta)
       8503 PIK3R3; phosphoinositide-3-kinase, regulatory subunit 3 (gamma)
       5290 PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha 
       5293 PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta 
       5291 PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta 
       5294 PIK3CG; phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma 
       5170 PDPK1; 3-phosphoinositide dependent protein kinase 1 
       207 AKT1; v-akt murine thymoma viral oncogene homolog 1 
       208 AKT2; v-akt murine thymoma viral oncogene homolog 2 
       10000 AKT3; v-akt murine thymoma viral oncogene homolog 3 
       1326 MAP3K8; mitogen-activated protein kinase kinase kinase 8 
       9020 MAP3K14; mitogen-activated protein kinase kinase kinase 14 
       2932 GSK3B; glycogen synthase kinase 3 beta 
       5133 PDCD1; programmed cell death 1
       1493 CTLA4; cytotoxic T-lymphocyte-associated protein 4
       5777 PTPN6; protein tyrosine phosphatase, non-receptor type 6 
       23624 CBLC; Cbl proto-oncogene C, E3 ubiquitin protein ligase
       867 CBL; Cbl proto-oncogene, E3 ubiquitin protein ligase
       868 CBLB; Cbl proto-oncogene B, E3 ubiquitin protein ligase
       3558 IL2; interleukin 2
       3565 IL4; interleukin 4
       3567 IL5; interleukin 5
       3586 IL10; interleukin 10
       3458 IFNG; interferon, gamma
       1437 CSF2; colony stimulating factor 2 (granulocyte-macrophage)
       7124 TNF; tumor necrosis factor
       1019 CDK4; cyclin-dependent kinase 4 
       5601 MAPK9; mitogen-activated protein kinase 9 
K06450 CD3D; T-cell surface glycoprotein CD3 delta chain
K06451 CD3E; T-cell surface glycoprotein CD3 epsilon chain
K06452 CD3G; T-cell surface glycoprotein CD3 gamma chain
K06453 CD3Z; CD3Z antigen, zeta polypeptide
K06454 CD4; CD4 antigen
K06458 CD8A; CD8A antigen, alpha polypeptide
K06459 CD8B; CD8B antigen, beta polypeptide
K06478 PTPRC; receptor-type tyrosine-protein phosphatase C [EC:3.1.3.48]
K05856 LCK; lymphocyte cell-specific protein tyrosine kinase [EC:2.7.10.2]
K05703 FYN; tyrosine-protein kinase Fyn [EC:2.7.10.2]
K07360 ZAP70; tyrosine-protein kinase ZAP-70 [EC:2.7.10.2]
K07361 LCP2; lymphocyte cytosolic protein 2
K07362 LAT; linker for activation of T cells
K07363 ITK; IL2-inducible T-cell kinase [EC:2.7.10.2]
K07364 TEC; tyrosine-protein kinase Tec [EC:2.7.10.2]
K07365 NCK; NCK adaptor protein
K07365 NCK; NCK adaptor protein
K05730 VAV; guanine nucleotide exchange factor VAV
K05730 VAV; guanine nucleotide exchange factor VAV
K05730 VAV; guanine nucleotide exchange factor VAV
K07366 GRAP2; GRB2-related adaptor protein 2
K04364 GRB2; growth factor receptor-binding protein 2
K04409 PAK1; p21-activated kinase 1 [EC:2.7.11.1]
K04410 PAK2; p21-activated kinase 2 [EC:2.7.11.1]
K05733 PAK3; p21-activated kinase 3 [EC:2.7.11.1]
K05734 PAK4; p21-activated kinase 4 [EC:2.7.11.1]
K05735 PAK6; p21-activated kinase 6 [EC:2.7.11.1]
K05736 PAK7; p21-activated kinase 7 [EC:2.7.11.1]
K04513 RHOA; Ras homolog gene family, member A
K04393 CDC42; cell division control protein 42
K12076 DLG1; disks large protein 1
K04441 P38; p38 MAP kinase [EC:2.7.11.24]
K04441 P38; p38 MAP kinase [EC:2.7.11.24]
K04441 P38; p38 MAP kinase [EC:2.7.11.24]
K04441 P38; p38 MAP kinase [EC:2.7.11.24]
K01116 PLCG1; phosphatidylinositol phospholipase C, gamma-1 [EC:3.1.4.11]
K04348 PPP3C; serine/threonine-protein phosphatase 2B catalytic subunit [EC:3.1.3.16]
K04348 PPP3C; serine/threonine-protein phosphatase 2B catalytic subunit [EC:3.1.3.16]
K04348 PPP3C; serine/threonine-protein phosphatase 2B catalytic subunit [EC:3.1.3.16]
K06268 PPP3R; serine/threonine-protein phosphatase 2B regulatory subunit
K06268 PPP3R; serine/threonine-protein phosphatase 2B regulatory subunit
K04446 NFATC1; nuclear factor of activated T-cells, cytoplasmic 1
K17332 NFATC2; nuclear factor of activated T-cells, cytoplasmic 2
K17333 NFATC3; nuclear factor of activated T-cells, cytoplasmic 3
K03099 SOS; son of sevenless
K03099 SOS; son of sevenless
K04350 RASGRP1; RAS guanyl-releasing protein 1
K02833 HRAS; GTPase HRas
K07827 KRAS; GTPase KRas
K07828 NRAS; GTPase NRas
K04366 RAF1; RAF proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1]
K04368 MAP2K1; mitogen-activated protein kinase kinase 1 [EC:2.7.12.2]
K04369 MAP2K2; mitogen-activated protein kinase kinase 2 [EC:2.7.12.2]
K04371 MAPK1_3; mitogen-activated protein kinase 1/3 [EC:2.7.11.24]
K04371 MAPK1_3; mitogen-activated protein kinase 1/3 [EC:2.7.11.24]
K04379 FOS; proto-oncogene protein c-fos
K04448 JUN; transcription factor AP-1
K18052 PRKCQ; novel protein kinase C theta type [EC:2.7.11.13]
K07367 CARD11; caspase recruitment domain-containing protein 11
K07368 BCL10; B-cell CLL/lymphoma 10
K07369 MALT1; mucosa-associated lymphoid tissue lymphoma translocation protein 1 [EC:3.4.22.-]
K04427 MAP3K7; mitogen-activated protein kinase kinase kinase 7 [EC:2.7.11.25]
K04431 MAP2K7; mitogen-activated protein kinase kinase 7 [EC:2.7.12.2]
K04467 IKBKA; inhibitor of nuclear factor kappa-B kinase subunit alpha [EC:2.7.11.10]
K07209 IKBKB; inhibitor of nuclear factor kappa-B kinase subunit beta [EC:2.7.11.10]
K07210 IKBKG; inhibitor of nuclear factor kappa-B kinase subunit gamma
K02580 NFKB1; nuclear factor NF-kappa-B p105 subunit
K04735 RELA; transcription factor p65
K04734 NFKBIA; NF-kappa-B inhibitor alpha
K02581 NFKBIB; NF-kappa-B inhibitor beta
K05872 NFKBIE; NF-kappa-B inhibitor epsilon
K06470 CD28; CD28 antigen
K06713 ICOS; inducible T-cell co-stimulator
K03161 TNFSF5; tumor necrosis factor ligand superfamily member 5
K02649 PIK3R; phosphoinositide-3-kinase, regulatory subunit
K02649 PIK3R; phosphoinositide-3-kinase, regulatory subunit
K02649 PIK3R; phosphoinositide-3-kinase, regulatory subunit
K02649 PIK3R; phosphoinositide-3-kinase, regulatory subunit
K00922 PIK3C; phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
K00922 PIK3C; phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
K00922 PIK3C; phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
K00922 PIK3C; phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
K06276 PDPK1; 3-phosphoinositide dependent protein kinase-1 [EC:2.7.11.1]
K04456 AKT; RAC serine/threonine-protein kinase [EC:2.7.11.1]
K04456 AKT; RAC serine/threonine-protein kinase [EC:2.7.11.1]
K04456 AKT; RAC serine/threonine-protein kinase [EC:2.7.11.1]
K04415 MAP3K8; mitogen-activated protein kinase kinase kinase 8 [EC:2.7.11.25]
K04466 MAP3K14; mitogen-activated protein kinase kinase kinase 14 [EC:2.7.11.25]
K03083 GSK3B; glycogen synthase kinase 3 beta [EC:2.7.11.26]
K06744 PDCD1; programmed cell death protein 1
K06538 CTLA4; cytotoxic T-lymphocyte-associated protein 4
K05697 PTPN6; tyrosine-protein phosphatase non-receptor type 6 [EC:3.1.3.48]
K04707 CBL; E3 ubiquitin-protein ligase CBL [EC:6.3.2.19]
K04707 CBL; E3 ubiquitin-protein ligase CBL [EC:6.3.2.19]
K04707 CBL; E3 ubiquitin-protein ligase CBL [EC:6.3.2.19]
K05429 IL2; interleukin 2
K05430 IL4; interleukin 4
K05428 IL5; interleukin 5
K05443 IL10; interleukin 10
K04687 IFNG; interferon gamma
K05427 CSF2; granulocyte-macrophage colony-stimulating factor
K03156 TNFA; tumor necrosis factor superfamily, member 2
K02089 CDK4; cyclin-dependent kinase 4 [EC:2.7.11.22]
K04440 JNK; c-Jun N-terminal kinase [EC:2.7.11.24]
     04662 B cell receptor signaling pathway [PATH:hsa04662]
     04664 Fc epsilon RI signaling pathway [PATH:hsa04664]
       2205 FCER1A; Fc fragment of IgE, high affinity I, receptor for; alpha polypeptide
       2206 MS4A2; membrane-spanning 4-domains, subfamily A, member 2
       2207 FCER1G; Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide
       6850 SYK; spleen tyrosine kinase 
       4067 LYN; v-yes-1 Yamaguchi sarcoma viral related oncogene homolog 
       695 BTK; Bruton agammaglobulinemia tyrosine kinase 
       3635 INPP5D; inositol polyphosphate-5-phosphatase, 145kDa 
       5335 PLCG1; phospholipase C, gamma 1 
       5336 PLCG2; phospholipase C, gamma 2 (phosphatidylinositol-specific) 
       5290 PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha 
       5293 PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta 
       5291 PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta 
       5294 PIK3CG; phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma 
       5295 PIK3R1; phosphoinositide-3-kinase, regulatory subunit 1 (alpha)
       23533 PIK3R5; phosphoinositide-3-kinase, regulatory subunit 5
       5296 PIK3R2; phosphoinositide-3-kinase, regulatory subunit 2 (beta)
       8503 PIK3R3; phosphoinositide-3-kinase, regulatory subunit 3 (gamma)
       5170 PDPK1; 3-phosphoinositide dependent protein kinase 1 
       207 AKT1; v-akt murine thymoma viral oncogene homolog 1 
       208 AKT2; v-akt murine thymoma viral oncogene homolog 2 
       10000 AKT3; v-akt murine thymoma viral oncogene homolog 3 
       5879 RAC1; ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)
       5880 RAC2; ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2)
       5881 RAC3; ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3)
       6416 MAP2K4; mitogen-activated protein kinase kinase 4 
       5609 MAP2K7; mitogen-activated protein kinase kinase 7 
       5606 MAP2K3; mitogen-activated protein kinase kinase 3 
       5608 MAP2K6; mitogen-activated protein kinase kinase 6 
       5599 MAPK8; mitogen-activated protein kinase 8 
       5602 MAPK10; mitogen-activated protein kinase 10 
       5601 MAPK9; mitogen-activated protein kinase 9 
       5600 MAPK11; mitogen-activated protein kinase 11 
       6300 MAPK12; mitogen-activated protein kinase 12 
       5603 MAPK13; mitogen-activated protein kinase 13 
       1432 MAPK14; mitogen-activated protein kinase 14 
       3565 IL4; interleukin 4
       3596 IL13; interleukin 13
       3562 IL3; interleukin 3
       3567 IL5; interleukin 5
       1437 CSF2; colony stimulating factor 2 (granulocyte-macrophage)
       7124 TNF; tumor necrosis factor
       3937 LCP2; lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa)
       10451 VAV3; vav 3 guanine nucleotide exchange factor
       7409 VAV1; vav 1 guanine nucleotide exchange factor
       7410 VAV2; vav 2 guanine nucleotide exchange factor
       2534 FYN; FYN oncogene related to SRC, FGR, YES 
       9846 GAB2; GRB2-associated binding protein 2
       27040 LAT; linker for activation of T cells
       2885 GRB2; growth factor receptor-bound protein 2
       6654 SOS1; son of sevenless homolog 1 (Drosophila)
       6655 SOS2; son of sevenless homolog 2 (Drosophila)
       3265 HRAS; Harvey rat sarcoma viral oncogene homolog
       3845 KRAS; Kirsten rat sarcoma viral oncogene homolog
       4893 NRAS; neuroblastoma RAS viral (v-ras) oncogene homolog
       5894 RAF1; v-raf-1 murine leukemia viral oncogene homolog 1 
       5604 MAP2K1; mitogen-activated protein kinase kinase 1 
       5605 MAP2K2; mitogen-activated protein kinase kinase 2 
       5594 MAPK1; mitogen-activated protein kinase 1 
       5595 MAPK3; mitogen-activated protein kinase 3 
       123745 PLA2G4E; phospholipase A2, group IVE 
       5321 PLA2G4A; phospholipase A2, group IVA (cytosolic, calcium-dependent) 
       8681 JMJD7-PLA2G4B; JMJD7-PLA2G4B readthrough
       100137049 PLA2G4B; phospholipase A2, group IVB (cytosolic) 
       8605 PLA2G4C; phospholipase A2, group IVC (cytosolic, calcium-independent) 
       283748 PLA2G4D; phospholipase A2, group IVD (cytosolic) 
       255189 PLA2G4F; phospholipase A2, group IVF 
       5578 PRKCA; protein kinase C, alpha 
       5579 PRKCB; protein kinase C, beta 
       5580 PRKCD; protein kinase C, delta 
       5581 PRKCE; protein kinase C, epsilon 
K08089 FCER1A; Fc receptor, IgE, high affinity I, alpha polypeptide
K08090 MS4A2; membrane-spanning 4-domains, subfamily A, member 2
K07983 FCER1G; Fc receptor, IgE, high affinity I, gamma polypeptide
K05855 SYK; spleen tyrosine kinase [EC:2.7.10.2]
K05854 LYN; tyrosine-protein kinase Lyn [EC:2.7.10.2]
K07370 BTK; Bruton agammaglobulinemia tyrosine kinase [EC:2.7.10.2]
K03084 SHIP1; phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase 1 [EC:3.1.3.86]
K01116 PLCG1; phosphatidylinositol phospholipase C, gamma-1 [EC:3.1.4.11]
K05859 PLCG2; phosphatidylinositol phospholipase C, gamma-2 [EC:3.1.4.11]
K00922 PIK3C; phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
K00922 PIK3C; phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
K00922 PIK3C; phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
K00922 PIK3C; phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
K02649 PIK3R; phosphoinositide-3-kinase, regulatory subunit
K02649 PIK3R; phosphoinositide-3-kinase, regulatory subunit
K02649 PIK3R; phosphoinositide-3-kinase, regulatory subunit
K02649 PIK3R; phosphoinositide-3-kinase, regulatory subunit
K06276 PDPK1; 3-phosphoinositide dependent protein kinase-1 [EC:2.7.11.1]
K04456 AKT; RAC serine/threonine-protein kinase [EC:2.7.11.1]
K04456 AKT; RAC serine/threonine-protein kinase [EC:2.7.11.1]
K04456 AKT; RAC serine/threonine-protein kinase [EC:2.7.11.1]
K04392 RAC1; Ras-related C3 botulinum toxin substrate 1
K07860 RAC2; Ras-related C3 botulinum toxin substrate 2
K07861 RAC3; Ras-related C3 botulinum toxin substrate 3
K04430 MAP2K4; mitogen-activated protein kinase kinase 4 [EC:2.7.12.2]
K04431 MAP2K7; mitogen-activated protein kinase kinase 7 [EC:2.7.12.2]
K04432 MAP2K3; mitogen-activated protein kinase kinase 3 [EC:2.7.12.2]
K04433 MAP2K6; mitogen-activated protein kinase kinase 6 [EC:2.7.12.2]
K04440 JNK; c-Jun N-terminal kinase [EC:2.7.11.24]
K04440 JNK; c-Jun N-terminal kinase [EC:2.7.11.24]
K04440 JNK; c-Jun N-terminal kinase [EC:2.7.11.24]
K04441 P38; p38 MAP kinase [EC:2.7.11.24]
K04441 P38; p38 MAP kinase [EC:2.7.11.24]
K04441 P38; p38 MAP kinase [EC:2.7.11.24]
K04441 P38; p38 MAP kinase [EC:2.7.11.24]
K05430 IL4; interleukin 4
K05435 IL13; interleukin 13
K04736 IL3; interleukin 3
K05428 IL5; interleukin 5
K05427 CSF2; granulocyte-macrophage colony-stimulating factor
K03156 TNFA; tumor necrosis factor superfamily, member 2
K07361 LCP2; lymphocyte cytosolic protein 2
K05730 VAV; guanine nucleotide exchange factor VAV
K05730 VAV; guanine nucleotide exchange factor VAV
K05730 VAV; guanine nucleotide exchange factor VAV
K05703 FYN; tyrosine-protein kinase Fyn [EC:2.7.10.2]
K08091 GAB2; growth factor receptor bound protein 2-associated protein 2
K07362 LAT; linker for activation of T cells
K04364 GRB2; growth factor receptor-binding protein 2
K03099 SOS; son of sevenless
K03099 SOS; son of sevenless
K02833 HRAS; GTPase HRas
K07827 KRAS; GTPase KRas
K07828 NRAS; GTPase NRas
K04366 RAF1; RAF proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1]
K04368 MAP2K1; mitogen-activated protein kinase kinase 1 [EC:2.7.12.2]
K04369 MAP2K2; mitogen-activated protein kinase kinase 2 [EC:2.7.12.2]
K04371 MAPK1_3; mitogen-activated protein kinase 1/3 [EC:2.7.11.24]
K04371 MAPK1_3; mitogen-activated protein kinase 1/3 [EC:2.7.11.24]
K16342 PLA2G4; cytosolic phospholipase A2 [EC:3.1.1.4]
K16342 PLA2G4; cytosolic phospholipase A2 [EC:3.1.1.4]
K16342 PLA2G4; cytosolic phospholipase A2 [EC:3.1.1.4]
K16342 PLA2G4; cytosolic phospholipase A2 [EC:3.1.1.4]
K16342 PLA2G4; cytosolic phospholipase A2 [EC:3.1.1.4]
K16342 PLA2G4; cytosolic phospholipase A2 [EC:3.1.1.4]
K16342 PLA2G4; cytosolic phospholipase A2 [EC:3.1.1.4]
K02677 CPKC; classical protein kinase C [EC:2.7.11.13]
K02677 CPKC; classical protein kinase C [EC:2.7.11.13]
K06068 PRKCD; novel protein kinase C delta type [EC:2.7.11.13]
K18050 PRKCE; novel protein kinase C epsilon type [EC:2.7.11.13]
     04666 Fc gamma R-mediated phagocytosis [PATH:hsa04666]
     04670 Leukocyte transendothelial migration [PATH:hsa04670]
     04672 Intestinal immune network for IgA production [PATH:hsa04672]
     04062 Chemokine signaling pathway [PATH:hsa04062]
 
   Endocrine system
     04911 Insulin secretion [PATH:hsa04911]
     04910 Insulin signaling pathway [PATH:hsa04910]
     04920 Adipocytokine signaling pathway [PATH:hsa04920]
       7124 TNF; tumor necrosis factor
       7132 TNFRSF1A; tumor necrosis factor receptor superfamily, member 1A
       8717 TRADD; TNFRSF1A-associated via death domain
       7133 TNFRSF1B; tumor necrosis factor receptor superfamily, member 1B
       7186 TRAF2; TNF receptor-associated factor 2
       2475 MTOR; mechanistic target of rapamycin (serine/threonine kinase) 
       5599 MAPK8; mitogen-activated protein kinase 8 
       5602 MAPK10; mitogen-activated protein kinase 10 
       5601 MAPK9; mitogen-activated protein kinase 9 
       1147 CHUK; conserved helix-loop-helix ubiquitous kinase 
       3551 IKBKB; inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta 
       8517 IKBKG; inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma
       4792 NFKBIA; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha
       4793 NFKBIB; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, beta
       4794 NFKBIE; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon
       4790 NFKB1; nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
       5970 RELA; v-rel avian reticuloendotheliosis viral oncogene homolog A
       9021 SOCS3; suppressor of cytokine signaling 3
       3667 IRS1; insulin receptor substrate 1
       8660 IRS2; insulin receptor substrate 2
       8471 IRS4; insulin receptor substrate 4
       207 AKT1; v-akt murine thymoma viral oncogene homolog 1 
       208 AKT2; v-akt murine thymoma viral oncogene homolog 2 
       10000 AKT3; v-akt murine thymoma viral oncogene homolog 3 
       948 CD36; CD36 molecule (thrombospondin receptor)
       23305 ACSL6; acyl-CoA synthetase long-chain family member 6 
       2182 ACSL4; acyl-CoA synthetase long-chain family member 4 
       2180 ACSL1; acyl-CoA synthetase long-chain family member 1 
       51703 ACSL5; acyl-CoA synthetase long-chain family member 5 
       2181 ACSL3; acyl-CoA synthetase long-chain family member 3 
       23205 ACSBG1; acyl-CoA synthetase bubblegum family member 1 
       81616 ACSBG2; acyl-CoA synthetase bubblegum family member 2 
       5588 PRKCQ; protein kinase C, theta 
       3952 LEP; leptin
       3953 LEPR; leptin receptor
       3717 JAK2; Janus kinase 2 
       6774 STAT3; signal transducer and activator of transcription 3 (acute-phase response factor)
       5443 POMC; proopiomelanocortin
       5562 PRKAA1; protein kinase, AMP-activated, alpha 1 catalytic subunit 
       5563 PRKAA2; protein kinase, AMP-activated, alpha 2 catalytic subunit 
       5564 PRKAB1; protein kinase, AMP-activated, beta 1 non-catalytic subunit
       5565 PRKAB2; protein kinase, AMP-activated, beta 2 non-catalytic subunit
       5571 PRKAG1; protein kinase, AMP-activated, gamma 1 non-catalytic subunit
       53632 PRKAG3; protein kinase, AMP-activated, gamma 3 non-catalytic subunit
       51422 PRKAG2; protein kinase, AMP-activated, gamma 2 non-catalytic subunit
       181 AGRP; agouti related protein homolog (mouse)
       4852 NPY; neuropeptide Y
       10891 PPARGC1A; peroxisome proliferator-activated receptor gamma, coactivator 1 alpha
       5105 PCK1; phosphoenolpyruvate carboxykinase 1 (soluble) 
       5106 PCK2; phosphoenolpyruvate carboxykinase 2 (mitochondrial) 
       2538 G6PC; glucose-6-phosphatase, catalytic subunit 
       57818 G6PC2; glucose-6-phosphatase, catalytic, 2 
       92579 G6PC3; glucose 6 phosphatase, catalytic, 3 
       5781 PTPN11; protein tyrosine phosphatase, non-receptor type 11 
       5465 PPARA; peroxisome proliferator-activated receptor alpha
       6256 RXRA; retinoid X receptor, alpha
       6257 RXRB; retinoid X receptor, beta
       6258 RXRG; retinoid X receptor, gamma
       9370 ADIPOQ; adiponectin, C1Q and collagen domain containing
       51094 ADIPOR1; adiponectin receptor 1
       79602 ADIPOR2; adiponectin receptor 2
       6794 STK11; serine/threonine kinase 11 
       84254 CAMKK1; calcium/calmodulin-dependent protein kinase kinase 1, alpha 
       10645 CAMKK2; calcium/calmodulin-dependent protein kinase kinase 2, beta 
       1374 CPT1A; carnitine palmitoyltransferase 1A (liver) 
       1375 CPT1B; carnitine palmitoyltransferase 1B (muscle) 
       126129 CPT1C; carnitine palmitoyltransferase 1C 
       6513 SLC2A1; solute carrier family 2 (facilitated glucose transporter), member 1
       6517 SLC2A4; solute carrier family 2 (facilitated glucose transporter), member 4
       32 ACACB; acetyl-CoA carboxylase beta 
K03156 TNFA; tumor necrosis factor superfamily, member 2
K03158 TNFRSF1A; tumor necrosis factor receptor superfamily member 1A
K03171 TRADD; tumor necrosis factor receptor type 1-associated DEATH domain protein
K05141 TNFRSF1B; tumor necrosis factor receptor superfamily member 1B
K03173 TRAF2; TNF receptor-associated factor 2
K07203 FRAP; FKBP12-rapamycin complex-associated protein
K04440 JNK; c-Jun N-terminal kinase [EC:2.7.11.24]
K04440 JNK; c-Jun N-terminal kinase [EC:2.7.11.24]
K04440 JNK; c-Jun N-terminal kinase [EC:2.7.11.24]
K04467 IKBKA; inhibitor of nuclear factor kappa-B kinase subunit alpha [EC:2.7.11.10]
K07209 IKBKB; inhibitor of nuclear factor kappa-B kinase subunit beta [EC:2.7.11.10]
K07210 IKBKG; inhibitor of nuclear factor kappa-B kinase subunit gamma
K04734 NFKBIA; NF-kappa-B inhibitor alpha
K02581 NFKBIB; NF-kappa-B inhibitor beta
K05872 NFKBIE; NF-kappa-B inhibitor epsilon
K02580 NFKB1; nuclear factor NF-kappa-B p105 subunit
K04735 RELA; transcription factor p65
K04696 SOCS3; suppressor of cytokine signaling 3
K16172 IRS1; insulin receptor substrate 1
K07187 IRS2; insulin receptor substrate 2
K17446 IRS4; insulin receptor substrate 4
K04456 AKT; RAC serine/threonine-protein kinase [EC:2.7.11.1]
K04456 AKT; RAC serine/threonine-protein kinase [EC:2.7.11.1]
K04456 AKT; RAC serine/threonine-protein kinase [EC:2.7.11.1]
K06259 CD36; CD36 antigen
K01897 ACSL; long-chain acyl-CoA synthetase [EC:6.2.1.3]
K01897 ACSL; long-chain acyl-CoA synthetase [EC:6.2.1.3]
K01897 ACSL; long-chain acyl-CoA synthetase [EC:6.2.1.3]
K01897 ACSL; long-chain acyl-CoA synthetase [EC:6.2.1.3]
K01897 ACSL; long-chain acyl-CoA synthetase [EC:6.2.1.3]
K15013 ACSBG; long-chain-fatty-acid--CoA ligase ACSBG [EC:6.2.1.3]
K15013 ACSBG; long-chain-fatty-acid--CoA ligase ACSBG [EC:6.2.1.3]
K18052 PRKCQ; novel protein kinase C theta type [EC:2.7.11.13]
K05424 LEP; leptin
K05062 LEPR; leptin receptor
K04447 JAK2; Janus kinase 2 [EC:2.7.10.2]
K04692 STAT3; signal transducer and activator of transcription 3
K05228 POMC; proopiomelanocortin
K07198 PRKAA; 5'-AMP-activated protein kinase, catalytic alpha subunit [EC:2.7.11.11]
K07198 PRKAA; 5'-AMP-activated protein kinase, catalytic alpha subunit [EC:2.7.11.11]
K07199 PRKAB; 5'-AMP-activated protein kinase, regulatory beta subunit
K07199 PRKAB; 5'-AMP-activated protein kinase, regulatory beta subunit
K07200 PRKAG; 5'-AMP-activated protein kinase, regulatory gamma subunit
K07200 PRKAG; 5'-AMP-activated protein kinase, regulatory gamma subunit
K07200 PRKAG; 5'-AMP-activated protein kinase, regulatory gamma subunit
K05231 AGRP; agouti related protein
K05232 NPY; neuropeptide Y
K07202 PPARGC1A; alpha peroxisome proliferator-activated receptor gamma coactivator 1-alpha
K01596 E4.1.1.32; phosphoenolpyruvate carboxykinase (GTP) [EC:4.1.1.32]
K01596 E4.1.1.32; phosphoenolpyruvate carboxykinase (GTP) [EC:4.1.1.32]
K01084 G6PC; glucose-6-phosphatase [EC:3.1.3.9]
K01084 G6PC; glucose-6-phosphatase [EC:3.1.3.9]
K01084 G6PC; glucose-6-phosphatase [EC:3.1.3.9]
K07293 PTPN11; tyrosine-protein phosphatase non-receptor type 11 [EC:3.1.3.48]
K07294 NR1C1; peroxisome proliferator-activated receptor alpha
K08524 NR2B1; retinoid X receptor alpha
K08525 NR2B2; retinoid X receptor beta
K08526 NR2B3; retinoid X receptor gamma
K07296 ACDC; adiponectin
K07297 ADIPOR; adiponectin receptor
K07297 ADIPOR; adiponectin receptor
K07298 STK11; serine/threonine-protein kinase 11
K07359 CAMKK; calcium/calmodulin-dependent protein kinase kinase [EC:2.7.11.17]
K07359 CAMKK; calcium/calmodulin-dependent protein kinase kinase [EC:2.7.11.17]
K08765 CPT1; carnitine O-palmitoyltransferase 1 [EC:2.3.1.21]
K08765 CPT1; carnitine O-palmitoyltransferase 1 [EC:2.3.1.21]
K08765 CPT1; carnitine O-palmitoyltransferase 1 [EC:2.3.1.21]
K07299 SLC2A1; MFS transporter, SP family, solute carrier family 2 (facilitated glucose transporter), member 1
K07191 SLC2A4; MFS transporter, SP family, solute carrier family 2 (facilitated glucose transporter), member 4
K11262 ACAC; acetyl-CoA carboxylase / biotin carboxylase [EC:6.4.1.2 6.3.4.14]
     03320 PPAR signaling pathway [PATH:hsa03320]
     04912 GnRH signaling pathway [PATH:hsa04912]
     04913 Ovarian Steroidogenesis [PATH:hsa04913]
     04915 Estrogen signaling pathway [PATH:hsa04915]
     04914 Progesterone-mediated oocyte maturation [PATH:hsa04914]
     04917 Prolactin signaling pathway [PATH:hsa04917]
     04921 Oxytocin signaling pathway [PATH:hsa04921]
     04918 Thyroid hormone synthesis [PATH:hsa04918]
     04919 Thyroid hormone signaling pathway [PATH:hsa04919]
     04916 Melanogenesis [PATH:hsa04916]
     04614 Renin-angiotensin system [PATH:hsa04614]
 
   Circulatory system
 
   Digestive system
 
   Excretory system
 
   Nervous system
 
   Sensory system
 
   Development
     04320 Dorso-ventral axis formation [PATH:hsa04320]
     04360 Axon guidance [PATH:hsa04360]
     04380 Osteoclast differentiation [PATH:hsa04380]
       1435 CSF1; colony stimulating factor 1 (macrophage) 
       1436 CSF1R; colony stimulating factor 1 receptor 
       2885 GRB2; growth factor receptor-bound protein 2
       5594 MAPK1; mitogen-activated protein kinase 1 
       5595 MAPK3; mitogen-activated protein kinase 3 
       5290 PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha 
       5293 PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta 
       5291 PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta 
       5294 PIK3CG; phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma 
       5295 PIK3R1; phosphoinositide-3-kinase, regulatory subunit 1 (alpha)
       23533 PIK3R5; phosphoinositide-3-kinase, regulatory subunit 5
       5296 PIK3R2; phosphoinositide-3-kinase, regulatory subunit 2 (beta)
       8503 PIK3R3; phosphoinositide-3-kinase, regulatory subunit 3 (gamma)
       207 AKT1; v-akt murine thymoma viral oncogene homolog 1 
       208 AKT2; v-akt murine thymoma viral oncogene homolog 2 
       10000 AKT3; v-akt murine thymoma viral oncogene homolog 3 
       3458 IFNG; interferon, gamma
       3459 IFNGR1; interferon gamma receptor 1
       3460 IFNGR2; interferon gamma receptor 2 (interferon gamma transducer 1)
       6772 STAT1; signal transducer and activator of transcription 1, 91kDa
       3552 IL1A; interleukin 1, alpha
       3553 IL1B; interleukin 1, beta
       3554 IL1R1; interleukin 1 receptor, type I
       7124 TNF; tumor necrosis factor
       7132 TNFRSF1A; tumor necrosis factor receptor superfamily, member 1A
       7040 TGFB1; transforming growth factor, beta 1
       7042 TGFB2; transforming growth factor, beta 2
       7046 TGFBR1; transforming growth factor, beta receptor 1 
       7048 TGFBR2; transforming growth factor, beta receptor II (70/80kDa) 
       8600 TNFSF11; tumor necrosis factor (ligand) superfamily, member 11
       8792 TNFRSF11A; tumor necrosis factor receptor superfamily, member 11a, NFKB activator
       4982 TNFRSF11B; tumor necrosis factor receptor superfamily, member 11b
       7186 TRAF2; TNF receptor-associated factor 2
       7189 TRAF6; TNF receptor-associated factor 6, E3 ubiquitin protein ligase
       3932 LCK; lymphocyte-specific protein tyrosine kinase 
       2534 FYN; FYN oncogene related to SRC, FGR, YES 
       9020 MAP3K14; mitogen-activated protein kinase kinase kinase 14 
       1147 CHUK; conserved helix-loop-helix ubiquitous kinase 
       5971 RELB; v-rel avian reticuloendotheliosis viral oncogene homolog B
       4791 NFKB2; nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100)
       6885 MAP3K7; mitogen-activated protein kinase kinase kinase 7 
       10454 TAB1; TGF-beta activated kinase 1/MAP3K7 binding protein 1
       23118 TAB2; TGF-beta activated kinase 1/MAP3K7 binding protein 2
       8517 IKBKG; inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma
       3551 IKBKB; inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta 
       4792 NFKBIA; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha
       5970 RELA; v-rel avian reticuloendotheliosis viral oncogene homolog A
       4790 NFKB1; nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
       4773 NFATC2; nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2
       4772 NFATC1; nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1
       3456 IFNB1; interferon, beta 1, fibroblast
       5604 MAP2K1; mitogen-activated protein kinase kinase 1 
       5608 MAP2K6; mitogen-activated protein kinase kinase 6 
       5600 MAPK11; mitogen-activated protein kinase 11 
       6300 MAPK12; mitogen-activated protein kinase 12 
       5603 MAPK13; mitogen-activated protein kinase 13 
       1432 MAPK14; mitogen-activated protein kinase 14 
       5609 MAP2K7; mitogen-activated protein kinase kinase 7 
       5599 MAPK8; mitogen-activated protein kinase 8 
       5602 MAPK10; mitogen-activated protein kinase 10 
       5601 MAPK9; mitogen-activated protein kinase 9 
       2353 FOS; FBJ murine osteosarcoma viral oncogene homolog
       2354 FOSB; FBJ murine osteosarcoma viral oncogene homolog B
       2355 FOSL2; FOS-like antigen 2
       8061 FOSL1; FOS-like antigen 1
       3725 JUN; jun proto-oncogene
       3727 JUND; jun D proto-oncogene
       3726 JUNB; jun B proto-oncogene
       5879 RAC1; ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)
       50508 NOX3; NADPH oxidase 3
       27035 NOX1; NADPH oxidase 1
       1536 CYBB; cytochrome b-245, beta polypeptide
       1535 CYBA; cytochrome b-245, alpha polypeptide
       4688 NCF2; neutrophil cytosolic factor 2
       653361 NCF1; neutrophil cytosolic factor 1
       4689 NCF4; neutrophil cytosolic factor 4, 40kDa
       695 BTK; Bruton agammaglobulinemia tyrosine kinase 
       7006 TEC; tec protein tyrosine kinase 
       126014 OSCAR; osteoclast associated, immunoglobulin-like receptor
       10288 LILRB2; leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 2
       10859 LILRB1; leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1
       10990 LILRB5; leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 5
       11006 LILRB4; leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 4
       11024 LILRA1; leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 1
       11025 LILRB3; leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3
       11026 LILRA3; leukocyte immunoglobulin-like receptor, subfamily A (without TM domain), member 3
       11027 LILRA2; leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 2
       23547 LILRA4; leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 4
       79168 LILRA6; leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6
       353514 LILRA5; leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 5
       2209 FCGR1A; Fc fragment of IgG, high affinity Ia, receptor (CD64)
       2212 FCGR2A; Fc fragment of IgG, low affinity IIa, receptor (CD32)
       2213 FCGR2B; Fc fragment of IgG, low affinity IIb, receptor (CD32)
       9103 FCGR2C; Fc fragment of IgG, low affinity IIc, receptor for (CD32) (gene/pseudogene)
       2214 FCGR3A; Fc fragment of IgG, low affinity IIIa, receptor (CD16a)
       2215 FCGR3B; Fc fragment of IgG, low affinity IIIb, receptor (CD16b)
       54209 TREM2; triggering receptor expressed on myeloid cells 2
       140885 SIRPA; signal-regulatory protein alpha 
       55423 SIRPG; signal-regulatory protein gamma
       10326 SIRPB1; signal-regulatory protein beta 1
       7305 TYROBP; TYRO protein tyrosine kinase binding protein
       6850 SYK; spleen tyrosine kinase 
       29760 BLNK; B-cell linker
       3937 LCP2; lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa)
       5336 PLCG2; phospholipase C, gamma 2 (phosphatidylinositol-specific) 
       5530 PPP3CA; protein phosphatase 3, catalytic subunit, alpha isozyme 
       5532 PPP3CB; protein phosphatase 3, catalytic subunit, beta isozyme 
       5533 PPP3CC; protein phosphatase 3, catalytic subunit, gamma isozyme 
       5534 PPP3R1; protein phosphatase 3, regulatory subunit B, alpha 
       5535 PPP3R2; protein phosphatase 3, regulatory subunit B, beta 
       814 CAMK4; calcium/calmodulin-dependent protein kinase IV 
       1385 CREB1; cAMP responsive element binding protein 1
       6688 SPI1; spleen focus forming virus (SFFV) proviral integration oncogene
       4286 MITF; microphthalmia-associated transcription factor
       1513 CTSK; cathepsin K 
       54 ACP5; acid phosphatase 5, tartrate resistant 
       799 CALCR; calcitonin receptor
       3690 ITGB3; integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)
       5468 PPARG; peroxisome proliferator-activated receptor gamma
       3454 IFNAR1; interferon (alpha, beta and omega) receptor 1
       3455 IFNAR2; interferon (alpha, beta and omega) receptor 2
       3716 JAK1; Janus kinase 1 
       7297 TYK2; tyrosine kinase 2 
       6773 STAT2; signal transducer and activator of transcription 2, 113kDa
       10379 IRF9; interferon regulatory factor 9
       8651 SOCS1; suppressor of cytokine signaling 1
       9021 SOCS3; suppressor of cytokine signaling 3
       9846 GAB2; GRB2-associated binding protein 2
       2274 FHL2; four and a half LIM domains 2
       1540 CYLD; cylindromatosis (turban tumor syndrome) 
       8878 SQSTM1; sequestosome 1
K05453 CSF1; macrophage colony-stimulating factor 1
K05090 CSF1R; macrophage colony-stimulating factor 1 receptor [EC:2.7.10.1]
K04364 GRB2; growth factor receptor-binding protein 2
K04371 MAPK1_3; mitogen-activated protein kinase 1/3 [EC:2.7.11.24]
K04371 MAPK1_3; mitogen-activated protein kinase 1/3 [EC:2.7.11.24]
K00922 PIK3C; phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
K00922 PIK3C; phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
K00922 PIK3C; phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
K00922 PIK3C; phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
K02649 PIK3R; phosphoinositide-3-kinase, regulatory subunit
K02649 PIK3R; phosphoinositide-3-kinase, regulatory subunit
K02649 PIK3R; phosphoinositide-3-kinase, regulatory subunit
K02649 PIK3R; phosphoinositide-3-kinase, regulatory subunit
K04456 AKT; RAC serine/threonine-protein kinase [EC:2.7.11.1]
K04456 AKT; RAC serine/threonine-protein kinase [EC:2.7.11.1]
K04456 AKT; RAC serine/threonine-protein kinase [EC:2.7.11.1]
K04687 IFNG; interferon gamma
K05132 IFNGR1; interferon gamma receptor 1
K05133 IFNGR2; interferon gamma receptor 2
K11220 STAT1; signal transducer and activator of transcription 1
K04383 IL1A; interleukin 1 alpha
K04519 IL1B; interleukin 1 beta
K04386 IL1R1; interleukin 1 receptor type I
K03156 TNFA; tumor necrosis factor superfamily, member 2
K03158 TNFRSF1A; tumor necrosis factor receptor superfamily member 1A
K13375 TGFB1; transforming growth factor beta-1
K13376 TGFB2; transforming growth factor beta-2
K04674 TGFBR1; TGF-beta receptor type-1 [EC:2.7.11.30]
K04388 TGFBR2; TGF-beta receptor type-2 [EC:2.7.11.30]
K05473 TNFSF11; tumor necrosis factor ligand superfamily member 11
K05147 TNFRSF11A; tumor necrosis factor receptor superfamily member 11A
K05148 TNFRSF11B; tumor necrosis factor receptor superfamily member 11B
K03173 TRAF2; TNF receptor-associated factor 2
K03175 TRAF6; TNF receptor-associated factor 6
K05856 LCK; lymphocyte cell-specific protein tyrosine kinase [EC:2.7.10.2]
K05703 FYN; tyrosine-protein kinase Fyn [EC:2.7.10.2]
K04466 MAP3K14; mitogen-activated protein kinase kinase kinase 14 [EC:2.7.11.25]
K04467 IKBKA; inhibitor of nuclear factor kappa-B kinase subunit alpha [EC:2.7.11.10]
K09253 RELB; transcription factor RelB
K04469 NFKB2; nuclear factor of kappa light polypeptide gene enhancer in B-cells 2
K04427 MAP3K7; mitogen-activated protein kinase kinase kinase 7 [EC:2.7.11.25]
K04403 MAP3K7IP1; TAK1-binding protein 1
K04404 MAP3K7IP2; TAK1-binding protein 2
K07210 IKBKG; inhibitor of nuclear factor kappa-B kinase subunit gamma
K07209 IKBKB; inhibitor of nuclear factor kappa-B kinase subunit beta [EC:2.7.11.10]
K04734 NFKBIA; NF-kappa-B inhibitor alpha
K04735 RELA; transcription factor p65
K02580 NFKB1; nuclear factor NF-kappa-B p105 subunit
K17332 NFATC2; nuclear factor of activated T-cells, cytoplasmic 2
K04446 NFATC1; nuclear factor of activated T-cells, cytoplasmic 1
K05415 IFNB; interferon beta
K04368 MAP2K1; mitogen-activated protein kinase kinase 1 [EC:2.7.12.2]
K04433 MAP2K6; mitogen-activated protein kinase kinase 6 [EC:2.7.12.2]
K04441 P38; p38 MAP kinase [EC:2.7.11.24]
K04441 P38; p38 MAP kinase [EC:2.7.11.24]
K04441 P38; p38 MAP kinase [EC:2.7.11.24]
K04441 P38; p38 MAP kinase [EC:2.7.11.24]
K04431 MAP2K7; mitogen-activated protein kinase kinase 7 [EC:2.7.12.2]
K04440 JNK; c-Jun N-terminal kinase [EC:2.7.11.24]
K04440 JNK; c-Jun N-terminal kinase [EC:2.7.11.24]
K04440 JNK; c-Jun N-terminal kinase [EC:2.7.11.24]
K04379 FOS; proto-oncogene protein c-fos
K09029 FOSB; protein FosB
K09030 FOSL2; fos-like antigen 2
K04502 FOSL1; fos-like antigen 1
K04448 JUN; transcription factor AP-1
K04449 JUND; transcription factor jun-D
K09028 JUNB; transcription factor jun-B
K04392 RAC1; Ras-related C3 botulinum toxin substrate 1
K08008 NOX; NADPH oxidase
K08008 NOX; NADPH oxidase
K08008 NOX; NADPH oxidase
K08009 CYBA; cytochrome b-245, alpha polypeptide
K08010 NCF2; neutrophil cytosolic factor 2
K08011 NCF1; neutrophil cytosolic factor 1
K08012 NCF4; neutrophil cytosolic factor 4
K07370 BTK; Bruton agammaglobulinemia tyrosine kinase [EC:2.7.10.2]
K07364 TEC; tyrosine-protein kinase Tec [EC:2.7.10.2]
K14377 OSCAR; osteoclast-associated immunoglobulin-like receptor
K06512 LILR; leukocyte immunoglobulin-like receptor
K06512 LILR; leukocyte immunoglobulin-like receptor
K06512 LILR; leukocyte immunoglobulin-like receptor
K06512 LILR; leukocyte immunoglobulin-like receptor
K06512 LILR; leukocyte immunoglobulin-like receptor
K06512 LILR; leukocyte immunoglobulin-like receptor
K06512 LILR; leukocyte immunoglobulin-like receptor
K06512 LILR; leukocyte immunoglobulin-like receptor
K06512 LILR; leukocyte immunoglobulin-like receptor
K06512 LILR; leukocyte immunoglobulin-like receptor
K06512 LILR; leukocyte immunoglobulin-like receptor
K06498 FCGR1A; high affinity immunoglobulin gamma Fc receptor I
K06472 FCGR2A; low affinity immunoglobulin gamma Fc region receptor II-a
K12560 FCGR2B; low affinity immunoglobulin gamma Fc region receptor II-b
K16824 FCGR2C; low affinity immunoglobulin gamma Fc region receptor II-c
K06463 FCGR3; low affinity immunoglobulin gamma Fc region receptor III
K06463 FCGR3; low affinity immunoglobulin gamma Fc region receptor III
K14378 TREM2; triggering receptor expressed on myeloid cells 2
K06551 SIRPA_B1_G; signal-regulatory protein alpha/beta1/gamma
K06551 SIRPA_B1_G; signal-regulatory protein alpha/beta1/gamma
K06551 SIRPA_B1_G; signal-regulatory protein alpha/beta1/gamma
K07992 TYROBP; TYRO protein tyrosine kinase binding protein
K05855 SYK; spleen tyrosine kinase [EC:2.7.10.2]
K07371 BLNK; B-cell linker protein
K07361 LCP2; lymphocyte cytosolic protein 2
K05859 PLCG2; phosphatidylinositol phospholipase C, gamma-2 [EC:3.1.4.11]
K04348 PPP3C; serine/threonine-protein phosphatase 2B catalytic subunit [EC:3.1.3.16]
K04348 PPP3C; serine/threonine-protein phosphatase 2B catalytic subunit [EC:3.1.3.16]
K04348 PPP3C; serine/threonine-protein phosphatase 2B catalytic subunit [EC:3.1.3.16]
K06268 PPP3R; serine/threonine-protein phosphatase 2B regulatory subunit
K06268 PPP3R; serine/threonine-protein phosphatase 2B regulatory subunit
K05869 CAMK4; calcium/calmodulin-dependent protein kinase IV [EC:2.7.11.17]
K05870 CREB1; cyclic AMP-responsive element-binding protein 1
K09438 SPI1; transcription factor PU.1
K09455 MITF; microphthalmia-associated transcription factor
K01371 CTSK; cathepsin K [EC:3.4.22.38]
K14379 ACP5; tartrate-resistant acid phosphatase type 5 [EC:3.1.3.2]
K04576 CALCR; calcitonin receptor
K06493 ITGB3; integrin beta 3
K08530 NR1C3; peroxisome proliferator-activated receptor gamma
K05130 IFNAR1; interferon receptor 1
K05131 IFNAR2; interferon receptor 2
K11217 JAK1; Janus kinase 1 [EC:2.7.10.2]
K11219 TYK2; non-receptor tyrosine-protein kinase TYK2 [EC:2.7.10.2]
K11221 STAT2; signal transducer and activator of transcription 2
K04693 IRF9; interferon regulatory factor 9
K04694 SOCS1; suppressor of cytokine signaling 1
K04696 SOCS3; suppressor of cytokine signaling 3
K08091 GAB2; growth factor receptor bound protein 2-associated protein 2
K14380 FHL2; four and a half LIM domains protein 2
K08601 CYLD; ubiquitin thioesterase CYLD [EC:3.1.2.15]
K14381 SQSTM1; sequestosome 1
 
   Environmental adaptation
 
 Human Diseases
 
   Cancers
     05200 Pathways in cancer [PATH:hsa05200]
     05202 Transcriptional misregulation in cancers [PATH:hsa05202]
     05206 MicroRNAs in cancer [PATH:hsa05206]
     05205 Proteoglycans in cancer [PATH:hsa05205]
       960 CD44; CD44 molecule (Indian blood group)
       6714 SRC; v-src avian sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog 
       2017 CTTN; cortactin
       3059 HCLS1; hematopoietic cell-specific Lyn substrate 1
       2064 ERBB2; v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2 
       2885 GRB2; growth factor receptor-bound protein 2
       3265 HRAS; Harvey rat sarcoma viral oncogene homolog
       3845 KRAS; Kirsten rat sarcoma viral oncogene homolog
       4893 NRAS; neuroblastoma RAS viral (v-ras) oncogene homolog
       6237 RRAS; related RAS viral (r-ras) oncogene homolog
       22800 RRAS2; related RAS viral (r-ras) oncogene homolog 2
       22808 MRAS; muscle RAS oncogene homolog
       673 BRAF; v-raf murine sarcoma viral oncogene homolog B 
       5894 RAF1; v-raf-1 murine leukemia viral oncogene homolog 1 
       369 ARAF; v-raf murine sarcoma 3611 viral oncogene homolog 
       5604 MAP2K1; mitogen-activated protein kinase kinase 1 
       5605 MAP2K2; mitogen-activated protein kinase kinase 2 
       5594 MAPK1; mitogen-activated protein kinase 1 
       5595 MAPK3; mitogen-activated protein kinase 3 
       5879 RAC1; ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)
       8826 IQGAP1; IQ motif containing GTPase activating protein 1
       998 CDC42; cell division cycle 42
       2002 ELK1; ELK1, member of ETS oncogene family
       2099 ESR1; estrogen receptor 1
       595 CCND1; cyclin D1
       60 ACTB; actin, beta
       71 ACTG1; actin, gamma 1
       2316 FLNA; filamin A, alpha
       2318 FLNC; filamin C, gamma
       2317 FLNB; filamin B, beta
       5058 PAK1; p21 protein (Cdc42/Rac)-activated kinase 1 
       7074 TIAM1; T-cell lymphoma invasion and metastasis 1
       9138 ARHGEF1; Rho guanine nucleotide exchange factor (GEF) 1
       387 RHOA; ras homolog family member A
       6093 ROCK1; Rho-associated, coiled-coil containing protein kinase 1 
       9475 ROCK2; Rho-associated, coiled-coil containing protein kinase 2 
       286 ANK1; ankyrin 1, erythrocytic
       287 ANK2; ankyrin 2, neuronal
       288 ANK3; ankyrin 3, node of Ranvier (ankyrin G)
       2549 GAB1; GRB2-associated binding protein 1
       5290 PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha 
       5293 PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta 
       5291 PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta 
       5294 PIK3CG; phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma 
       5295 PIK3R1; phosphoinositide-3-kinase, regulatory subunit 1 (alpha)
       23533 PIK3R5; phosphoinositide-3-kinase, regulatory subunit 5
       5296 PIK3R2; phosphoinositide-3-kinase, regulatory subunit 2 (beta)
       8503 PIK3R3; phosphoinositide-3-kinase, regulatory subunit 3 (gamma)
       207 AKT1; v-akt murine thymoma viral oncogene homolog 1 
       208 AKT2; v-akt murine thymoma viral oncogene homolog 2 
       10000 AKT3; v-akt murine thymoma viral oncogene homolog 3 
       6548 SLC9A1; solute carrier family 9, subfamily A (NHE1, cation proton antiporter 1), member 1
       5499 PPP1CA; protein phosphatase 1, catalytic subunit, alpha isozyme 
       5500 PPP1CB; protein phosphatase 1, catalytic subunit, beta isozyme 
       5501 PPP1CC; protein phosphatase 1, catalytic subunit, gamma isozyme 
       4659 PPP1R12A; protein phosphatase 1, regulatory subunit 12A
       4660 PPP1R12B; protein phosphatase 1, regulatory subunit 12B 
       54776 PPP1R12C; protein phosphatase 1, regulatory subunit 12C
       23365 ARHGEF12; Rho guanine nucleotide exchange factor (GEF) 12
       51196 PLCE1; phospholipase C, epsilon 1 
       3708 ITPR1; inositol 1,4,5-trisphosphate receptor, type 1
       3709 ITPR2; inositol 1,4,5-trisphosphate receptor, type 2
       3710 ITPR3; inositol 1,4,5-trisphosphate receptor, type 3
       815 CAMK2A; calcium/calmodulin-dependent protein kinase II alpha 
       817 CAMK2D; calcium/calmodulin-dependent protein kinase II delta 
       816 CAMK2B; calcium/calmodulin-dependent protein kinase II beta 
       818 CAMK2G; calcium/calmodulin-dependent protein kinase II gamma 
       79923 NANOG; Nanog homeobox
       1655 DDX5; DEAD (Asp-Glu-Ala-Asp) box helicase 5 
       29102 DROSHA; drosha, ribonuclease type III 
       6774 STAT3; signal transducer and activator of transcription 3 (acute-phase response factor)
       406991 MIR21; microRNA 21
       7291 TWIST1; twist family bHLH transcription factor 1
       117581 TWIST2; twist family bHLH transcription factor 2
       406902 MIR10A; microRNA 10a
       406903 MIR10B; microRNA 10b
       3236 HOXD10; homeobox D10
       1634 DCN; decorin
       3479 IGF1; insulin-like growth factor 1 (somatomedin C)
       3480 IGF1R; insulin-like growth factor 1 receptor 
       2475 MTOR; mechanistic target of rapamycin (serine/threonine kinase) 
       5170 PDPK1; 3-phosphoinositide dependent protein kinase 1 
       6198 RPS6KB1; ribosomal protein S6 kinase, 70kDa, polypeptide 1 
       6199 RPS6KB2; ribosomal protein S6 kinase, 70kDa, polypeptide 2 
       1975 EIF4B; eukaryotic translation initiation factor 4B
       6194 RPS6; ribosomal protein S6
       1956 EGFR; epidermal growth factor receptor 
       857 CAV1; caveolin 1, caveolae protein, 22kDa
       858 CAV2; caveolin 2
       859 CAV3; caveolin 3
       967 CD63; CD63 molecule
       1026 CDKN1A; cyclin-dependent kinase inhibitor 1A (p21, Cip1)
       836 CASP3; caspase 3, apoptosis-related cysteine peptidase 
       7040 TGFB1; transforming growth factor, beta 1
       7097 TLR2; toll-like receptor 2
       7099 TLR4; toll-like receptor 4
       27250 PDCD4; programmed cell death 4 (neoplastic transformation inhibitor)
       7124 TNF; tumor necrosis factor
       3593 IL12B; interleukin 12B
       2065 ERBB3; v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 3 
       2066 ERBB4; v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 4 
       4609 MYC; v-myc avian myelocytomatosis viral oncogene homolog
       1499 CTNNB1; catenin (cadherin-associated protein), beta 1, 88kDa
       3091 HIF1A; hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
       7023 TFAP4; transcription factor AP-4 (activating enhancer binding protein 4)
       7422 VEGFA; vascular endothelial growth factor A
       3791 KDR; kinase insert domain receptor (a type III receptor tyrosine kinase) 
       4233 MET; met proto-oncogene 
       23624 CBLC; Cbl proto-oncogene C, E3 ubiquitin protein ligase
       867 CBL; Cbl proto-oncogene, E3 ubiquitin protein ligase
       868 CBLB; Cbl proto-oncogene B, E3 ubiquitin protein ligase
       7078 TIMP3; TIMP metallopeptidase inhibitor 3
       7057 THBS1; thrombospondin 1
       4313 MMP2; matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) 
       4318 MMP9; matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) 
       4060 LUM; lumican
       356 FASLG; Fas ligand (TNF superfamily, member 6)
       355 FAS; Fas cell surface death receptor
       4193 MDM2; MDM2 oncogene, E3 ubiquitin protein ligase
       7157 TP53; tumor protein p53
       7042 TGFB2; transforming growth factor, beta 2
       10855 HPSE; heparanase 
       60495 HPSE2; heparanase 2 (inactive)
       6382 SDC1; syndecan 1
       5328 PLAU; plasminogen activator, urokinase 
       5329 PLAUR; plasminogen activator, urokinase receptor
       3673 ITGA2; integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor)
       3688 ITGB1; integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
       7448 VTN; vitronectin
       3685 ITGAV; integrin, alpha V
       3690 ITGB3; integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)
       2335 FN1; fibronectin 1
       3693 ITGB5; integrin, beta 5
       3082 HGF; hepatocyte growth factor (hepapoietin A; scatter factor)
       7471 WNT1; wingless-type MMTV integration site family, member 1
       8321 FZD1; frizzled class receptor 1
       8324 FZD7; frizzled class receptor 7
       2535 FZD2; frizzled class receptor 2
       7976 FZD3; frizzled class receptor 3
       8322 FZD4; frizzled class receptor 4
       7855 FZD5; frizzled class receptor 5
       8325 FZD8; frizzled class receptor 8
       8323 FZD6; frizzled class receptor 6
       11211 FZD10; frizzled class receptor 10
       8326 FZD9; frizzled class receptor 9
       3678 ITGA5; integrin, alpha 5 (fibronectin receptor, alpha polypeptide)
       6383 SDC2; syndecan 2
       7430 EZR; ezrin
       5962 RDX; radixin
       4478 MSN; moesin
       6385 SDC4; syndecan 4
       2246 FGF1; fibroblast growth factor 1 (acidic)
       2247 FGF2; fibroblast growth factor 2 (basic)
       2248 FGF3; fibroblast growth factor 3
       2249 FGF4; fibroblast growth factor 4
       8822 FGF17; fibroblast growth factor 17
       2251 FGF6; fibroblast growth factor 6
       2252 FGF7; fibroblast growth factor 7
       2253 FGF8; fibroblast growth factor 8 (androgen-induced)
       2254 FGF9; fibroblast growth factor 9
       2255 FGF10; fibroblast growth factor 10
       2256 FGF11; fibroblast growth factor 11
       2257 FGF12; fibroblast growth factor 12
       2258 FGF13; fibroblast growth factor 13
       2259 FGF14; fibroblast growth factor 14
       8823 FGF16; fibroblast growth factor 16
       2250 FGF5; fibroblast growth factor 5
       8817 FGF18; fibroblast growth factor 18
       9965 FGF19; fibroblast growth factor 19
       26281 FGF20; fibroblast growth factor 20
       26291 FGF21; fibroblast growth factor 21
       27006 FGF22; fibroblast growth factor 22
       8074 FGF23; fibroblast growth factor 23
       2260 FGFR1; fibroblast growth factor receptor 1 
       10818 FRS2; fibroblast growth factor receptor substrate 2
       5781 PTPN11; protein tyrosine phosphatase, non-receptor type 11 
       6654 SOS1; son of sevenless homolog 1 (Drosophila)
       6655 SOS2; son of sevenless homolog 2 (Drosophila)
       5335 PLCG1; phospholipase C, gamma 1 
       5336 PLCG2; phospholipase C, gamma 2 (phosphatidylinositol-specific) 
       5578 PRKCA; protein kinase C, alpha 
       5579 PRKCB; protein kinase C, beta 
       5582 PRKCG; protein kinase C, gamma 
       84309 NUDT16L1; nudix (nucleoside diphosphate linked moiety X)-type motif 16-like 1
       5829 PXN; paxillin
       5747 PTK2; protein tyrosine kinase 2 
       1839 HBEGF; heparin-binding EGF-like growth factor
       2817 GPC1; glypican 1
       3481 IGF2; insulin-like growth factor 2 (somatomedin A)
       2719 GPC3; glypican 3
       7472 WNT2; wingless-type MMTV integration site family member 2
       7482 WNT2B; wingless-type MMTV integration site family, member 2B
       7473 WNT3; wingless-type MMTV integration site family, member 3
       89780 WNT3A; wingless-type MMTV integration site family, member 3A
       54361 WNT4; wingless-type MMTV integration site family, member 4
       7474 WNT5A; wingless-type MMTV integration site family, member 5A
       81029 WNT5B; wingless-type MMTV integration site family, member 5B
       7475 WNT6; wingless-type MMTV integration site family, member 6
       7476 WNT7A; wingless-type MMTV integration site family, member 7A
       7477 WNT7B; wingless-type MMTV integration site family, member 7B
       7478 WNT8A; wingless-type MMTV integration site family, member 8A
       7479 WNT8B; wingless-type MMTV integration site family, member 8B
       7483 WNT9A; wingless-type MMTV integration site family, member 9A
       7484 WNT9B; wingless-type MMTV integration site family, member 9B
       7480 WNT10B; wingless-type MMTV integration site family, member 10B
       80326 WNT10A; wingless-type MMTV integration site family, member 10A
       7481 WNT11; wingless-type MMTV integration site family, member 11
       51384 WNT16; wingless-type MMTV integration site family, member 16
       5727 PTCH1; patched 1
       6608 SMO; smoothened, frizzled class receptor
       3339 HSPG2; heparan sulfate proteoglycan 2
       1514 CTSL; cathepsin L 
       5566 PRKACA; protein kinase, cAMP-dependent, catalytic, alpha 
       5567 PRKACB; protein kinase, cAMP-dependent, catalytic, beta 
       5568 PRKACG; protein kinase, cAMP-dependent, catalytic, gamma 
       5613 PRKX; protein kinase, X-linked 
       5600 MAPK11; mitogen-activated protein kinase 11 
       6300 MAPK12; mitogen-activated protein kinase 12 
       5603 MAPK13; mitogen-activated protein kinase 13 
       1432 MAPK14; mitogen-activated protein kinase 14 
       3316 HSPB2; heat shock 27kDa protein 2
       5777 PTPN6; protein tyrosine phosphatase, non-receptor type 6 
       4087 SMAD2; SMAD family member 2
       7410 VAV2; vav 2 guanine nucleotide exchange factor
       81578 COL21A1; collagen, type XXI, alpha 1
K06256 CD44; CD44 antigen
K05704 SRC; tyrosine-protein kinase Src [EC:2.7.10.2]
K06106 CTTN; cortactin
K06106 CTTN; cortactin
K05083 ERBB2; receptor tyrosine-protein kinase erbB-2 [EC:2.7.10.1]
K04364 GRB2; growth factor receptor-binding protein 2
K02833 HRAS; GTPase HRas
K07827 KRAS; GTPase KRas
K07828 NRAS; GTPase NRas
K07829 RRAS; Ras-related protein R-Ras
K07830 RRAS2; Ras-related protein R-Ras2
K07831 MRAS; Ras-related protein M-Ras
K04365 BRAF; B-Raf proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1]
K04366 RAF1; RAF proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1]
K08845 ARAF; A-Raf proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1]
K04368 MAP2K1; mitogen-activated protein kinase kinase 1 [EC:2.7.12.2]
K04369 MAP2K2; mitogen-activated protein kinase kinase 2 [EC:2.7.12.2]
K04371 MAPK1_3; mitogen-activated protein kinase 1/3 [EC:2.7.11.24]
K04371 MAPK1_3; mitogen-activated protein kinase 1/3 [EC:2.7.11.24]
K04392 RAC1; Ras-related C3 botulinum toxin substrate 1
K16848 IQGAP1; Ras GTPase-activating-like protein IQGAP1
K04393 CDC42; cell division control protein 42
K04375 ELK1; ETS domain-containing protein Elk-1
K08550 NR3A1; estrogen receptor alpha
K04503 CCND1; cyclin D1
K05692 ACTB_G1; actin beta/gamma 1
K05692 ACTB_G1; actin beta/gamma 1
K04437 FLNA; filamin
K04437 FLNA; filamin
K04437 FLNA; filamin
K04409 PAK1; p21-activated kinase 1 [EC:2.7.11.1]
K05731 TIAM1; T-lymphoma invasion and metastasis-inducing protein 1
K12330 ARHGEF1; Rho guanine nucleotide exchange factor 1
K04513 RHOA; Ras homolog gene family, member A
K04514 ROCK1; Rho-associated protein kinase 1 [EC:2.7.11.1]
K17388 ROCK2; Rho-associated protein kinase 2 [EC:2.7.11.1]
K10380 ANK; ankyrin
K10380 ANK; ankyrin
K10380 ANK; ankyrin
K09593 GAB1; GRB2-associated-binding protein 1
K00922 PIK3C; phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
K00922 PIK3C; phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
K00922 PIK3C; phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
K00922 PIK3C; phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
K02649 PIK3R; phosphoinositide-3-kinase, regulatory subunit
K02649 PIK3R; phosphoinositide-3-kinase, regulatory subunit
K02649 PIK3R; phosphoinositide-3-kinase, regulatory subunit
K02649 PIK3R; phosphoinositide-3-kinase, regulatory subunit
K04456 AKT; RAC serine/threonine-protein kinase [EC:2.7.11.1]
K04456 AKT; RAC serine/threonine-protein kinase [EC:2.7.11.1]
K04456 AKT; RAC serine/threonine-protein kinase [EC:2.7.11.1]
K05742 SLC9A1; solute carrier family 9 (sodium/hydrogen exchanger), member 1
K06269 PPP1C; serine/threonine-protein phosphatase PP1 catalytic subunit [EC:3.1.3.16]
K06269 PPP1C; serine/threonine-protein phosphatase PP1 catalytic subunit [EC:3.1.3.16]
K06269 PPP1C; serine/threonine-protein phosphatase PP1 catalytic subunit [EC:3.1.3.16]
K06270 PPP1R12A; protein phosphatase 1 regulatory subunit 12A
K12329 PPP1R12B; protein phosphatase 1 regulatory subunit 12B
K17457 PPP1R12C; protein phosphatase 1 regulatory subunit 12C
K07532 ARHGEF12; Rho guanine nucleotide exchange factor 12
K05860 PLCE; phosphatidylinositol phospholipase C, epsilon [EC:3.1.4.11]
K04958 ITPR1; inositol 1,4,5-triphosphate receptor type 1
K04959 ITPR2; inositol 1,4,5-triphosphate receptor type 2
K04960 ITPR3; inositol 1,4,5-triphosphate receptor type 3
K04515 CAMK2; calcium/calmodulin-dependent protein kinase (CaM kinase) II [EC:2.7.11.17]
K04515 CAMK2; calcium/calmodulin-dependent protein kinase (CaM kinase) II [EC:2.7.11.17]
K04515 CAMK2; calcium/calmodulin-dependent protein kinase (CaM kinase) II [EC:2.7.11.17]
K04515 CAMK2; calcium/calmodulin-dependent protein kinase (CaM kinase) II [EC:2.7.11.17]
K10164 NANOG; homeobox protein Nanog
K12823 DDX5; ATP-dependent RNA helicase DDX5/DBP2 [EC:3.6.4.13]
K03685 rnc; ribonuclease III [EC:3.1.26.3]
K04692 STAT3; signal transducer and activator of transcription 3
K16863 MIR21; microRNA 21
K09069 TWIST; twist
K09069 TWIST; twist
K16864 MIR10A; microRNA 10a
K17393 MIR10B; microRNA 10b
K09295 HOXD10; homrobox protein Hox-D10
K04660 DCN; decorin
K05459 IGF1; insulin-like growth factor 1
K05087 IGF1R; insulin-like growth factor 1 receptor [EC:2.7.10.1]
K07203 FRAP; FKBP12-rapamycin complex-associated protein
K06276 PDPK1; 3-phosphoinositide dependent protein kinase-1 [EC:2.7.11.1]
K04688 RPS6KB; p70 ribosomal S6 kinase [EC:2.7.11.1]
K04688 RPS6KB; p70 ribosomal S6 kinase [EC:2.7.11.1]
K03258 EIF4B; translation initiation factor 4B
K02991 RP-S6e; small subunit ribosomal protein S6e
K04361 EGFR; epidermal growth factor receptor [EC:2.7.10.1]
K06278 CAV1; caveolin 1
K12958 CAV2; caveolin 2
K12959 CAV3; caveolin 3
K06497 CD63; CD63 antigen
K06625 CDKN1A; cyclin-dependent kinase inhibitor 1A
K02187 CASP3; caspase 3 [EC:3.4.22.56]
K13375 TGFB1; transforming growth factor beta-1
K10159 TLR2; toll-like receptor 2
K10160 TLR4; toll-like receptor 4
K16865 PDCD4; programmed cell death protein 4
K03156 TNFA; tumor necrosis factor superfamily, member 2
K05425 IL12B; interleukin 12B
K05084 ERBB3; receptor tyrosine-protein kinase erbB-3 [EC:2.7.10.1]
K05085 ERBB4; receptor tyrosine-protein kinase erbB-4 [EC:2.7.10.1]
K04377 MYC; Myc proto-oncogene protein
K02105 CTNNB1; catenin beta 1
K08268 HIF1A; hypoxia-inducible factor 1 alpha
K09108 TFAP4; transcription factor AP-4
K05448 VEGFA; vascular endothelial growth factor A
K05098 KDR; kinase insert domain protein receptor [EC:2.7.10.1]
K05099 MET; proto-oncogene tyrosine-protein kinase Met [EC:2.7.10.1]
K04707 CBL; E3 ubiquitin-protein ligase CBL [EC:6.3.2.19]
K04707 CBL; E3 ubiquitin-protein ligase CBL [EC:6.3.2.19]
K04707 CBL; E3 ubiquitin-protein ligase CBL [EC:6.3.2.19]
K16866 TIMP3; metalloproteinase inhibitor 3
K16857 THBS1; thrombospondin 1
K01398 MMP2; matrix metalloproteinase-2 (gelatinase A) [EC:3.4.24.24]
K01403 MMP9; matrix metalloproteinase-9 (gelatinase B) [EC:3.4.24.35]
K08122 LUM; lumican
K04389 TNFSF6; tumor necrosis factor ligand superfamily member 6
K04390 TNFRSF6; tumor necrosis factor receptor superfamily member 6
K06643 MDM2; E3 ubiquitin-protein ligase Mdm2 [EC:6.3.2.19]
K04451 TP53; tumor protein p53
K13376 TGFB2; transforming growth factor beta-2
K07964 HPSE; heparanase 1 [EC:3.2.1.166]
K07965 HPSE2; heparanase 2 [EC:3.2.1.-]
K06257 SDC1; syndecan 1
K01348 PLAU; urokinase plasminogen activator [EC:3.4.21.73]
K03985 PLAUR; plasminogen activator, urokinase receptor
K06481 ITGA2; integrin alpha 2
K05719 ITGB1; integrin beta 1
K06251 VTN; vitronectin
K06487 ITGAV; integrin alpha V
K06493 ITGB3; integrin beta 3
K05717 FN1; fibronectin 1
K06588 ITGB5; integrin beta 5
K05460 HGF; hepatocyte growth factor
K03209 WNT1; wingless-type MMTV integration site family, member 1
K02432 FZD1_7; frizzled 1/7
K02432 FZD1_7; frizzled 1/7
K02235 FZD2; frizzled 2
K02329 FZD3; frizzled 3
K02354 FZD4; frizzled 4
K02375 FZD5_8; frizzled 5/8
K02375 FZD5_8; frizzled 5/8
K02376 FZD6; frizzled 6
K02842 FZD9_10; frizzled 9/10
K02842 FZD9_10; frizzled 9/10
K06484 ITGA5; integrin alpha 5
K16336 SDC2; syndecan 2
K08007 VIL2; villin 2 (ezrin)
K05762 RDX; radixin
K05763 MSN; moesin
K16338 SDC4; syndecan 4
K04358 FGF; fibroblast growth factor
K04358 FGF; fibroblast growth factor
K04358 FGF; fibroblast growth factor
K04358 FGF; fibroblast growth factor
K04358 FGF; fibroblast growth factor
K04358 FGF; fibroblast growth factor
K04358 FGF; fibroblast growth factor
K04358 FGF; fibroblast growth factor
K04358 FGF; fibroblast growth factor
K04358 FGF; fibroblast growth factor
K04358 FGF; fibroblast growth factor
K04358 FGF; fibroblast growth factor
K04358 FGF; fibroblast growth factor
K04358 FGF; fibroblast growth factor
K04358 FGF; fibroblast growth factor
K04358 FGF; fibroblast growth factor
K04358 FGF; fibroblast growth factor
K04358 FGF; fibroblast growth factor
K04358 FGF; fibroblast growth factor
K04358 FGF; fibroblast growth factor
K04358 FGF; fibroblast growth factor
K04358 FGF; fibroblast growth factor
K04362 FGFR1; fibroblast growth factor receptor 1 [EC:2.7.10.1]
K12461 FRS2; fibroblast growth factor receptor substrate 2
K07293 PTPN11; tyrosine-protein phosphatase non-receptor type 11 [EC:3.1.3.48]
K03099 SOS; son of sevenless
K03099 SOS; son of sevenless
K01116 PLCG1; phosphatidylinositol phospholipase C, gamma-1 [EC:3.1.4.11]
K05859 PLCG2; phosphatidylinositol phospholipase C, gamma-2 [EC:3.1.4.11]
K02677 CPKC; classical protein kinase C [EC:2.7.11.13]
K02677 CPKC; classical protein kinase C [EC:2.7.11.13]
K02677 CPKC; classical protein kinase C [EC:2.7.11.13]
K16867 NUDT16L1; NUDT16-like protein 1
K05760 PXN; paxillin
K05725 PTK2; focal adhesion kinase 1 [EC:2.7.10.2]
K08523 HBEGF; heparin-binding EGF-like growth factor
K08107 GPC1; glypican 1
K13769 IGF2; insulin-like growth factor 2
K08109 GPC3; glypican 3 (OCI-5)
K00182 WNT2; wingless-type MMTV integration site family, member 2
K00182 WNT2; wingless-type MMTV integration site family, member 2
K00312 WNT3; wingless-type MMTV integration site family, member 3
K00312 WNT3; wingless-type MMTV integration site family, member 3
K00408 WNT4; wingless-type MMTV integration site family, member 4
K00444 WNT5; wingless-type MMTV integration site family, member 5
K00444 WNT5; wingless-type MMTV integration site family, member 5
K00445 WNT6; wingless-type MMTV integration site family, member 6
K00572 WNT7; wingless-type MMTV integration site family, member 7
K00572 WNT7; wingless-type MMTV integration site family, member 7
K00714 WNT8; wingless-type MMTV integration site family, member 8
K00714 WNT8; wingless-type MMTV integration site family, member 8
K01064 WNT9; wingless-type MMTV integration site family, member 9
K01064 WNT9; wingless-type MMTV integration site family, member 9
K01357 WNT10; wingless-type MMTV integration site family, member 10
K01357 WNT10; wingless-type MMTV integration site family, member 10
K01384 WNT11; wingless-type MMTV integration site family, member 11
K01558 WNT16; wingless-type MMTV integration site family, member 16
K06225 PTCH1; patched 1
K06226 SMO; smoothened
K06255 HSPG2; heparan sulfate proteoglycan 2 (perlecan)
K01365 CTSL; cathepsin L [EC:3.4.22.15]
K04345 PKA; protein kinase A [EC:2.7.11.11]
K04345 PKA; protein kinase A [EC:2.7.11.11]
K04345 PKA; protein kinase A [EC:2.7.11.11]
K04345 PKA; protein kinase A [EC:2.7.11.11]
K04441 P38; p38 MAP kinase [EC:2.7.11.24]
K04441 P38; p38 MAP kinase [EC:2.7.11.24]
K04441 P38; p38 MAP kinase [EC:2.7.11.24]
K04441 P38; p38 MAP kinase [EC:2.7.11.24]
K09543 HSPB2; heat shock protein beta-2
K05697 PTPN6; tyrosine-protein phosphatase non-receptor type 6 [EC:3.1.3.48]
K04500 SMAD2_3; mothers against decapentaplegic homolog 2/3
K05730 VAV; guanine nucleotide exchange factor VAV
K16629 COL21A; collagen, type XXI, alpha
     05204 Chemical carcinogenesis [PATH:hsa05204]
     05203 Viral carcinogenesis [PATH:hsa05203]
     05210 Colorectal cancer [PATH:hsa05210]
     05212 Pancreatic cancer [PATH:hsa05212]
     05214 Glioma [PATH:hsa05214]
     05216 Thyroid cancer [PATH:hsa05216]
     05221 Acute myeloid leukemia [PATH:hsa05221]
     05220 Chronic myeloid leukemia [PATH:hsa05220]
     05217 Basal cell carcinoma [PATH:hsa05217]
     05218 Melanoma [PATH:hsa05218]
     05211 Renal cell carcinoma [PATH:hsa05211]
     05219 Bladder cancer [PATH:hsa05219]
     05215 Prostate cancer [PATH:hsa05215]
     05213 Endometrial cancer [PATH:hsa05213]
     05222 Small cell lung cancer [PATH:hsa05222]
     05223 Non-small cell lung cancer [PATH:hsa05223]
 
   Immune diseases
     05310 Asthma [PATH:hsa05310]
       3108 HLA-DMA; major histocompatibility complex, class II, DM alpha
       3109 HLA-DMB; major histocompatibility complex, class II, DM beta
       3111 HLA-DOA; major histocompatibility complex, class II, DO alpha
       3112 HLA-DOB; major histocompatibility complex, class II, DO beta
       3113 HLA-DPA1; major histocompatibility complex, class II, DP alpha 1
       3115 HLA-DPB1; major histocompatibility complex, class II, DP beta 1
       3117 HLA-DQA1; major histocompatibility complex, class II, DQ alpha 1
       3118 HLA-DQA2; major histocompatibility complex, class II, DQ alpha 2
       3119 HLA-DQB1; major histocompatibility complex, class II, DQ beta 1
       3122 HLA-DRA; major histocompatibility complex, class II, DR alpha
       3123 HLA-DRB1; major histocompatibility complex, class II, DR beta 1
       3125 HLA-DRB3; major histocompatibility complex, class II, DR beta 3
       3126 HLA-DRB4; major histocompatibility complex, class II, DR beta 4
       3127 HLA-DRB5; major histocompatibility complex, class II, DR beta 5
       100509457 HLA class II histocompatibility antigen
       101060835 HLA class II histocompatibility antigen
       3565 IL4; interleukin 4
       959 CD40LG; CD40 ligand
       958 CD40; CD40 molecule, TNF receptor superfamily member 5
       2205 FCER1A; Fc fragment of IgE, high affinity I, receptor for; alpha polypeptide
       2206 MS4A2; membrane-spanning 4-domains, subfamily A, member 2
       2207 FCER1G; Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide
       3578 IL9; interleukin 9
       3586 IL10; interleukin 10
       3596 IL13; interleukin 13
       3567 IL5; interleukin 5
       6356 CCL11; chemokine (C-C motif) ligand 11
       7124 TNF; tumor necrosis factor
       3562 IL3; interleukin 3
       5553 PRG2; proteoglycan 2, bone marrow (natural killer cell activator, eosinophil granule major basic protein)
       6037 RNASE3; ribonuclease, RNase A family, 3 
       8288 EPX; eosinophil peroxidase 
K06752 MHC2; major histocompatibility complex, class II
K06752 MHC2; major histocompatibility complex, class II
K06752 MHC2; major histocompatibility complex, class II
K06752 MHC2; major histocompatibility complex, class II
K06752 MHC2; major histocompatibility complex, class II
K06752 MHC2; major histocompatibility complex, class II
K06752 MHC2; major histocompatibility complex, class II
K06752 MHC2; major histocompatibility complex, class II
K06752 MHC2; major histocompatibility complex, class II
K06752 MHC2; major histocompatibility complex, class II
K06752 MHC2; major histocompatibility complex, class II
K06752 MHC2; major histocompatibility complex, class II
K06752 MHC2; major histocompatibility complex, class II
K06752 MHC2; major histocompatibility complex, class II
K06752 MHC2; major histocompatibility complex, class II
K06752 MHC2; major histocompatibility complex, class II
K05430 IL4; interleukin 4
K03161 TNFSF5; tumor necrosis factor ligand superfamily member 5
K03160 TNFRSF5; tumor necrosis factor receptor superfamily member 5
K08089 FCER1A; Fc receptor, IgE, high affinity I, alpha polypeptide
K08090 MS4A2; membrane-spanning 4-domains, subfamily A, member 2
K07983 FCER1G; Fc receptor, IgE, high affinity I, gamma polypeptide
K05432 IL9; interleukin 9
K05443 IL10; interleukin 10
K05435 IL13; interleukin 13
K05428 IL5; interleukin 5
K16597 CCL11; C-C motif chemokine 11
K03156 TNFA; tumor necrosis factor superfamily, member 2
K04736 IL3; interleukin 3
K10786 PRG2; bone marrow proteoglycan
K10787 RNASE3; eosinophil cationic protein [EC:3.1.27.-]
K10788 EPX; eosinophil peroxidase [EC:1.11.1.7]
     05322 Systemic lupus erythematosus [PATH:hsa05322]
       712 C1QA; complement component 1, q subcomponent, A chain
       713 C1QB; complement component 1, q subcomponent, B chain
       714 C1QC; complement component 1, q subcomponent, C chain
       717 C2; complement component 2 
       720 C4A; complement component 4A (Rodgers blood group)
       721 C4B; complement component 4B (Chido blood group)
       3014 H2AFX; H2A histone family, member X
       8338 HIST2H2AC; histone cluster 2, H2ac
       85235 HIST1H2AH; histone cluster 1, H2ah
       221613 HIST1H2AA; histone cluster 1, H2aa
       92815 HIST3H2A; histone cluster 3, H2a
       83740 H2AFB3; H2A histone family, member B3
       3012 HIST1H2AE; histone cluster 1, H2ae
       8335 HIST1H2AB; histone cluster 1, H2ab
       55506 H2AFY2; H2A histone family, member Y2
       9555 H2AFY; H2A histone family, member Y
       723790 HIST2H2AA4; histone cluster 2, H2aa4
       55766 H2AFJ; H2A histone family, member J
       474382 H2AFB1; H2A histone family, member B1
       8336 HIST1H2AM; histone cluster 1, H2am
       8337 HIST2H2AA3; histone cluster 2, H2aa3
       8969 HIST1H2AG; histone cluster 1, H2ag
       317772 HIST2H2AB; histone cluster 2, H2ab
       94239 H2AFV; H2A histone family, member V
       3013 HIST1H2AD; histone cluster 1, H2ad
       3015 H2AFZ; H2A histone family, member Z
       8330 HIST1H2AK; histone cluster 1, H2ak
       8334 HIST1H2AC; histone cluster 1, H2ac
       8329 HIST1H2AI; histone cluster 1, H2ai
       8331 HIST1H2AJ; histone cluster 1, H2aj
       8332 HIST1H2AL; histone cluster 1, H2al
       474381 H2AFB2; H2A histone family, member B2
       8341 HIST1H2BN; histone cluster 1, H2bn
       8345 HIST1H2BH; histone cluster 1, H2bh
       8342 HIST1H2BM; histone cluster 1, H2bm
       158983 H2BFWT; H2B histone family, member W, testis-specific
       255626 HIST1H2BA; histone cluster 1, H2ba
       440689 HIST2H2BF; histone cluster 2, H2bf
       8348 HIST1H2BO; histone cluster 1, H2bo
       3018 HIST1H2BB; histone cluster 1, H2bb
       8339 HIST1H2BG; histone cluster 1, H2bg
       8340 HIST1H2BL; histone cluster 1, H2bl
       8347 HIST1H2BC; histone cluster 1, H2bc
       3017 HIST1H2BD; histone cluster 1, H2bd
       8344 HIST1H2BE; histone cluster 1, H2be
       8346 HIST1H2BI; histone cluster 1, H2bi
       8349 HIST2H2BE; histone cluster 2, H2be
       8970 HIST1H2BJ; histone cluster 1, H2bj
       85236 HIST1H2BK; histone cluster 1, H2bk
       128312 HIST3H2BB; histone cluster 3, H2bb
       8343 HIST1H2BF; histone cluster 1, H2bf
       286436 H2BFM; H2B histone family, member M
       440093 H3F3C; H3 histone, family 3C
       3021 H3F3B; H3 histone, family 3B (H3.3B)
       8351 HIST1H3D; histone cluster 1, H3d
       8352 HIST1H3C; histone cluster 1, H3c
       8350 HIST1H3A; histone cluster 1, H3a
       3020 H3F3A; H3 histone, family 3A
       8290 HIST3H3; histone cluster 3, H3
       126961 HIST2H3C; histone cluster 2, H3c
       333932 HIST2H3A; histone cluster 2, H3a
       653604 HIST2H3D; histone cluster 2, H3d
       8353 HIST1H3E; histone cluster 1, H3e
       8354 HIST1H3I; histone cluster 1, H3i
       8355 HIST1H3G; histone cluster 1, H3g
       8356 HIST1H3J; histone cluster 1, H3j
       8357 HIST1H3H; histone cluster 1, H3h
       8358 HIST1H3B; histone cluster 1, H3b
       8968 HIST1H3F; histone cluster 1, H3f
       121504 HIST4H4; histone cluster 4, H4
       554313 HIST2H4B; histone cluster 2, H4b
       8294 HIST1H4I; histone cluster 1, H4i
       8360 HIST1H4D; histone cluster 1, H4d
       8361 HIST1H4F; histone cluster 1, H4f
       8362 HIST1H4K; histone cluster 1, H4k
       8363 HIST1H4J; histone cluster 1, H4j
       8364 HIST1H4C; histone cluster 1, H4c
       8365 HIST1H4H; histone cluster 1, H4h
       8366 HIST1H4B; histone cluster 1, H4b
       8367 HIST1H4E; histone cluster 1, H4e
       8368 HIST1H4L; histone cluster 1, H4l
       8370 HIST2H4A; histone cluster 2, H4a
       8359 HIST1H4A; histone cluster 1, H4a
       8369 HIST1H4G; histone cluster 1, H4g
       6628 SNRPB; small nuclear ribonucleoprotein polypeptides B and B1
       6632 SNRPD1; small nuclear ribonucleoprotein D1 polypeptide 16kDa
       6634 SNRPD3; small nuclear ribonucleoprotein D3 polypeptide 18kDa
       2903 GRIN2A; glutamate receptor, ionotropic, N-methyl D-aspartate 2A
       2904 GRIN2B; glutamate receptor, ionotropic, N-methyl D-aspartate 2B
       6737 TRIM21; tripartite motif containing 21
       6738 TROVE2; TROVE domain family, member 2
       6741 SSB; Sjogren syndrome antigen B (autoantigen La)
       87 ACTN1; actinin, alpha 1
       88 ACTN2; actinin, alpha 2
       89 ACTN3; actinin, alpha 3
       81 ACTN4; actinin, alpha 4
       3108 HLA-DMA; major histocompatibility complex, class II, DM alpha
       3109 HLA-DMB; major histocompatibility complex, class II, DM beta
       3111 HLA-DOA; major histocompatibility complex, class II, DO alpha
       3112 HLA-DOB; major histocompatibility complex, class II, DO beta
       3113 HLA-DPA1; major histocompatibility complex, class II, DP alpha 1
       3115 HLA-DPB1; major histocompatibility complex, class II, DP beta 1
       3117 HLA-DQA1; major histocompatibility complex, class II, DQ alpha 1
       3118 HLA-DQA2; major histocompatibility complex, class II, DQ alpha 2
       3119 HLA-DQB1; major histocompatibility complex, class II, DQ beta 1
       3122 HLA-DRA; major histocompatibility complex, class II, DR alpha
       3123 HLA-DRB1; major histocompatibility complex, class II, DR beta 1
       3125 HLA-DRB3; major histocompatibility complex, class II, DR beta 3
       3126 HLA-DRB4; major histocompatibility complex, class II, DR beta 4
       3127 HLA-DRB5; major histocompatibility complex, class II, DR beta 5
       100509457 HLA class II histocompatibility antigen
       101060835 HLA class II histocompatibility antigen
       941 CD80; CD80 molecule
       942 CD86; CD86 molecule
       940 CD28; CD28 molecule
       959 CD40LG; CD40 ligand
       958 CD40; CD40 molecule, TNF receptor superfamily member 5
       7124 TNF; tumor necrosis factor
       3458 IFNG; interferon, gamma
       3586 IL10; interleukin 10
       715 C1R; complement component 1, r subcomponent 
       716 C1S; complement component 1, s subcomponent 
       718 C3; complement component 3 
       727 C5; complement component 5
       729 C6; complement component 6
       730 C7; complement component 7
       731 C8A; complement component 8, alpha polypeptide
       732 C8B; complement component 8, beta polypeptide
       733 C8G; complement component 8, gamma polypeptide
       735 C9; complement component 9
       1511 CTSG; cathepsin G 
       1991 ELANE; elastase, neutrophil expressed 
       2209 FCGR1A; Fc fragment of IgG, high affinity Ia, receptor (CD64)
       2212 FCGR2A; Fc fragment of IgG, low affinity IIa, receptor (CD32)
       2214 FCGR3A; Fc fragment of IgG, low affinity IIIa, receptor (CD16a)
       2215 FCGR3B; Fc fragment of IgG, low affinity IIIb, receptor (CD16b)
K03986 C1QA; complement C1q subcomponent subunit A
K03987 C1QB; complement C1q subcomponent subunit B
K03988 C1QG; complement C1q subcomponent subunit C
K01332 C2; complement component 2 [EC:3.4.21.43]
K03989 C4; complement component 4
K03989 C4; complement component 4
K11251 H2A; histone H2A
K11251 H2A; histone H2A
K11251 H2A; histone H2A
K11251 H2A; histone H2A
K11251 H2A; histone H2A
K11251 H2A; histone H2A
K11251 H2A; histone H2A
K11251 H2A; histone H2A
K11251 H2A; histone H2A
K11251 H2A; histone H2A
K11251 H2A; histone H2A
K11251 H2A; histone H2A
K11251 H2A; histone H2A
K11251 H2A; histone H2A
K11251 H2A; histone H2A
K11251 H2A; histone H2A
K11251 H2A; histone H2A
K11251 H2A; histone H2A
K11251 H2A; histone H2A
K11251 H2A; histone H2A
K11251 H2A; histone H2A
K11251 H2A; histone H2A
K11251 H2A; histone H2A
K11251 H2A; histone H2A
K11251 H2A; histone H2A
K11251 H2A; histone H2A
K11252 H2B; histone H2B
K11252 H2B; histone H2B
K11252 H2B; histone H2B
K11252 H2B; histone H2B
K11252 H2B; histone H2B
K11252 H2B; histone H2B
K11252 H2B; histone H2B
K11252 H2B; histone H2B
K11252 H2B; histone H2B
K11252 H2B; histone H2B
K11252 H2B; histone H2B
K11252 H2B; histone H2B
K11252 H2B; histone H2B
K11252 H2B; histone H2B
K11252 H2B; histone H2B
K11252 H2B; histone H2B
K11252 H2B; histone H2B
K11252 H2B; histone H2B
K11252 H2B; histone H2B
K11252 H2B; histone H2B
K11253 H3; histone H3
K11253 H3; histone H3
K11253 H3; histone H3
K11253 H3; histone H3
K11253 H3; histone H3
K11253 H3; histone H3
K11253 H3; histone H3
K11253 H3; histone H3
K11253 H3; histone H3
K11253 H3; histone H3
K11253 H3; histone H3
K11253 H3; histone H3
K11253 H3; histone H3
K11253 H3; histone H3
K11253 H3; histone H3
K11253 H3; histone H3
K11253 H3; histone H3
K11254 H4; histone H4
K11254 H4; histone H4
K11254 H4; histone H4
K11254 H4; histone H4
K11254 H4; histone H4
K11254 H4; histone H4
K11254 H4; histone H4
K11254 H4; histone H4
K11254 H4; histone H4
K11254 H4; histone H4
K11254 H4; histone H4
K11254 H4; histone H4
K11254 H4; histone H4
K11254 H4; histone H4
K11254 H4; histone H4
K11086 SNRPB; small nuclear ribonucleoprotein B and B'
K11087 SNRPD1; small nuclear ribonucleoprotein D1
K11088 SNRPD3; small nuclear ribonucleoprotein D3
K05209 GRIN2A; glutamate receptor ionotropic, NMDA 2A
K05210 GRIN2B; glutamate receptor ionotropic, NMDA 2B
K10651 TRIM21; tripartite motif-containing protein 21 [EC:6.3.2.19]
K11089 TROVE2; 60 kDa SS-A/Ro ribonucleoprotein
K11090 LA; lupus La protein
K05699 ACTN; actinin alpha
K05699 ACTN; actinin alpha
K05699 ACTN; actinin alpha
K05699 ACTN; actinin alpha
K06752 MHC2; major histocompatibility complex, class II
K06752 MHC2; major histocompatibility complex, class II
K06752 MHC2; major histocompatibility complex, class II
K06752 MHC2; major histocompatibility complex, class II
K06752 MHC2; major histocompatibility complex, class II
K06752 MHC2; major histocompatibility complex, class II
K06752 MHC2; major histocompatibility complex, class II
K06752 MHC2; major histocompatibility complex, class II
K06752 MHC2; major histocompatibility complex, class II
K06752 MHC2; major histocompatibility complex, class II
K06752 MHC2; major histocompatibility complex, class II
K06752 MHC2; major histocompatibility complex, class II
K06752 MHC2; major histocompatibility complex, class II
K06752 MHC2; major histocompatibility complex, class II
K06752 MHC2; major histocompatibility complex, class II
K06752 MHC2; major histocompatibility complex, class II
K05412 CD80; CD80 antigen
K05413 CD86; CD86 antigen
K06470 CD28; CD28 antigen
K03161 TNFSF5; tumor necrosis factor ligand superfamily member 5
K03160 TNFRSF5; tumor necrosis factor receptor superfamily member 5
K03156 TNFA; tumor necrosis factor superfamily, member 2
K04687 IFNG; interferon gamma
K05443 IL10; interleukin 10
K01330 C1R; complement component 1, r subcomponent [EC:3.4.21.41]
K01331 C1S; complement component 1, s subcomponent [EC:3.4.21.42]
K03990 C3; complement component 3
K03994 C5; complement component 5
K03995 C6; complement component 6
K03996 C7; complement component 7
K03997 C8A; complement component 8 subunit alpha
K03998 C8B; complement component 8 subunit beta
K03999 C8G; complement component 8 subunit gamma
K04000 C9; complement component 9
K01319 CTSG; cathepsin G [EC:3.4.21.20]
K01327 ELANE; leukocyte elastase [EC:3.4.21.37]
K06498 FCGR1A; high affinity immunoglobulin gamma Fc receptor I
K06472 FCGR2A; low affinity immunoglobulin gamma Fc region receptor II-a
K06463 FCGR3; low affinity immunoglobulin gamma Fc region receptor III
K06463 FCGR3; low affinity immunoglobulin gamma Fc region receptor III
     05323 Rheumatoid arthritis [PATH:hsa05323]
       941 CD80; CD80 molecule
       942 CD86; CD86 molecule
       940 CD28; CD28 molecule
       1493 CTLA4; cytotoxic T-lymphocyte-associated protein 4
       3108 HLA-DMA; major histocompatibility complex, class II, DM alpha
       3109 HLA-DMB; major histocompatibility complex, class II, DM beta
       3111 HLA-DOA; major histocompatibility complex, class II, DO alpha
       3112 HLA-DOB; major histocompatibility complex, class II, DO beta
       3113 HLA-DPA1; major histocompatibility complex, class II, DP alpha 1
       3115 HLA-DPB1; major histocompatibility complex, class II, DP beta 1
       3117 HLA-DQA1; major histocompatibility complex, class II, DQ alpha 1
       3118 HLA-DQA2; major histocompatibility complex, class II, DQ alpha 2
       3119 HLA-DQB1; major histocompatibility complex, class II, DQ beta 1
       3122 HLA-DRA; major histocompatibility complex, class II, DR alpha
       3123 HLA-DRB1; major histocompatibility complex, class II, DR beta 1
       3125 HLA-DRB3; major histocompatibility complex, class II, DR beta 3
       3126 HLA-DRB4; major histocompatibility complex, class II, DR beta 4
       3127 HLA-DRB5; major histocompatibility complex, class II, DR beta 5
       100509457 HLA class II histocompatibility antigen
       101060835 HLA class II histocompatibility antigen
       3683 ITGAL; integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide)
       3689 ITGB2; integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)
       3383 ICAM1; intercellular adhesion molecule 1
       3600 IL15; interleukin 15
       8741 TNFSF13; tumor necrosis factor (ligand) superfamily, member 13
       10673 TNFSF13B; tumor necrosis factor (ligand) superfamily, member 13b
       4050 LTB; lymphotoxin beta (TNF superfamily, member 3)
       7124 TNF; tumor necrosis factor
       3552 IL1A; interleukin 1, alpha
       3553 IL1B; interleukin 1, beta
       3569 IL6; interleukin 6
       3589 IL11; interleukin 11
       3606 IL18; interleukin 18
       7097 TLR2; toll-like receptor 2
       7099 TLR4; toll-like receptor 4
       3725 JUN; jun proto-oncogene
       2353 FOS; FBJ murine osteosarcoma viral oncogene homolog
       7040 TGFB1; transforming growth factor, beta 1
       7042 TGFB2; transforming growth factor, beta 2
       7043 TGFB3; transforming growth factor, beta 3
       51561 IL23A; interleukin 23, alpha subunit p19
       3605 IL17A; interleukin 17A
       1435 CSF1; colony stimulating factor 1 (macrophage) 
       8600 TNFSF11; tumor necrosis factor (ligand) superfamily, member 11
       8792 TNFRSF11A; tumor necrosis factor receptor superfamily, member 11a, NFKB activator
       523 ATP6V1A; ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A 
       525 ATP6V1B1; ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1 
       526 ATP6V1B2; ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2 
       245973 ATP6V1C2; ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C2 
       528 ATP6V1C1; ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1 
       51382 ATP6V1D; ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D 
       90423 ATP6V1E2; ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E2
       529 ATP6V1E1; ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E1 
       9296 ATP6V1F; ATPase, H+ transporting, lysosomal 14kDa, V1 subunit F 
       9550 ATP6V1G1; ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1 
       127124 ATP6V1G3; ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G3 
       534 ATP6V1G2; ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2 
       8992 ATP6V0E1; ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1 
       155066 ATP6V0E2; ATPase, H+ transporting V0 subunit e2
       10312 TCIRG1; T-cell, immune regulator 1, ATPase, H+ transporting, lysosomal V0 subunit A3 
       23545 ATP6V0A2; ATPase, H+ transporting, lysosomal V0 subunit a2 
       50617 ATP6V0A4; ATPase, H+ transporting, lysosomal V0 subunit a4 
       535 ATP6V0A1; ATPase, H+ transporting, lysosomal V0 subunit a1 
       9114 ATP6V0D1; ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d1 
       245972 ATP6V0D2; ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d2 
       51606 ATP6V1H; ATPase, H+ transporting, lysosomal 50/57kDa, V1 subunit H 
       537 ATP6AP1; ATPase, H+ transporting, lysosomal accessory protein 1 
       527 ATP6V0C; ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c 
       533 ATP6V0B; ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b 
       1513 CTSK; cathepsin K 
       54 ACP5; acid phosphatase 5, tartrate resistant 
       4312 MMP1; matrix metallopeptidase 1 (interstitial collagenase) 
       4314 MMP3; matrix metallopeptidase 3 (stromelysin 1, progelatinase) 
       1514 CTSL; cathepsin L 
       1437 CSF2; colony stimulating factor 2 (granulocyte-macrophage)
       6352 CCL5; chemokine (C-C motif) ligand 5
       6347 CCL2; chemokine (C-C motif) ligand 2
       6348 CCL3; chemokine (C-C motif) ligand 3
       6349 CCL3L1; chemokine (C-C motif) ligand 3-like 1
       414062 CCL3L3; chemokine (C-C motif) ligand 3-like 3
       6364 CCL20; chemokine (C-C motif) ligand 20
       6374 CXCL5; chemokine (C-X-C motif) ligand 5
       6372 CXCL6; chemokine (C-X-C motif) ligand 6
       3576 CXCL8; chemokine (C-X-C motif) ligand 8
       6387 CXCL12; chemokine (C-X-C motif) ligand 12
       7422 VEGFA; vascular endothelial growth factor A
       2321 FLT1; fms-related tyrosine kinase 1 
       284 ANGPT1; angiopoietin 1
       7010 TEK; TEK tyrosine kinase, endothelial 
       3458 IFNG; interferon, gamma
       2919 CXCL1; chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha)
K05412 CD80; CD80 antigen
K05413 CD86; CD86 antigen
K06470 CD28; CD28 antigen
K06538 CTLA4; cytotoxic T-lymphocyte-associated protein 4
K06752 MHC2; major histocompatibility complex, class II
K06752 MHC2; major histocompatibility complex, class II
K06752 MHC2; major histocompatibility complex, class II
K06752 MHC2; major histocompatibility complex, class II
K06752 MHC2; major histocompatibility complex, class II
K06752 MHC2; major histocompatibility complex, class II
K06752 MHC2; major histocompatibility complex, class II
K06752 MHC2; major histocompatibility complex, class II
K06752 MHC2; major histocompatibility complex, class II
K06752 MHC2; major histocompatibility complex, class II
K06752 MHC2; major histocompatibility complex, class II
K06752 MHC2; major histocompatibility complex, class II
K06752 MHC2; major histocompatibility complex, class II
K06752 MHC2; major histocompatibility complex, class II
K06752 MHC2; major histocompatibility complex, class II
K06752 MHC2; major histocompatibility complex, class II
K05718 ITGAL; integrin alpha L
K06464 ITGB2; integrin beta 2
K06490 ICAM1; intercellular adhesion molecule 1
K05433 IL15; interleukin 15
K05475 TNFSF13; tumor necrosis factor ligand superfamily member 13
K05476 TNFSF13B; tumor necrosis factor ligand superfamily member 13B
K03157 LTB; lymphotoxin beta (TNF superfamily, member 3)
K03156 TNFA; tumor necrosis factor superfamily, member 2
K04383 IL1A; interleukin 1 alpha
K04519 IL1B; interleukin 1 beta
K05405 IL6; interleukin 6
K05417 IL11; interleukin 11
K05482 IL18; interleukin 18
K10159 TLR2; toll-like receptor 2
K10160 TLR4; toll-like receptor 4
K04448 JUN; transcription factor AP-1
K04379 FOS; proto-oncogene protein c-fos
K13375 TGFB1; transforming growth factor beta-1
K13376 TGFB2; transforming growth factor beta-2
K13377 TGFB3; transforming growth factor beta-3
K05426 IL23A; interleukin 23, alpha subunit p19
K05489 IL17; interleukin 17
K05453 CSF1; macrophage colony-stimulating factor 1
K05473 TNFSF11; tumor necrosis factor ligand superfamily member 11
K05147 TNFRSF11A; tumor necrosis factor receptor superfamily member 11A
K02145 ATPeV1A; V-type H+-transporting ATPase subunit A [EC:3.6.3.14]
K02147 ATPeV1B; V-type H+-transporting ATPase subunit B
K02147 ATPeV1B; V-type H+-transporting ATPase subunit B
K02148 ATPeV1C; V-type H+-transporting ATPase subunit C
K02148 ATPeV1C; V-type H+-transporting ATPase subunit C
K02149 ATPeV1D; V-type H+-transporting ATPase subunit D
K02150 ATPeV1E; V-type H+-transporting ATPase subunit E
K02150 ATPeV1E; V-type H+-transporting ATPase subunit E
K02151 ATPeV1F; V-type H+-transporting ATPase subunit F
K02152 ATPeV1G; V-type H+-transporting ATPase subunit G
K02152 ATPeV1G; V-type H+-transporting ATPase subunit G
K02152 ATPeV1G; V-type H+-transporting ATPase subunit G
K02153 ATPeV0E; V-type H+-transporting ATPase subunit e
K02153 ATPeV0E; V-type H+-transporting ATPase subunit e
K02154 ATPeV0A; V-type H+-transporting ATPase subunit a
K02154 ATPeV0A; V-type H+-transporting ATPase subunit a
K02154 ATPeV0A; V-type H+-transporting ATPase subunit a
K02154 ATPeV0A; V-type H+-transporting ATPase subunit a
K02146 ATPeV0D; V-type H+-transporting ATPase subunit d
K02146 ATPeV0D; V-type H+-transporting ATPase subunit d
K02144 ATPeV1H; V-type H+-transporting ATPase subunit H
K03662 ATPeVS1; V-type H+-transporting ATPase S1 subunit
K02155 ATPeV0C; V-type H+-transporting ATPase 16kDa proteolipid subunit
K03661 ATPeV0B; V-type H+-transporting ATPase 21kDa proteolipid subunit
K01371 CTSK; cathepsin K [EC:3.4.22.38]
K14379 ACP5; tartrate-resistant acid phosphatase type 5 [EC:3.1.3.2]
K01388 MMP1; matrix metalloproteinase-1 (interstitial collagenase) [EC:3.4.24.7]
K01394 MMP3; matrix metalloproteinase-3 (stromelysin 1, progelatinase) [EC:3.4.24.17]
K01365 CTSL; cathepsin L [EC:3.4.22.15]
K05427 CSF2; granulocyte-macrophage colony-stimulating factor
K12499 CCL5; C-C motif chemokine 5
K14624 CCL2; C-C motif chemokine 2
K05408 CCL3; C-C motif chemokine 3
K05408 CCL3; C-C motif chemokine 3
K05408 CCL3; C-C motif chemokine 3
K14625 CCL20; C-C motif chemokine 20
K05506 CXCL5_6; C-X-C motif chemokine 5/6
K05506 CXCL5_6; C-X-C motif chemokine 5/6
K10030 IL8; interleukin 8
K10031 CXCL12; C-X-C motif chemokine 12
K05448 VEGFA; vascular endothelial growth factor A
K05096 FLT1; FMS-like tyrosine kinase 1 [EC:2.7.10.1]
K05465 ANGPT1; angiopoietin 1
K05121 TEK; endothelial-specific receptor tyrosine kinase [EC:2.7.10.1]
K04687 IFNG; interferon gamma
K05505 CXCL1_2_3; C-X-C motif chemokine 1/2/3
     05320 Autoimmune thyroid disease [PATH:hsa05320]
     05321 Inflammatiory bowel disease (IBD) [PATH:hsa05321]
       7097 TLR2; toll-like receptor 2
       7099 TLR4; toll-like receptor 4
       7100 TLR5; toll-like receptor 5
       4790 NFKB1; nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
       5970 RELA; v-rel avian reticuloendotheliosis viral oncogene homolog A
       64127 NOD2; nucleotide-binding oligomerization domain containing 2
       3108 HLA-DMA; major histocompatibility complex, class II, DM alpha
       3109 HLA-DMB; major histocompatibility complex, class II, DM beta
       3111 HLA-DOA; major histocompatibility complex, class II, DO alpha
       3112 HLA-DOB; major histocompatibility complex, class II, DO beta
       3113 HLA-DPA1; major histocompatibility complex, class II, DP alpha 1
       3115 HLA-DPB1; major histocompatibility complex, class II, DP beta 1
       3117 HLA-DQA1; major histocompatibility complex, class II, DQ alpha 1
       3118 HLA-DQA2; major histocompatibility complex, class II, DQ alpha 2
       3119 HLA-DQB1; major histocompatibility complex, class II, DQ beta 1
       3122 HLA-DRA; major histocompatibility complex, class II, DR alpha
       3123 HLA-DRB1; major histocompatibility complex, class II, DR beta 1
       3125 HLA-DRB3; major histocompatibility complex, class II, DR beta 3
       3126 HLA-DRB4; major histocompatibility complex, class II, DR beta 4
       3127 HLA-DRB5; major histocompatibility complex, class II, DR beta 5
       100509457 HLA class II histocompatibility antigen
       101060835 HLA class II histocompatibility antigen
       3458 IFNG; interferon, gamma
       3459 IFNGR1; interferon gamma receptor 1
       3460 IFNGR2; interferon gamma receptor 2 (interferon gamma transducer 1)
       6772 STAT1; signal transducer and activator of transcription 1, 91kDa
       30009 TBX21; T-box 21
       3565 IL4; interleukin 4
       3567 IL5; interleukin 5
       3592 IL12A; interleukin 12A
       3593 IL12B; interleukin 12B
       3595 IL12RB2; interleukin 12 receptor, beta 2
       3594 IL12RB1; interleukin 12 receptor, beta 1
       6775 STAT4; signal transducer and activator of transcription 4
       3558 IL2; interleukin 2
       3606 IL18; interleukin 18
       8809 IL18R1; interleukin 18 receptor 1
       8807 IL18RAP; interleukin 18 receptor accessory protein
       3725 JUN; jun proto-oncogene
       7124 TNF; tumor necrosis factor
       3569 IL6; interleukin 6
       3552 IL1A; interleukin 1, alpha
       3553 IL1B; interleukin 1, beta
       7040 TGFB1; transforming growth factor, beta 1
       7042 TGFB2; transforming growth factor, beta 2
       7043 TGFB3; transforming growth factor, beta 3
       4087 SMAD2; SMAD family member 2
       4088 SMAD3; SMAD family member 3
       6774 STAT3; signal transducer and activator of transcription 3 (acute-phase response factor)
       59067 IL21; interleukin 21
       50615 IL21R; interleukin 21 receptor
       51561 IL23A; interleukin 23, alpha subunit p19
       149233 IL23R; interleukin 23 receptor
       6097 RORC; RAR-related orphan receptor C
       6095 RORA; RAR-related orphan receptor A
       50943 FOXP3; forkhead box P3
       3605 IL17A; interleukin 17A
       112744 IL17F; interleukin 17F
       50616 IL22; interleukin 22
       3566 IL4R; interleukin 4 receptor
       3561 IL2RG; interleukin 2 receptor, gamma
       6778 STAT6; signal transducer and activator of transcription 6, interleukin-4 induced
       3586 IL10; interleukin 10
       3596 IL13; interleukin 13
       4094 MAF; v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog
       4772 NFATC1; nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1
       2625 GATA3; GATA binding protein 3
K10159 TLR2; toll-like receptor 2
K10160 TLR4; toll-like receptor 4
K10168 TLR5; toll-like receptor 5
K02580 NFKB1; nuclear factor NF-kappa-B p105 subunit
K04735 RELA; transcription factor p65
K10165 NOD2; nucleotide-binding oligomerization domain-containing protein 2
K06752 MHC2; major histocompatibility complex, class II
K06752 MHC2; major histocompatibility complex, class II
K06752 MHC2; major histocompatibility complex, class II
K06752 MHC2; major histocompatibility complex, class II
K06752 MHC2; major histocompatibility complex, class II
K06752 MHC2; major histocompatibility complex, class II
K06752 MHC2; major histocompatibility complex, class II
K06752 MHC2; major histocompatibility complex, class II
K06752 MHC2; major histocompatibility complex, class II
K06752 MHC2; major histocompatibility complex, class II
K06752 MHC2; major histocompatibility complex, class II
K06752 MHC2; major histocompatibility complex, class II
K06752 MHC2; major histocompatibility complex, class II
K06752 MHC2; major histocompatibility complex, class II
K06752 MHC2; major histocompatibility complex, class II
K06752 MHC2; major histocompatibility complex, class II
K04687 IFNG; interferon gamma
K05132 IFNGR1; interferon gamma receptor 1
K05133 IFNGR2; interferon gamma receptor 2
K11220 STAT1; signal transducer and activator of transcription 1
K10166 TBX21; T-box protein 21
K05430 IL4; interleukin 4
K05428 IL5; interleukin 5
K05406 IL12A; interleukin 12A
K05425 IL12B; interleukin 12B
K05064 IL12RB2; interleukin 12 receptor beta-2
K05063 IL12RB1; interleukin 12 receptor beta-1
K11222 STAT4; signal transducer and activator of transcription 4
K05429 IL2; interleukin 2
K05482 IL18; interleukin 18
K05173 IL18R1; interleukin 18 receptor 1
K05174 IL18RAP; interleukin 18 receptor accessory protein
K04448 JUN; transcription factor AP-1
K03156 TNFA; tumor necrosis factor superfamily, member 2
K05405 IL6; interleukin 6
K04383 IL1A; interleukin 1 alpha
K04519 IL1B; interleukin 1 beta
K13375 TGFB1; transforming growth factor beta-1
K13376 TGFB2; transforming growth factor beta-2
K13377 TGFB3; transforming growth factor beta-3
K04500 SMAD2_3; mothers against decapentaplegic homolog 2/3
K04500 SMAD2_3; mothers against decapentaplegic homolog 2/3
K04692 STAT3; signal transducer and activator of transcription 3
K05434 IL21; interleukin 21
K05075 IL21R; interleukin 21 receptor
K05426 IL23A; interleukin 23, alpha subunit p19
K05065 IL23R; interleukin 23 receptor
K08534 NR1F3; RAR-related orphan receptor gamma
K08532 NR1F1; RAR-related orphan receptor alpha
K10163 FOXP3; forkhead box P3
K05489 IL17; interleukin 17
K05494 IL17F; interleukin 17F
K05445 IL22; interleukin 22
K05071 IL4R; interleukin 4 receptor
K05070 IL2RG; interleukin 2 receptor gamma
K11225 STAT6; signal transducer and activator of transcription 6
K05443 IL10; interleukin 10
K05435 IL13; interleukin 13
K09035 CMAF; transcription factor Maf
K04446 NFATC1; nuclear factor of activated T-cells, cytoplasmic 1
K17895 GATA3; GATA-binding protein 3
     05330 Allograft rejection [PATH:hsa05330]
       3105 HLA-A; major histocompatibility complex, class I, A
       3106 HLA-B; major histocompatibility complex, class I, B
       3107 HLA-C; major histocompatibility complex, class I, C
       3134 HLA-F; major histocompatibility complex, class I, F
       3135 HLA-G; major histocompatibility complex, class I, G
       3133 HLA-E; major histocompatibility complex, class I, E
       941 CD80; CD80 molecule
       942 CD86; CD86 molecule
       940 CD28; CD28 molecule
       3592 IL12A; interleukin 12A
       3593 IL12B; interleukin 12B
       356 FASLG; Fas ligand (TNF superfamily, member 6)
       355 FAS; Fas cell surface death receptor
       5551 PRF1; perforin 1 (pore forming protein)
       3002 GZMB; granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1) 
       3108 HLA-DMA; major histocompatibility complex, class II, DM alpha
       3109 HLA-DMB; major histocompatibility complex, class II, DM beta
       3111 HLA-DOA; major histocompatibility complex, class II, DO alpha
       3112 HLA-DOB; major histocompatibility complex, class II, DO beta
       3113 HLA-DPA1; major histocompatibility complex, class II, DP alpha 1
       3115 HLA-DPB1; major histocompatibility complex, class II, DP beta 1
       3117 HLA-DQA1; major histocompatibility complex, class II, DQ alpha 1
       3118 HLA-DQA2; major histocompatibility complex, class II, DQ alpha 2
       3119 HLA-DQB1; major histocompatibility complex, class II, DQ beta 1
       3122 HLA-DRA; major histocompatibility complex, class II, DR alpha
       3123 HLA-DRB1; major histocompatibility complex, class II, DR beta 1
       3125 HLA-DRB3; major histocompatibility complex, class II, DR beta 3
       3126 HLA-DRB4; major histocompatibility complex, class II, DR beta 4
       3127 HLA-DRB5; major histocompatibility complex, class II, DR beta 5
       100509457 HLA class II histocompatibility antigen
       101060835 HLA class II histocompatibility antigen
       3558 IL2; interleukin 2
       959 CD40LG; CD40 ligand
       958 CD40; CD40 molecule, TNF receptor superfamily member 5
       3458 IFNG; interferon, gamma
       7124 TNF; tumor necrosis factor
       3565 IL4; interleukin 4
       3567 IL5; interleukin 5
       3586 IL10; interleukin 10
K06751 MHC1; major histocompatibility complex, class I
K06751 MHC1; major histocompatibility complex, class I
K06751 MHC1; major histocompatibility complex, class I
K06751 MHC1; major histocompatibility complex, class I
K06751 MHC1; major histocompatibility complex, class I
K06751 MHC1; major histocompatibility complex, class I
K05412 CD80; CD80 antigen
K05413 CD86; CD86 antigen
K06470 CD28; CD28 antigen
K05406 IL12A; interleukin 12A
K05425 IL12B; interleukin 12B
K04389 TNFSF6; tumor necrosis factor ligand superfamily member 6
K04390 TNFRSF6; tumor necrosis factor receptor superfamily member 6
K07818 PRF1; perforin 1
K01353 GZMB; granzyme B [EC:3.4.21.79]
K06752 MHC2; major histocompatibility complex, class II
K06752 MHC2; major histocompatibility complex, class II
K06752 MHC2; major histocompatibility complex, class II
K06752 MHC2; major histocompatibility complex, class II
K06752 MHC2; major histocompatibility complex, class II
K06752 MHC2; major histocompatibility complex, class II
K06752 MHC2; major histocompatibility complex, class II
K06752 MHC2; major histocompatibility complex, class II
K06752 MHC2; major histocompatibility complex, class II
K06752 MHC2; major histocompatibility complex, class II
K06752 MHC2; major histocompatibility complex, class II
K06752 MHC2; major histocompatibility complex, class II
K06752 MHC2; major histocompatibility complex, class II
K06752 MHC2; major histocompatibility complex, class II
K06752 MHC2; major histocompatibility complex, class II
K06752 MHC2; major histocompatibility complex, class II
K05429 IL2; interleukin 2
K03161 TNFSF5; tumor necrosis factor ligand superfamily member 5
K03160 TNFRSF5; tumor necrosis factor receptor superfamily member 5
K04687 IFNG; interferon gamma
K03156 TNFA; tumor necrosis factor superfamily, member 2
K05430 IL4; interleukin 4
K05428 IL5; interleukin 5
K05443 IL10; interleukin 10
     05332 Graft-versus-host disease [PATH:hsa05332]
       3569 IL6; interleukin 6
       3552 IL1A; interleukin 1, alpha
       3553 IL1B; interleukin 1, beta
       7124 TNF; tumor necrosis factor
       3108 HLA-DMA; major histocompatibility complex, class II, DM alpha
       3109 HLA-DMB; major histocompatibility complex, class II, DM beta
       3111 HLA-DOA; major histocompatibility complex, class II, DO alpha
       3112 HLA-DOB; major histocompatibility complex, class II, DO beta
       3113 HLA-DPA1; major histocompatibility complex, class II, DP alpha 1
       3115 HLA-DPB1; major histocompatibility complex, class II, DP beta 1
       3117 HLA-DQA1; major histocompatibility complex, class II, DQ alpha 1
       3118 HLA-DQA2; major histocompatibility complex, class II, DQ alpha 2
       3119 HLA-DQB1; major histocompatibility complex, class II, DQ beta 1
       3122 HLA-DRA; major histocompatibility complex, class II, DR alpha
       3123 HLA-DRB1; major histocompatibility complex, class II, DR beta 1
       3125 HLA-DRB3; major histocompatibility complex, class II, DR beta 3
       3126 HLA-DRB4; major histocompatibility complex, class II, DR beta 4
       3127 HLA-DRB5; major histocompatibility complex, class II, DR beta 5
       100509457 HLA class II histocompatibility antigen
       101060835 HLA class II histocompatibility antigen
       941 CD80; CD80 molecule
       942 CD86; CD86 molecule
       940 CD28; CD28 molecule
       3558 IL2; interleukin 2
       3105 HLA-A; major histocompatibility complex, class I, A
       3106 HLA-B; major histocompatibility complex, class I, B
       3107 HLA-C; major histocompatibility complex, class I, C
       3134 HLA-F; major histocompatibility complex, class I, F
       3135 HLA-G; major histocompatibility complex, class I, G
       3133 HLA-E; major histocompatibility complex, class I, E
       356 FASLG; Fas ligand (TNF superfamily, member 6)
       355 FAS; Fas cell surface death receptor
       5551 PRF1; perforin 1 (pore forming protein)
       3002 GZMB; granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1) 
       3458 IFNG; interferon, gamma
       3824 KLRD1; killer cell lectin-like receptor subfamily D, member 1
       3802 KIR2DL1; killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1
       3803 KIR2DL2; killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 2
       3804 KIR2DL3; killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3
       3811 KIR3DL1; killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1
       3812 KIR3DL2; killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2
       3821 KLRC1; killer cell lectin-like receptor subfamily C, member 1
       57292 KIR2DL5A; killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 5A
K05405 IL6; interleukin 6
K04383 IL1A; interleukin 1 alpha
K04519 IL1B; interleukin 1 beta
K03156 TNFA; tumor necrosis factor superfamily, member 2
K06752 MHC2; major histocompatibility complex, class II
K06752 MHC2; major histocompatibility complex, class II
K06752 MHC2; major histocompatibility complex, class II
K06752 MHC2; major histocompatibility complex, class II
K06752 MHC2; major histocompatibility complex, class II
K06752 MHC2; major histocompatibility complex, class II
K06752 MHC2; major histocompatibility complex, class II
K06752 MHC2; major histocompatibility complex, class II
K06752 MHC2; major histocompatibility complex, class II
K06752 MHC2; major histocompatibility complex, class II
K06752 MHC2; major histocompatibility complex, class II
K06752 MHC2; major histocompatibility complex, class II
K06752 MHC2; major histocompatibility complex, class II
K06752 MHC2; major histocompatibility complex, class II
K06752 MHC2; major histocompatibility complex, class II
K06752 MHC2; major histocompatibility complex, class II
K05412 CD80; CD80 antigen
K05413 CD86; CD86 antigen
K06470 CD28; CD28 antigen
K05429 IL2; interleukin 2
K06751 MHC1; major histocompatibility complex, class I
K06751 MHC1; major histocompatibility complex, class I
K06751 MHC1; major histocompatibility complex, class I
K06751 MHC1; major histocompatibility complex, class I
K06751 MHC1; major histocompatibility complex, class I
K06751 MHC1; major histocompatibility complex, class I
K04389 TNFSF6; tumor necrosis factor ligand superfamily member 6
K04390 TNFRSF6; tumor necrosis factor receptor superfamily member 6
K07818 PRF1; perforin 1
K01353 GZMB; granzyme B [EC:3.4.21.79]
K04687 IFNG; interferon gamma
K06516 KLRD1; killer cell lectin-like receptor subfamily D member 1
K07981 KIR2DL; killer cell immunoglobulin-like receptor 2DL
K07981 KIR2DL; killer cell immunoglobulin-like receptor 2DL
K07981 KIR2DL; killer cell immunoglobulin-like receptor 2DL
K07980 KIR3DL; killer cell immunoglobulin-like receptor 3DL
K07980 KIR3DL; killer cell immunoglobulin-like receptor 3DL
K06541 KLRC; killer cell lectin-like receptor subfamily C
K07981 KIR2DL; killer cell immunoglobulin-like receptor 2DL
     05340 Primary immunodeficiency [PATH:hsa05340]
 
   Neurodegenerative diseases
     05010 Alzheimer's disease [PATH:hsa05010]
       102 ADAM10; ADAM metallopeptidase domain 10 
       6868 ADAM17; ADAM metallopeptidase domain 17 
       351 APP; amyloid beta (A4) precursor protein
       8883 NAE1; NEDD8 activating enzyme E1 subunit 1
       322 APBB1; amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65)
       2597 GAPDH; glyceraldehyde-3-phosphate dehydrogenase 
       23621 BACE1; beta-site APP-cleaving enzyme 1 
       25825 BACE2; beta-site APP-cleaving enzyme 2 
       55851 PSENEN; presenilin enhancer gamma secretase subunit
       5663 PSEN1; presenilin 1 
       5664 PSEN2; presenilin 2
       23385 NCSTN; nicastrin
       51107 APH1A; APH1A gamma secretase subunit
       83464 APH1B; APH1B gamma secretase subunit
       3416 IDE; insulin-degrading enzyme 
       4311 MME; membrane metallo-endopeptidase 
       4723 NDUFV1; NADH dehydrogenase (ubiquinone) flavoprotein 1, 51kDa 
       4729 NDUFV2; NADH dehydrogenase (ubiquinone) flavoprotein 2, 24kDa 
       4731 NDUFV3; NADH dehydrogenase (ubiquinone) flavoprotein 3, 10kDa 
       4694 NDUFA1; NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 1, 7.5kDa 
       4695 NDUFA2; NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 2, 8kDa
       4696 NDUFA3; NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 3, 9kDa
       4697 NDUFA4; NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 4, 9kDa 
       56901 NDUFA4L2; NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 4-like 2
       4698 NDUFA5; NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 5 
       4700 NDUFA6; NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 6, 14kDa
       4701 NDUFA7; NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 7, 14.5kDa
       4702 NDUFA8; NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 8, 19kDa 
       4704 NDUFA9; NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 9, 39kDa
       4705 NDUFA10; NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 10, 42kDa 
       4706 NDUFAB1; NADH dehydrogenase (ubiquinone) 1, alpha/beta subcomplex, 1, 8kDa
       126328 NDUFA11; NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 11, 14.7kDa 
       55967 NDUFA12; NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 12
       51079 NDUFA13; NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 13
       4707 NDUFB1; NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 1, 7kDa
       4708 NDUFB2; NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 2, 8kDa 
       4709 NDUFB3; NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 3, 12kDa
       4710 NDUFB4; NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 4, 15kDa 
       4711 NDUFB5; NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 5, 16kDa 
       4712 NDUFB6; NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 6, 17kDa 
       4713 NDUFB7; NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 7, 18kDa 
       4714 NDUFB8; NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 8, 19kDa
       4715 NDUFB9; NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 9, 22kDa
       4716 NDUFB10; NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 10, 22kDa
       54539 NDUFB11; NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 11, 17.3kDa
       4719 NDUFS1; NADH dehydrogenase (ubiquinone) Fe-S protein 1, 75kDa (NADH-coenzyme Q reductase) 
       4720 NDUFS2; NADH dehydrogenase (ubiquinone) Fe-S protein 2, 49kDa (NADH-coenzyme Q reductase) 
       4722 NDUFS3; NADH dehydrogenase (ubiquinone) Fe-S protein 3, 30kDa (NADH-coenzyme Q reductase) 
       4724 NDUFS4; NADH dehydrogenase (ubiquinone) Fe-S protein 4, 18kDa (NADH-coenzyme Q reductase)
       4725 NDUFS5; NADH dehydrogenase (ubiquinone) Fe-S protein 5, 15kDa (NADH-coenzyme Q reductase)
       4726 NDUFS6; NADH dehydrogenase (ubiquinone) Fe-S protein 6, 13kDa (NADH-coenzyme Q reductase) 
       374291 NDUFS7; NADH dehydrogenase (ubiquinone) Fe-S protein 7, 20kDa (NADH-coenzyme Q reductase) 
       4728 NDUFS8; NADH dehydrogenase (ubiquinone) Fe-S protein 8, 23kDa (NADH-coenzyme Q reductase) 
       4717 NDUFC1; NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 1, 6kDa
       4718 NDUFC2; NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 2, 14.5kDa
       100532726 NDUFC2-KCTD14; NDUFC2-KCTD14 readthrough
       6389 SDHA; succinate dehydrogenase complex, subunit A, flavoprotein (Fp) 
       6390 SDHB; succinate dehydrogenase complex, subunit B, iron sulfur (Ip) 
       6391 SDHC; succinate dehydrogenase complex, subunit C, integral membrane protein, 15kDa
       6392 SDHD; succinate dehydrogenase complex, subunit D, integral membrane protein
       7386 UQCRFS1; ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1 
       4519 CYTB; cytochrome b
       1537 CYC1; cytochrome c-1
       7384 UQCRC1; ubiquinol-cytochrome c reductase core protein I 
       7385 UQCRC2; ubiquinol-cytochrome c reductase core protein II 
       7388 UQCRH; ubiquinol-cytochrome c reductase hinge protein 
       440567 UQCRHL; ubiquinol-cytochrome c reductase hinge protein-like
       7381 UQCRB; ubiquinol-cytochrome c reductase binding protein 
       27089 UQCRQ; ubiquinol-cytochrome c reductase, complex III subunit VII, 9.5kDa 
       29796 UQCR10; ubiquinol-cytochrome c reductase, complex III subunit X
       10975 UQCR11; ubiquinol-cytochrome c reductase, complex III subunit XI
       4514 COX3; cytochrome c oxidase III
       4512 COX1; cytochrome c oxidase subunit I
       4513 COX2; cytochrome c oxidase subunit II
       84701 COX4I2; cytochrome c oxidase subunit IV isoform 2 (lung)
       1327 COX4I1; cytochrome c oxidase subunit IV isoform 1 
       9377 COX5A; cytochrome c oxidase subunit Va 
       1329 COX5B; cytochrome c oxidase subunit Vb 
       1337 COX6A1; cytochrome c oxidase subunit VIa polypeptide 1 
       1339 COX6A2; cytochrome c oxidase subunit VIa polypeptide 2 
       1340 COX6B1; cytochrome c oxidase subunit VIb polypeptide 1 (ubiquitous) 
       125965 COX6B2; cytochrome c oxidase subunit VIb polypeptide 2 (testis)
       1345 COX6C; cytochrome c oxidase subunit VIc 
       1346 COX7A1; cytochrome c oxidase subunit VIIa polypeptide 1 (muscle) 
       1347 COX7A2; cytochrome c oxidase subunit VIIa polypeptide 2 (liver) 
       9167 COX7A2L; cytochrome c oxidase subunit VIIa polypeptide 2 like
       1349 COX7B; cytochrome c oxidase subunit VIIb 
       170712 COX7B2; cytochrome c oxidase subunit VIIb2 
       1350 COX7C; cytochrome c oxidase subunit VIIc 
       341947 COX8C; cytochrome c oxidase subunit VIIIC
       1351 COX8A; cytochrome c oxidase subunit VIIIA (ubiquitous) 
       498 ATP5A1; ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle
       506 ATP5B; ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide 
       509 ATP5C1; ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1 
       513 ATP5D; ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit 
       514 ATP5E; ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit 
       4508 ATP6; ATP synthase F0 subunit 6
       515 ATP5F1; ATP synthase, H+ transporting, mitochondrial Fo complex, subunit B1
       516 ATP5G1; ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C1 (subunit 9)
       517 ATP5G2; ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)
       518 ATP5G3; ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)
       10476 ATP5H; ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d 
       539 ATP5O; ATP synthase, H+ transporting, mitochondrial F1 complex, O subunit 
       522 ATP5J; ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F6 
       4509 ATP8; ATP synthase F0 subunit 8
       3028 HSD17B10; hydroxysteroid (17-beta) dehydrogenase 10 
       4023 LPL; lipoprotein lipase 
       348 APOE; apolipoprotein E
       4035 LRP1; low density lipoprotein receptor-related protein 1
       355 FAS; Fas cell surface death receptor
       7132 TNFRSF1A; tumor necrosis factor receptor superfamily, member 1A
       8772 FADD; Fas (TNFRSF6)-associated via death domain
       841 CASP8; caspase 8, apoptosis-related cysteine peptidase 
       637 BID; BH3 interacting domain death agonist
       810 CALML3; calmodulin-like 3
       805 CALM2; calmodulin 2 (phosphorylase kinase, delta) 
       808 CALM3; calmodulin 3 (phosphorylase kinase, delta) 
       801 CALM1; calmodulin 1 (phosphorylase kinase, delta) 
       163688 CALML6; calmodulin-like 6
       51806 CALML5; calmodulin-like 5
       5530 PPP3CA; protein phosphatase 3, catalytic subunit, alpha isozyme 
       5532 PPP3CB; protein phosphatase 3, catalytic subunit, beta isozyme 
       5533 PPP3CC; protein phosphatase 3, catalytic subunit, gamma isozyme 
       5534 PPP3R1; protein phosphatase 3, regulatory subunit B, alpha 
       5535 PPP3R2; protein phosphatase 3, regulatory subunit B, beta 
       572 BAD; BCL2-associated agonist of cell death
       54205 CYCS; cytochrome c, somatic
       317 APAF1; apoptotic peptidase activating factor 1
       842 CASP9; caspase 9, apoptosis-related cysteine peptidase 
       836 CASP3; caspase 3, apoptosis-related cysteine peptidase 
       2776 GNAQ; guanine nucleotide binding protein (G protein), q polypeptide
       23236 PLCB1; phospholipase C, beta 1 (phosphoinositide-specific) 
       5330 PLCB2; phospholipase C, beta 2 
       5331 PLCB3; phospholipase C, beta 3 (phosphatidylinositol-specific) 
       5332 PLCB4; phospholipase C, beta 4 
       2902 GRIN1; glutamate receptor, ionotropic, N-methyl D-aspartate 1
       2903 GRIN2A; glutamate receptor, ionotropic, N-methyl D-aspartate 2A
       2904 GRIN2B; glutamate receptor, ionotropic, N-methyl D-aspartate 2B
       2905 GRIN2C; glutamate receptor, ionotropic, N-methyl D-aspartate 2C
       2906 GRIN2D; glutamate receptor, ionotropic, N-methyl D-aspartate 2D
       775 CACNA1C; calcium channel, voltage-dependent, L type, alpha 1C subunit
       776 CACNA1D; calcium channel, voltage-dependent, L type, alpha 1D subunit
       778 CACNA1F; calcium channel, voltage-dependent, L type, alpha 1F subunit
       779 CACNA1S; calcium channel, voltage-dependent, L type, alpha 1S subunit
       5594 MAPK1; mitogen-activated protein kinase 1 
       5595 MAPK3; mitogen-activated protein kinase 3 
       6263 RYR3; ryanodine receptor 3
       3708 ITPR1; inositol 1,4,5-trisphosphate receptor, type 1
       3709 ITPR2; inositol 1,4,5-trisphosphate receptor, type 2
       3710 ITPR3; inositol 1,4,5-trisphosphate receptor, type 3
       487 ATP2A1; ATPase, Ca++ transporting, cardiac muscle, fast twitch 1 
       489 ATP2A3; ATPase, Ca++ transporting, ubiquitous 
       488 ATP2A2; ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 
       22926 ATF6; activating transcription factor 6
       2081 ERN1; endoplasmic reticulum to nucleus signaling 1 
       9451 EIF2AK3; eukaryotic translation initiation factor 2-alpha kinase 3 
       100506742 CASP12; caspase 12 (gene/pseudogene)
       4842 NOS1; nitric oxide synthase 1 (neuronal) 
       823 CAPN1; calpain 1, (mu/I) large subunit 
       824 CAPN2; calpain 2, (m/II) large subunit 
       8851 CDK5R1; cyclin-dependent kinase 5, regulatory subunit 1 (p35)
       1020 CDK5; cyclin-dependent kinase 5 
       4137 MAPT; microtubule-associated protein tau
       2932 GSK3B; glycogen synthase kinase 3 beta 
       840 CASP7; caspase 7, apoptosis-related cysteine peptidase 
       6622 SNCA; synuclein, alpha (non A4 component of amyloid precursor)
       7124 TNF; tumor necrosis factor
       3553 IL1B; interleukin 1, beta
K06704 ADAM10; disintegrin and metalloproteinase domain-containing protein 10 [EC:3.4.24.81]
K06059 ADAM17; disintegrin and metalloproteinase domain-containing protein 17 [EC:3.4.24.86]
K04520 APP; amyloid beta A4 protein
K04532 APPBP1; amyloid beta precursor protein binding protein 1
K04529 APBB1; amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65)
K00134 GAPDH; glyceraldehyde 3-phosphate dehydrogenase [EC:1.2.1.12]
K04521 BACE1; beta-site APP-cleaving enzyme 1 (memapsin 2) [EC:3.4.23.46]
K07747 BACE2; beta-site APP-cleaving enzyme 2 (memapsin 1) [EC:3.4.23.45]
K06170 PEN2; presenilin enhancer 2
K04505 PSEN1; presenilin 1 [EC:3.4.23.-]
K04522 PSEN2; presenilin 2 [EC:3.4.23.-]
K06171 NCSTN; nicastrin
K06172 APH1; anterior pharynx defective 1
K06172 APH1; anterior pharynx defective 1
K01408 IDE; insulysin [EC:3.4.24.56]
K01389 MME; neprilysin [EC:3.4.24.11]
K03942 NDUFV1; NADH dehydrogenase (ubiquinone) flavoprotein 1 [EC:1.6.5.3 1.6.99.3]
K03943 NDUFV2; NADH dehydrogenase (ubiquinone) flavoprotein 2 [EC:1.6.5.3 1.6.99.3]
K03944 NDUFV3; NADH dehydrogenase (ubiquinone) flavoprotein 3
K03945 NDUFA1; NADH dehydrogenase (ubiquinone) 1 alpha subcomplex subunit 1
K03946 NDUFA2; NADH dehydrogenase (ubiquinone) 1 alpha subcomplex subunit 2
K03947 NDUFA3; NADH dehydrogenase (ubiquinone) 1 alpha subcomplex subunit 3
K03948 NDUFA4; NADH dehydrogenase (ubiquinone) 1 alpha subcomplex subunit 4
K03948 NDUFA4; NADH dehydrogenase (ubiquinone) 1 alpha subcomplex subunit 4
K03949 NDUFA5; NADH dehydrogenase (ubiquinone) 1 alpha subcomplex subunit 5
K03950 NDUFA6; NADH dehydrogenase (ubiquinone) 1 alpha subcomplex subunit 6
K03951 NDUFA7; NADH dehydrogenase (ubiquinone) 1 alpha subcomplex subunit 7
K03952 NDUFA8; NADH dehydrogenase (ubiquinone) 1 alpha subcomplex subunit 8
K03953 NDUFA9; NADH dehydrogenase (ubiquinone) 1 alpha subcomplex subunit 9
K03954 NDUFA10; NADH dehydrogenase (ubiquinone) 1 alpha subcomplex subunit 10
K03955 NDUFAB1; NADH dehydrogenase (ubiquinone) 1 alpha/beta subcomplex 1
K03956 NDUFA11; NADH dehydrogenase (ubiquinone) 1 alpha subcomplex subunit 11
K11352 NDUFA12; NADH dehydrogenase (ubiquinone) 1 alpha subcomplex subunit 12
K11353 NDUFA13; NADH dehydrogenase (ubiquinone) 1 alpha subcomplex subunit 13
K03957 NDUFB1; NADH dehydrogenase (ubiquinone) 1 beta subcomplex subunit 1
K03958 NDUFB2; NADH dehydrogenase (ubiquinone) 1 beta subcomplex subunit 2
K03959 NDUFB3; NADH dehydrogenase (ubiquinone) 1 beta subcomplex subunit 3
K03960 NDUFB4; NADH dehydrogenase (ubiquinone) 1 beta subcomplex subunit 4
K03961 NDUFB5; NADH dehydrogenase (ubiquinone) 1 beta subcomplex subunit 5
K03962 NDUFB6; NADH dehydrogenase (ubiquinone) 1 beta subcomplex subunit 6
K03963 NDUFB7; NADH dehydrogenase (ubiquinone) 1 beta subcomplex subunit 7
K03964 NDUFB8; NADH dehydrogenase (ubiquinone) 1 beta subcomplex subunit 8
K03965 NDUFB9; NADH dehydrogenase (ubiquinone) 1 beta subcomplex subunit 9
K03966 NDUFB10; NADH dehydrogenase (ubiquinone) 1 beta subcomplex subunit 10
K11351 NDUFB11; NADH dehydrogenase (ubiquinone) 1 beta subcomplex subunit 11
K03934 NDUFS1; NADH dehydrogenase (ubiquinone) Fe-S protein 1 [EC:1.6.5.3 1.6.99.3]
K03935 NDUFS2; NADH dehydrogenase (ubiquinone) Fe-S protein 2 [EC:1.6.5.3 1.6.99.3]
K03936 NDUFS3; NADH dehydrogenase (ubiquinone) Fe-S protein 3 [EC:1.6.5.3 1.6.99.3]
K03937 NDUFS4; NADH dehydrogenase (ubiquinone) Fe-S protein 4
K03938 NDUFS5; NADH dehydrogenase (ubiquinone) Fe-S protein 5
K03939 NDUFS6; NADH dehydrogenase (ubiquinone) Fe-S protein 6
K03940 NDUFS7; NADH dehydrogenase (ubiquinone) Fe-S protein 7 [EC:1.6.5.3 1.6.99.3]
K03941 NDUFS8; NADH dehydrogenase (ubiquinone) Fe-S protein 8 [EC:1.6.5.3 1.6.99.3]
K03967 NDUFC1; NADH dehydrogenase (ubiquinone) 1 subunit C1
K03968 NDUFC2; NADH dehydrogenase (ubiquinone) 1 subunit C2
K03968 NDUFC2; NADH dehydrogenase (ubiquinone) 1 subunit C2
K00234 SDHA; succinate dehydrogenase (ubiquinone) flavoprotein subunit [EC:1.3.5.1]
K00235 SDHB; succinate dehydrogenase (ubiquinone) iron-sulfur subunit [EC:1.3.5.1]
K00236 SDHC; succinate dehydrogenase (ubiquinone) cytochrome b560 subunit
K00237 SDHD; succinate dehydrogenase (ubiquinone) membrane anchor subunit
K00411 UQCRFS1; ubiquinol-cytochrome c reductase iron-sulfur subunit [EC:1.10.2.2]
K00412 CYTB; ubiquinol-cytochrome c reductase cytochrome b subunit
K00413 CYC1; ubiquinol-cytochrome c reductase cytochrome c1 subunit
K00414 QCR1; ubiquinol-cytochrome c reductase core subunit 1
K00415 QCR2; ubiquinol-cytochrome c reductase core subunit 2
K00416 QCR6; ubiquinol-cytochrome c reductase subunit 6
K00416 QCR6; ubiquinol-cytochrome c reductase subunit 6
K00417 QCR7; ubiquinol-cytochrome c reductase subunit 7
K00418 QCR8; ubiquinol-cytochrome c reductase subunit 8
K00419 QCR9; ubiquinol-cytochrome c reductase subunit 9
K00420 QCR10; ubiquinol-cytochrome c reductase subunit 10
K02262 COX3; cytochrome c oxidase subunit 3
K02256 COX1; cytochrome c oxidase subunit 1 [EC:1.9.3.1]
K02261 COX2; cytochrome c oxidase subunit 2
K02263 COX4; cytochrome c oxidase subunit 4
K02263 COX4; cytochrome c oxidase subunit 4
K02264 COX5A; cytochrome c oxidase subunit 5a
K02265 COX5B; cytochrome c oxidase subunit 5b
K02266 COX6A; cytochrome c oxidase subunit 6a
K02266 COX6A; cytochrome c oxidase subunit 6a
K02267 COX6B; cytochrome c oxidase subunit 6b
K02267 COX6B; cytochrome c oxidase subunit 6b
K02268 COX6C; cytochrome c oxidase subunit 6c
K02270 COX7A; cytochrome c oxidase subunit 7a
K02270 COX7A; cytochrome c oxidase subunit 7a
K02270 COX7A; cytochrome c oxidase subunit 7a
K02271 COX7B; cytochrome c oxidase subunit 7b
K02271 COX7B; cytochrome c oxidase subunit 7b
K02272 COX7C; cytochrome c oxidase subunit 7c
K02273 COX8; cytochrome c oxidase subunit 8
K02273 COX8; cytochrome c oxidase subunit 8
K02132 ATPeF1A; F-type H+-transporting ATPase subunit alpha
K02133 ATPeF1B; F-type H+-transporting ATPase subunit beta [EC:3.6.3.14]
K02136 ATPeF1G; F-type H+-transporting ATPase subunit gamma
K02134 ATPeF1D; F-type H+-transporting ATPase subunit delta
K02135 ATPeF1E; F-type H+-transporting ATPase subunit epsilon
K02126 ATPeF0A; F-type H+-transporting ATPase subunit a
K02127 ATPeF0B; F-type H+-transporting ATPase subunit b
K02128 ATPeF0C; F-type H+-transporting ATPase subunit c
K02128 ATPeF0C; F-type H+-transporting ATPase subunit c
K02128 ATPeF0C; F-type H+-transporting ATPase subunit c
K02138 ATPeF0D; F-type H+-transporting ATPase subunit d
K02137 ATPeF0O; F-type H+-transporting ATPase subunit O
K02131 ATPeF0F6; F-type H+-transporting ATPase subunit 6
K02125 ATPeF08; F-type H+-transporting ATPase subunit 8
K08683 HSD17B10; 3-hydroxyacyl-CoA dehydrogenase / 3-hydroxy-2-methylbutyryl-CoA dehydrogenase [EC:1.1.1.35 1.1.1.178]
K01059 LPL; lipoprotein lipase [EC:3.1.1.34]
K04524 APOE; apolipoprotein E
K04550 LRP1; low-density lipoprotein receptor-related protein 1 (alpha-2-macroglobulin receptor)
K04390 TNFRSF6; tumor necrosis factor receptor superfamily member 6
K03158 TNFRSF1A; tumor necrosis factor receptor superfamily member 1A
K02373 FADD; FAS-associated death domain protein
K04398 CASP8; caspase 8 [EC:3.4.22.61]
K04726 BID; BH3 interacting domain death agonist
K02183 CALM; calmodulin
K02183 CALM; calmodulin
K02183 CALM; calmodulin
K02183 CALM; calmodulin
K02183 CALM; calmodulin
K02183 CALM; calmodulin
K04348 PPP3C; serine/threonine-protein phosphatase 2B catalytic subunit [EC:3.1.3.16]
K04348 PPP3C; serine/threonine-protein phosphatase 2B catalytic subunit [EC:3.1.3.16]
K04348 PPP3C; serine/threonine-protein phosphatase 2B catalytic subunit [EC:3.1.3.16]
K06268 PPP3R; serine/threonine-protein phosphatase 2B regulatory subunit
K06268 PPP3R; serine/threonine-protein phosphatase 2B regulatory subunit
K02158 BAD; BCL2-antagonist of cell death
K08738 CYC; cytochrome c
K02084 APAF1; apoptotic protease-activating factor
K04399 CASP9; caspase 9 [EC:3.4.22.62]
K02187 CASP3; caspase 3 [EC:3.4.22.56]
K04634 GNAQ; guanine nucleotide-binding protein G(q) subunit alpha
K05858 PLCB; phosphatidylinositol phospholipase C, beta [EC:3.1.4.11]
K05858 PLCB; phosphatidylinositol phospholipase C, beta [EC:3.1.4.11]
K05858 PLCB; phosphatidylinositol phospholipase C, beta [EC:3.1.4.11]
K05858 PLCB; phosphatidylinositol phospholipase C, beta [EC:3.1.4.11]
K05208 GRIN1; glutamate receptor ionotropic, NMDA 1
K05209 GRIN2A; glutamate receptor ionotropic, NMDA 2A
K05210 GRIN2B; glutamate receptor ionotropic, NMDA 2B
K05211 GRIN2C; glutamate receptor ionotropic, NMDA 2C
K05212 GRIN2D; glutamate receptor ionotropic, NMDA 2D
K04850 CACNA1C; voltage-dependent calcium channel L type alpha-1C
K04851 CACNA1D; voltage-dependent calcium channel L type alpha-1D
K04853 CACNA1F; voltage-dependent calcium channel L type alpha-1F
K04857 CACNA1S; voltage-dependent calcium channel L type alpha-1S
K04371 MAPK1_3; mitogen-activated protein kinase 1/3 [EC:2.7.11.24]
K04371 MAPK1_3; mitogen-activated protein kinase 1/3 [EC:2.7.11.24]
K04963 RYR3; ryanodine receptor 3
K04958 ITPR1; inositol 1,4,5-triphosphate receptor type 1
K04959 ITPR2; inositol 1,4,5-triphosphate receptor type 2
K04960 ITPR3; inositol 1,4,5-triphosphate receptor type 3
K05853 ATP2A; Ca2+ transporting ATPase, sarcoplasmic/endoplasmic reticulum [EC:3.6.3.8]
K05853 ATP2A; Ca2+ transporting ATPase, sarcoplasmic/endoplasmic reticulum [EC:3.6.3.8]
K05853 ATP2A; Ca2+ transporting ATPase, sarcoplasmic/endoplasmic reticulum [EC:3.6.3.8]
K09054 ATF6A; cyclic AMP-dependent transcription factor ATF-6 alpha
K08852 ERN1; serine/threonine-protein kinase/endoribonuclease IRE1 [EC:2.7.11.1 3.1.26.-]
K08860 EIF2AK3; eukaryotic translation initiation factor 2-alpha kinase 3 [EC:2.7.11.1]
K04741 CASP12; caspase 12 [EC:3.4.22.-]
K13240 NOS1; nitric-oxide synthase, brain [EC:1.14.13.39]
K01367 CAPN1; calpain-1 [EC:3.4.22.52]
K03853 CAPN2; calpain-2 [EC:3.4.22.53]
K11716 CDK5R1; cyclin-dependent kinase 5 activator 1
K02090 CDK5; cyclin-dependent kinase 5 [EC:2.7.11.22]
K04380 MAPT; microtubule-associated protein tau
K03083 GSK3B; glycogen synthase kinase 3 beta [EC:2.7.11.26]
K04397 CASP7; caspase 7 [EC:3.4.22.60]
K04528 SNCA; synuclein, alpha (non A4 component of amyloid precursor)
K03156 TNFA; tumor necrosis factor superfamily, member 2
K04519 IL1B; interleukin 1 beta
     05012 Parkinson's disease [PATH:hsa05012]
     05014 Amyotrophic lateral sclerosis (ALS) [PATH:hsa05014]
       7157 TP53; tumor protein p53
       5530 PPP3CA; protein phosphatase 3, catalytic subunit, alpha isozyme 
       5532 PPP3CB; protein phosphatase 3, catalytic subunit, beta isozyme 
       5533 PPP3CC; protein phosphatase 3, catalytic subunit, gamma isozyme 
       5534 PPP3R1; protein phosphatase 3, regulatory subunit B, alpha 
       5535 PPP3R2; protein phosphatase 3, regulatory subunit B, beta 
       834 CASP1; caspase 1, apoptosis-related cysteine peptidase 
       637 BID; BH3 interacting domain death agonist
       596 BCL2; B-cell CLL/lymphoma 2
       598 BCL2L1; BCL2-like 1
       581 BAX; BCL2-associated X protein
       572 BAD; BCL2-associated agonist of cell death
       317 APAF1; apoptotic peptidase activating factor 1
       54205 CYCS; cytochrome c, somatic
       842 CASP9; caspase 9, apoptosis-related cysteine peptidase 
       836 CASP3; caspase 3, apoptosis-related cysteine peptidase 
       6647 SOD1; superoxide dismutase 1, soluble 
       10452 TOMM40; translocase of outer mitochondrial membrane 40 homolog (yeast)
       84134 TOMM40L; translocase of outer mitochondrial membrane 40 homolog (yeast)-like
       79139 DERL1; derlin 1
       100506742 CASP12; caspase 12 (gene/pseudogene)
       4217 MAP3K5; mitogen-activated protein kinase kinase kinase 5 
       7124 TNF; tumor necrosis factor
       7132 TNFRSF1A; tumor necrosis factor receptor superfamily, member 1A
       7133 TNFRSF1B; tumor necrosis factor receptor superfamily, member 1B
       1616 DAXX; death-domain associated protein
       5606 MAP2K3; mitogen-activated protein kinase kinase 3 
       5608 MAP2K6; mitogen-activated protein kinase kinase 6 
       5600 MAPK11; mitogen-activated protein kinase 11 
       6300 MAPK12; mitogen-activated protein kinase 12 
       5603 MAPK13; mitogen-activated protein kinase 13 
       1432 MAPK14; mitogen-activated protein kinase 14 
       4842 NOS1; nitric oxide synthase 1 (neuronal) 
       9973 CCS; copper chaperone for superoxide dismutase
       847 CAT; catalase 
       5630 PRPH; peripherin
       4747 NEFL; neurofilament, light polypeptide
       4741 NEFM; neurofilament, medium polypeptide
       4744 NEFH; neurofilament, heavy polypeptide
       57679 ALS2; amyotrophic lateral sclerosis 2 (juvenile)
       5868 RAB5A; RAB5A, member RAS oncogene family
       5879 RAC1; ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)
       6506 SLC1A2; solute carrier family 1 (glial high affinity glutamate transporter), member 2
       2890 GRIA1; glutamate receptor, ionotropic, AMPA 1
       2891 GRIA2; glutamate receptor, ionotropic, AMPA 2
       2902 GRIN1; glutamate receptor, ionotropic, N-methyl D-aspartate 1
       2903 GRIN2A; glutamate receptor, ionotropic, N-methyl D-aspartate 2A
       2904 GRIN2B; glutamate receptor, ionotropic, N-methyl D-aspartate 2B
       2905 GRIN2C; glutamate receptor, ionotropic, N-methyl D-aspartate 2C
       2906 GRIN2D; glutamate receptor, ionotropic, N-methyl D-aspartate 2D
       2876 GPX1; glutathione peroxidase 1 
K04451 TP53; tumor protein p53
K04348 PPP3C; serine/threonine-protein phosphatase 2B catalytic subunit [EC:3.1.3.16]
K04348 PPP3C; serine/threonine-protein phosphatase 2B catalytic subunit [EC:3.1.3.16]
K04348 PPP3C; serine/threonine-protein phosphatase 2B catalytic subunit [EC:3.1.3.16]
K06268 PPP3R; serine/threonine-protein phosphatase 2B regulatory subunit
K06268 PPP3R; serine/threonine-protein phosphatase 2B regulatory subunit
K01370 CASP1; caspase 1 [EC:3.4.22.36]
K04726 BID; BH3 interacting domain death agonist
K02161 BCL2; apoptosis regulator BCL-2
K04570 BCL2L1; BCL2-like 1 (apoptosis regulator Bcl-X)
K02159 BAX; apoptosis regulator BAX
K02158 BAD; BCL2-antagonist of cell death
K02084 APAF1; apoptotic protease-activating factor
K08738 CYC; cytochrome c
K04399 CASP9; caspase 9 [EC:3.4.22.62]
K02187 CASP3; caspase 3 [EC:3.4.22.56]
K04565 SOD1; superoxide dismutase, Cu-Zn family [EC:1.15.1.1]
K11518 TOM40; mitochondrial import receptor subunit TOM40
K11518 TOM40; mitochondrial import receptor subunit TOM40
K11519 DERL1; Derlin-1
K04741 CASP12; caspase 12 [EC:3.4.22.-]
K04426 MAP3K5; mitogen-activated protein kinase kinase kinase 5 [EC:2.7.11.25]
K03156 TNFA; tumor necrosis factor superfamily, member 2
K03158 TNFRSF1A; tumor necrosis factor receptor superfamily member 1A
K05141 TNFRSF1B; tumor necrosis factor receptor superfamily member 1B
K02308 DAXX; death-associated protein 6
K04432 MAP2K3; mitogen-activated protein kinase kinase 3 [EC:2.7.12.2]
K04433 MAP2K6; mitogen-activated protein kinase kinase 6 [EC:2.7.12.2]
K04441 P38; p38 MAP kinase [EC:2.7.11.24]
K04441 P38; p38 MAP kinase [EC:2.7.11.24]
K04441 P38; p38 MAP kinase [EC:2.7.11.24]
K04441 P38; p38 MAP kinase [EC:2.7.11.24]
K13240 NOS1; nitric-oxide synthase, brain [EC:1.14.13.39]
K04569 CCS; copper chaperone for superoxide dismutase
K03781 katE; catalase [EC:1.11.1.6]
K07607 PRPH; peripherin
K04572 NEFL; neurofilament light polypeptide
K04573 NEF3; neurofilament medium polypeptide (neurofilament 3)
K04574 NEFH; neurofilament heavy polypeptide
K04575 ALS2; amyotrophic lateral sclerosis 2 protein
K07887 RAB5A; Ras-related protein Rab-5A
K04392 RAC1; Ras-related C3 botulinum toxin substrate 1
K05613 SLC1A2; solute carrier family 1 (glial high affinity glutamate transporter), member 2
K05197 GRIA1; glutamate receptor 1
K05198 GRIA2; glutamate receptor 2
K05208 GRIN1; glutamate receptor ionotropic, NMDA 1
K05209 GRIN2A; glutamate receptor ionotropic, NMDA 2A
K05210 GRIN2B; glutamate receptor ionotropic, NMDA 2B
K05211 GRIN2C; glutamate receptor ionotropic, NMDA 2C
K05212 GRIN2D; glutamate receptor ionotropic, NMDA 2D
K00432 E1.11.1.9; glutathione peroxidase [EC:1.11.1.9]
     05016 Huntington's disease [PATH:hsa05016]
     05020 Prion diseases [PATH:hsa05020]
 
   Substance dependence
 
   Cardiovascular diseases
     05410 Hypertrophic cardiomyopathy (HCM) [PATH:hsa05410]
       3672 ITGA1; integrin, alpha 1
       3673 ITGA2; integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor)
       3674 ITGA2B; integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41)
       3675 ITGA3; integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor)
       3676 ITGA4; integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor)
       3678 ITGA5; integrin, alpha 5 (fibronectin receptor, alpha polypeptide)
       3655 ITGA6; integrin, alpha 6
       3679 ITGA7; integrin, alpha 7
       8516 ITGA8; integrin, alpha 8
       3680 ITGA9; integrin, alpha 9
       8515 ITGA10; integrin, alpha 10
       22801 ITGA11; integrin, alpha 11
       3685 ITGAV; integrin, alpha V
       3688 ITGB1; integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
       3690 ITGB3; integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)
       3691 ITGB4; integrin, beta 4
       3693 ITGB5; integrin, beta 5
       3694 ITGB6; integrin, beta 6
       3695 ITGB7; integrin, beta 7
       3696 ITGB8; integrin, beta 8
       6444 SGCD; sarcoglycan, delta (35kDa dystrophin-associated glycoprotein)
       6445 SGCG; sarcoglycan, gamma (35kDa dystrophin-associated glycoprotein)
       6442 SGCA; sarcoglycan, alpha (50kDa dystrophin-associated glycoprotein)
       6443 SGCB; sarcoglycan, beta (43kDa dystrophin-associated glycoprotein)
       1605 DAG1; dystroglycan 1 (dystrophin-associated glycoprotein 1)
       1674 DES; desmin
       1756 DMD; dystrophin
       60 ACTB; actin, beta
       71 ACTG1; actin, gamma 1
       7273 TTN; titin 
       7139 TNNT2; troponin T type 2 (cardiac)
       7134 TNNC1; troponin C type 1 (slow)
       7137 TNNI3; troponin I type 3 (cardiac)
       70 ACTC1; actin, alpha, cardiac muscle 1
       7168 TPM1; tropomyosin 1 (alpha)
       7169 TPM2; tropomyosin 2 (beta)
       7170 TPM3; tropomyosin 3
       7171 TPM4; tropomyosin 4
       4607 MYBPC3; myosin binding protein C, cardiac
       4634 MYL3; myosin, light chain 3, alkali; ventricular, skeletal, slow
       4633 MYL2; myosin, light chain 2, regulatory, cardiac, slow
       2010 EMD; emerin
       4000 LMNA; lamin A/C
       775 CACNA1C; calcium channel, voltage-dependent, L type, alpha 1C subunit
       776 CACNA1D; calcium channel, voltage-dependent, L type, alpha 1D subunit
       778 CACNA1F; calcium channel, voltage-dependent, L type, alpha 1F subunit
       779 CACNA1S; calcium channel, voltage-dependent, L type, alpha 1S subunit
       782 CACNB1; calcium channel, voltage-dependent, beta 1 subunit
       783 CACNB2; calcium channel, voltage-dependent, beta 2 subunit
       784 CACNB3; calcium channel, voltage-dependent, beta 3 subunit
       785 CACNB4; calcium channel, voltage-dependent, beta 4 subunit
       781 CACNA2D1; calcium channel, voltage-dependent, alpha 2/delta subunit 1
       9254 CACNA2D2; calcium channel, voltage-dependent, alpha 2/delta subunit 2
       55799 CACNA2D3; calcium channel, voltage-dependent, alpha 2/delta subunit 3
       93589 CACNA2D4; calcium channel, voltage-dependent, alpha 2/delta subunit 4
       786 CACNG1; calcium channel, voltage-dependent, gamma subunit 1
       10369 CACNG2; calcium channel, voltage-dependent, gamma subunit 2
       10368 CACNG3; calcium channel, voltage-dependent, gamma subunit 3
       27092 CACNG4; calcium channel, voltage-dependent, gamma subunit 4
       27091 CACNG5; calcium channel, voltage-dependent, gamma subunit 5
       59285 CACNG6; calcium channel, voltage-dependent, gamma subunit 6
       59284 CACNG7; calcium channel, voltage-dependent, gamma subunit 7
       59283 CACNG8; calcium channel, voltage-dependent, gamma subunit 8
       6262 RYR2; ryanodine receptor 2 (cardiac)
       5562 PRKAA1; protein kinase, AMP-activated, alpha 1 catalytic subunit 
       5563 PRKAA2; protein kinase, AMP-activated, alpha 2 catalytic subunit 
       5564 PRKAB1; protein kinase, AMP-activated, beta 1 non-catalytic subunit
       5565 PRKAB2; protein kinase, AMP-activated, beta 2 non-catalytic subunit
       5571 PRKAG1; protein kinase, AMP-activated, gamma 1 non-catalytic subunit
       53632 PRKAG3; protein kinase, AMP-activated, gamma 3 non-catalytic subunit
       51422 PRKAG2; protein kinase, AMP-activated, gamma 2 non-catalytic subunit
       1636 ACE; angiotensin I converting enzyme 
       3479 IGF1; insulin-like growth factor 1 (somatomedin C)
       7040 TGFB1; transforming growth factor, beta 1
       7042 TGFB2; transforming growth factor, beta 2
       7043 TGFB3; transforming growth factor, beta 3
       7124 TNF; tumor necrosis factor
       3569 IL6; interleukin 6
       1906 EDN1; endothelin 1
       183 AGT; angiotensinogen (serpin peptidase inhibitor, clade A, member 8)
       3908 LAMA2; laminin, alpha 2
       4624 MYH6; myosin, heavy chain 6, cardiac muscle, alpha
       4625 MYH7; myosin, heavy chain 7, cardiac muscle, beta
       488 ATP2A2; ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 
       6546 SLC8A1; solute carrier family 8 (sodium/calcium exchanger), member 1
K06480 ITGA1; integrin alpha 1
K06481 ITGA2; integrin alpha 2
K06476 ITGA2B; integrin alpha 2B
K06482 ITGA3; integrin alpha 3
K06483 ITGA4; integrin alpha 4
K06484 ITGA5; integrin alpha 5
K06485 ITGA6; integrin alpha 6
K06583 ITGA7; integrin alpha 7
K06584 ITGA8; integrin alpha 8
K06585 ITGA9; integrin alpha 9
K06586 ITGA10; integrin alpha 10
K06587 ITGA11; integrin alpha 11
K06487 ITGAV; integrin alpha V
K05719 ITGB1; integrin beta 1
K06493 ITGB3; integrin beta 3
K06525 ITGB4; integrin beta 4
K06588 ITGB5; integrin beta 5
K06589 ITGB6; integrin beta 6
K06590 ITGB7; integrin beta 7
K06591 ITGB8; integrin beta 8
K12563 SGCD; delta-sarcoglycan
K12564 SGCG; gamma-sarcoglycan
K12565 SGCA; alpha-sarcoglycan
K12566 SGCB; beta-sarcoglycan
K06265 DAG1; dystroglycan 1
K07610 DES; desmin
K10366 DMD; dystrophin
K05692 ACTB_G1; actin beta/gamma 1
K05692 ACTB_G1; actin beta/gamma 1
K12567 TTN; titin [EC:2.7.11.1]
K12045 TNNT2; troponin T, cardiac muscle
K05865 TNNC1; troponin C, slow skeletal and cardiac muscles
K12044 TNNI3; troponin I, cardiac muscle
K12314 ACTC1; actin, alpha cardiac muscle
K10373 TPM1; tropomyosin 1
K10374 TPM2; tropomyosin 2
K09290 TPM3; tropomyosin 3
K10375 TPM4; tropomyosin 4
K12568 MYBPC3; myosin-binding protein C, cardiac-type
K12749 MYL3; myosin light chain 3
K10351 MYL2; myosin regulatory light chain 2
K12569 EMD; emerin
K12641 LMNA; lamin A/C
K04850 CACNA1C; voltage-dependent calcium channel L type alpha-1C
K04851 CACNA1D; voltage-dependent calcium channel L type alpha-1D
K04853 CACNA1F; voltage-dependent calcium channel L type alpha-1F
K04857 CACNA1S; voltage-dependent calcium channel L type alpha-1S
K04862 CACNB1; voltage-dependent calcium channel beta-1
K04863 CACNB2; voltage-dependent calcium channel beta-2
K04864 CACNB3; voltage-dependent calcium channel beta-3
K04865 CACNB4; voltage-dependent calcium channel beta-4
K04858 CACNA2D1; voltage-dependent calcium channel alpha-2/delta-1
K04859 CACNA2D2; voltage-dependent calcium channel alpha-2/delta-2
K04860 CACNA2D3; voltage-dependent calcium channel alpha-2/delta-3
K04861 CACNA2D4; voltage-dependent calcium channel alpha-2/delta-4
K04866 CACNG1; voltage-dependent calcium channel gamma-1
K04867 CACNG2; voltage-dependent calcium channel gamma-2
K04868 CACNG3; voltage-dependent calcium channel gamma-3
K04869 CACNG4; voltage-dependent calcium channel gamma-4
K04870 CACNG5; voltage-dependent calcium channel gamma-5
K04871 CACNG6; voltage-dependent calcium channel gamma-6
K04872 CACNG7; voltage-dependent calcium channel gamma-7
K04873 CACNG8; voltage-dependent calcium channel gamma-8
K04962 RYR2; ryanodine receptor 2
K07198 PRKAA; 5'-AMP-activated protein kinase, catalytic alpha subunit [EC:2.7.11.11]
K07198 PRKAA; 5'-AMP-activated protein kinase, catalytic alpha subunit [EC:2.7.11.11]
K07199 PRKAB; 5'-AMP-activated protein kinase, regulatory beta subunit
K07199 PRKAB; 5'-AMP-activated protein kinase, regulatory beta subunit
K07200 PRKAG; 5'-AMP-activated protein kinase, regulatory gamma subunit
K07200 PRKAG; 5'-AMP-activated protein kinase, regulatory gamma subunit
K07200 PRKAG; 5'-AMP-activated protein kinase, regulatory gamma subunit
K01283 E3.4.15.1; peptidyl-dipeptidase A [EC:3.4.15.1]
K05459 IGF1; insulin-like growth factor 1
K13375 TGFB1; transforming growth factor beta-1
K13376 TGFB2; transforming growth factor beta-2
K13377 TGFB3; transforming growth factor beta-3
K03156 TNFA; tumor necrosis factor superfamily, member 2
K05405 IL6; interleukin 6
K16366 EDN1; endothelin-1
K09821 AGT; angiotensinogen
K05637 LAMA1_2; laminin, alpha 1/2
K17751 MYH6_7; myosin heavy chain 6/7
K17751 MYH6_7; myosin heavy chain 6/7
K05853 ATP2A; Ca2+ transporting ATPase, sarcoplasmic/endoplasmic reticulum [EC:3.6.3.8]
K05849 SLC8A; solute carrier family 8 (sodium/calcium exchanger)
     05412 Arrhythmogenic right ventricular cardiomyopathy (ARVC) [PATH:hsa05412]
     05414 Dilated cardiomyopathy (DCM) [PATH:hsa05414]
       3672 ITGA1; integrin, alpha 1
       3673 ITGA2; integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor)
       3674 ITGA2B; integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41)
       3675 ITGA3; integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor)
       3676 ITGA4; integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor)
       3678 ITGA5; integrin, alpha 5 (fibronectin receptor, alpha polypeptide)
       3655 ITGA6; integrin, alpha 6
       3679 ITGA7; integrin, alpha 7
       8516 ITGA8; integrin, alpha 8
       3680 ITGA9; integrin, alpha 9
       8515 ITGA10; integrin, alpha 10
       22801 ITGA11; integrin, alpha 11
       3685 ITGAV; integrin, alpha V
       3688 ITGB1; integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
       3690 ITGB3; integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)
       3691 ITGB4; integrin, beta 4
       3693 ITGB5; integrin, beta 5
       3694 ITGB6; integrin, beta 6
       3695 ITGB7; integrin, beta 7
       3696 ITGB8; integrin, beta 8
       6444 SGCD; sarcoglycan, delta (35kDa dystrophin-associated glycoprotein)
       6445 SGCG; sarcoglycan, gamma (35kDa dystrophin-associated glycoprotein)
       6442 SGCA; sarcoglycan, alpha (50kDa dystrophin-associated glycoprotein)
       6443 SGCB; sarcoglycan, beta (43kDa dystrophin-associated glycoprotein)
       1605 DAG1; dystroglycan 1 (dystrophin-associated glycoprotein 1)
       1674 DES; desmin
       1756 DMD; dystrophin
       60 ACTB; actin, beta
       71 ACTG1; actin, gamma 1
       7273 TTN; titin 
       7139 TNNT2; troponin T type 2 (cardiac)
       7134 TNNC1; troponin C type 1 (slow)
       7137 TNNI3; troponin I type 3 (cardiac)
       70 ACTC1; actin, alpha, cardiac muscle 1
       7168 TPM1; tropomyosin 1 (alpha)
       7169 TPM2; tropomyosin 2 (beta)
       7170 TPM3; tropomyosin 3
       7171 TPM4; tropomyosin 4
       4607 MYBPC3; myosin binding protein C, cardiac
       4634 MYL3; myosin, light chain 3, alkali; ventricular, skeletal, slow
       4633 MYL2; myosin, light chain 2, regulatory, cardiac, slow
       2010 EMD; emerin
       4000 LMNA; lamin A/C
       153 ADRB1; adrenoceptor beta 1
       2778 GNAS; GNAS complex locus
       107 ADCY1; adenylate cyclase 1 (brain) 
       108 ADCY2; adenylate cyclase 2 (brain) 
       109 ADCY3; adenylate cyclase 3 
       196883 ADCY4; adenylate cyclase 4 
       111 ADCY5; adenylate cyclase 5 
       112 ADCY6; adenylate cyclase 6 
       113 ADCY7; adenylate cyclase 7 
       114 ADCY8; adenylate cyclase 8 (brain) 
       115 ADCY9; adenylate cyclase 9 
       5566 PRKACA; protein kinase, cAMP-dependent, catalytic, alpha 
       5567 PRKACB; protein kinase, cAMP-dependent, catalytic, beta 
       5568 PRKACG; protein kinase, cAMP-dependent, catalytic, gamma 
       5613 PRKX; protein kinase, X-linked 
       775 CACNA1C; calcium channel, voltage-dependent, L type, alpha 1C subunit
       776 CACNA1D; calcium channel, voltage-dependent, L type, alpha 1D subunit
       778 CACNA1F; calcium channel, voltage-dependent, L type, alpha 1F subunit
       779 CACNA1S; calcium channel, voltage-dependent, L type, alpha 1S subunit
       782 CACNB1; calcium channel, voltage-dependent, beta 1 subunit
       783 CACNB2; calcium channel, voltage-dependent, beta 2 subunit
       784 CACNB3; calcium channel, voltage-dependent, beta 3 subunit
       785 CACNB4; calcium channel, voltage-dependent, beta 4 subunit
       781 CACNA2D1; calcium channel, voltage-dependent, alpha 2/delta subunit 1
       9254 CACNA2D2; calcium channel, voltage-dependent, alpha 2/delta subunit 2
       55799 CACNA2D3; calcium channel, voltage-dependent, alpha 2/delta subunit 3
       93589 CACNA2D4; calcium channel, voltage-dependent, alpha 2/delta subunit 4
       786 CACNG1; calcium channel, voltage-dependent, gamma subunit 1
       10369 CACNG2; calcium channel, voltage-dependent, gamma subunit 2
       10368 CACNG3; calcium channel, voltage-dependent, gamma subunit 3
       27092 CACNG4; calcium channel, voltage-dependent, gamma subunit 4
       27091 CACNG5; calcium channel, voltage-dependent, gamma subunit 5
       59285 CACNG6; calcium channel, voltage-dependent, gamma subunit 6
       59284 CACNG7; calcium channel, voltage-dependent, gamma subunit 7
       59283 CACNG8; calcium channel, voltage-dependent, gamma subunit 8
       6262 RYR2; ryanodine receptor 2 (cardiac)
       5350 PLN; phospholamban
       3479 IGF1; insulin-like growth factor 1 (somatomedin C)
       7040 TGFB1; transforming growth factor, beta 1
       7042 TGFB2; transforming growth factor, beta 2
       7043 TGFB3; transforming growth factor, beta 3
       7124 TNF; tumor necrosis factor
       3908 LAMA2; laminin, alpha 2
       4624 MYH6; myosin, heavy chain 6, cardiac muscle, alpha
       4625 MYH7; myosin, heavy chain 7, cardiac muscle, beta
       488 ATP2A2; ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 
       6546 SLC8A1; solute carrier family 8 (sodium/calcium exchanger), member 1
K06480 ITGA1; integrin alpha 1
K06481 ITGA2; integrin alpha 2
K06476 ITGA2B; integrin alpha 2B
K06482 ITGA3; integrin alpha 3
K06483 ITGA4; integrin alpha 4
K06484 ITGA5; integrin alpha 5
K06485 ITGA6; integrin alpha 6
K06583 ITGA7; integrin alpha 7
K06584 ITGA8; integrin alpha 8
K06585 ITGA9; integrin alpha 9
K06586 ITGA10; integrin alpha 10
K06587 ITGA11; integrin alpha 11
K06487 ITGAV; integrin alpha V
K05719 ITGB1; integrin beta 1
K06493 ITGB3; integrin beta 3
K06525 ITGB4; integrin beta 4
K06588 ITGB5; integrin beta 5
K06589 ITGB6; integrin beta 6
K06590 ITGB7; integrin beta 7
K06591 ITGB8; integrin beta 8
K12563 SGCD; delta-sarcoglycan
K12564 SGCG; gamma-sarcoglycan
K12565 SGCA; alpha-sarcoglycan
K12566 SGCB; beta-sarcoglycan
K06265 DAG1; dystroglycan 1
K07610 DES; desmin
K10366 DMD; dystrophin
K05692 ACTB_G1; actin beta/gamma 1
K05692 ACTB_G1; actin beta/gamma 1
K12567 TTN; titin [EC:2.7.11.1]
K12045 TNNT2; troponin T, cardiac muscle
K05865 TNNC1; troponin C, slow skeletal and cardiac muscles
K12044 TNNI3; troponin I, cardiac muscle
K12314 ACTC1; actin, alpha cardiac muscle
K10373 TPM1; tropomyosin 1
K10374 TPM2; tropomyosin 2
K09290 TPM3; tropomyosin 3
K10375 TPM4; tropomyosin 4
K12568 MYBPC3; myosin-binding protein C, cardiac-type
K12749 MYL3; myosin light chain 3
K10351 MYL2; myosin regulatory light chain 2
K12569 EMD; emerin
K12641 LMNA; lamin A/C
K04141 ADRB1; adrenergic receptor beta-1
K04632 GNAS; guanine nucleotide-binding protein G(s) subunit alpha
K08041 ADCY1; adenylate cyclase 1 [EC:4.6.1.1]
K08042 ADCY2; adenylate cyclase 2 [EC:4.6.1.1]
K08043 ADCY3; adenylate cyclase 3 [EC:4.6.1.1]
K08044 ADCY4; adenylate cyclase 4 [EC:4.6.1.1]
K08045 ADCY5; adenylate cyclase 5 [EC:4.6.1.1]
K08046 ADCY6; adenylate cyclase 6 [EC:4.6.1.1]
K08047 ADCY7; adenylate cyclase 7 [EC:4.6.1.1]
K08048 ADCY8; adenylate cyclase 8 [EC:4.6.1.1]
K08049 ADCY9; adenylate cyclase 9 [EC:4.6.1.1]
K04345 PKA; protein kinase A [EC:2.7.11.11]
K04345 PKA; protein kinase A [EC:2.7.11.11]
K04345 PKA; protein kinase A [EC:2.7.11.11]
K04345 PKA; protein kinase A [EC:2.7.11.11]
K04850 CACNA1C; voltage-dependent calcium channel L type alpha-1C
K04851 CACNA1D; voltage-dependent calcium channel L type alpha-1D
K04853 CACNA1F; voltage-dependent calcium channel L type alpha-1F
K04857 CACNA1S; voltage-dependent calcium channel L type alpha-1S
K04862 CACNB1; voltage-dependent calcium channel beta-1
K04863 CACNB2; voltage-dependent calcium channel beta-2
K04864 CACNB3; voltage-dependent calcium channel beta-3
K04865 CACNB4; voltage-dependent calcium channel beta-4
K04858 CACNA2D1; voltage-dependent calcium channel alpha-2/delta-1
K04859 CACNA2D2; voltage-dependent calcium channel alpha-2/delta-2
K04860 CACNA2D3; voltage-dependent calcium channel alpha-2/delta-3
K04861 CACNA2D4; voltage-dependent calcium channel alpha-2/delta-4
K04866 CACNG1; voltage-dependent calcium channel gamma-1
K04867 CACNG2; voltage-dependent calcium channel gamma-2
K04868 CACNG3; voltage-dependent calcium channel gamma-3
K04869 CACNG4; voltage-dependent calcium channel gamma-4
K04870 CACNG5; voltage-dependent calcium channel gamma-5
K04871 CACNG6; voltage-dependent calcium channel gamma-6
K04872 CACNG7; voltage-dependent calcium channel gamma-7
K04873 CACNG8; voltage-dependent calcium channel gamma-8
K04962 RYR2; ryanodine receptor 2
K05852 PLN; phospholamban
K05459 IGF1; insulin-like growth factor 1
K13375 TGFB1; transforming growth factor beta-1
K13376 TGFB2; transforming growth factor beta-2
K13377 TGFB3; transforming growth factor beta-3
K03156 TNFA; tumor necrosis factor superfamily, member 2
K05637 LAMA1_2; laminin, alpha 1/2
K17751 MYH6_7; myosin heavy chain 6/7
K17751 MYH6_7; myosin heavy chain 6/7
K05853 ATP2A; Ca2+ transporting ATPase, sarcoplasmic/endoplasmic reticulum [EC:3.6.3.8]
K05849 SLC8A; solute carrier family 8 (sodium/calcium exchanger)
     05416 Viral myocarditis [PATH:hsa05416]
 
   Endocrine and metabolic diseases
     04940 Type I diabetes mellitus [PATH:hsa04940]
       3630 INS; insulin
       2571 GAD1; glutamate decarboxylase 1 (brain, 67kDa) 
       2572 GAD2; glutamate decarboxylase 2 (pancreatic islets and brain, 65kDa) 
       5798 PTPRN; protein tyrosine phosphatase, receptor type, N 
       5799 PTPRN2; protein tyrosine phosphatase, receptor type, N polypeptide 2 
       1363 CPE; carboxypeptidase E 
       3329 HSPD1; heat shock 60kDa protein 1 (chaperonin)
       3108 HLA-DMA; major histocompatibility complex, class II, DM alpha
       3109 HLA-DMB; major histocompatibility complex, class II, DM beta
       3111 HLA-DOA; major histocompatibility complex, class II, DO alpha
       3112 HLA-DOB; major histocompatibility complex, class II, DO beta
       3113 HLA-DPA1; major histocompatibility complex, class II, DP alpha 1
       3115 HLA-DPB1; major histocompatibility complex, class II, DP beta 1
       3117 HLA-DQA1; major histocompatibility complex, class II, DQ alpha 1
       3118 HLA-DQA2; major histocompatibility complex, class II, DQ alpha 2
       3119 HLA-DQB1; major histocompatibility complex, class II, DQ beta 1
       3122 HLA-DRA; major histocompatibility complex, class II, DR alpha
       3123 HLA-DRB1; major histocompatibility complex, class II, DR beta 1
       3125 HLA-DRB3; major histocompatibility complex, class II, DR beta 3
       3126 HLA-DRB4; major histocompatibility complex, class II, DR beta 4
       3127 HLA-DRB5; major histocompatibility complex, class II, DR beta 5
       100509457 HLA class II histocompatibility antigen
       101060835 HLA class II histocompatibility antigen
       941 CD80; CD80 molecule
       942 CD86; CD86 molecule
       940 CD28; CD28 molecule
       3592 IL12A; interleukin 12A
       3593 IL12B; interleukin 12B
       3558 IL2; interleukin 2
       3458 IFNG; interferon, gamma
       3105 HLA-A; major histocompatibility complex, class I, A
       3106 HLA-B; major histocompatibility complex, class I, B
       3107 HLA-C; major histocompatibility complex, class I, C
       3134 HLA-F; major histocompatibility complex, class I, F
       3135 HLA-G; major histocompatibility complex, class I, G
       3133 HLA-E; major histocompatibility complex, class I, E
       356 FASLG; Fas ligand (TNF superfamily, member 6)
       355 FAS; Fas cell surface death receptor
       5551 PRF1; perforin 1 (pore forming protein)
       3002 GZMB; granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1) 
       4049 LTA; lymphotoxin alpha
       7124 TNF; tumor necrosis factor
       3552 IL1A; interleukin 1, alpha
       3553 IL1B; interleukin 1, beta
       3382 ICA1; islet cell autoantigen 1, 69kDa
K04526 INS; insulin
K01580 E4.1.1.15; glutamate decarboxylase [EC:4.1.1.15]
K01580 E4.1.1.15; glutamate decarboxylase [EC:4.1.1.15]
K07817 PTPRN; receptor-type tyrosine-protein phosphatase N [EC:3.1.3.48]
K07817 PTPRN; receptor-type tyrosine-protein phosphatase N [EC:3.1.3.48]
K01294 CPE; carboxypeptidase E [EC:3.4.17.10]
K04077 groEL; chaperonin GroEL
K06752 MHC2; major histocompatibility complex, class II
K06752 MHC2; major histocompatibility complex, class II
K06752 MHC2; major histocompatibility complex, class II
K06752 MHC2; major histocompatibility complex, class II
K06752 MHC2; major histocompatibility complex, class II
K06752 MHC2; major histocompatibility complex, class II
K06752 MHC2; major histocompatibility complex, class II
K06752 MHC2; major histocompatibility complex, class II
K06752 MHC2; major histocompatibility complex, class II
K06752 MHC2; major histocompatibility complex, class II
K06752 MHC2; major histocompatibility complex, class II
K06752 MHC2; major histocompatibility complex, class II
K06752 MHC2; major histocompatibility complex, class II
K06752 MHC2; major histocompatibility complex, class II
K06752 MHC2; major histocompatibility complex, class II
K06752 MHC2; major histocompatibility complex, class II
K05412 CD80; CD80 antigen
K05413 CD86; CD86 antigen
K06470 CD28; CD28 antigen
K05406 IL12A; interleukin 12A
K05425 IL12B; interleukin 12B
K05429 IL2; interleukin 2
K04687 IFNG; interferon gamma
K06751 MHC1; major histocompatibility complex, class I
K06751 MHC1; major histocompatibility complex, class I
K06751 MHC1; major histocompatibility complex, class I
K06751 MHC1; major histocompatibility complex, class I
K06751 MHC1; major histocompatibility complex, class I
K06751 MHC1; major histocompatibility complex, class I
K04389 TNFSF6; tumor necrosis factor ligand superfamily member 6
K04390 TNFRSF6; tumor necrosis factor receptor superfamily member 6
K07818 PRF1; perforin 1
K01353 GZMB; granzyme B [EC:3.4.21.79]
K05468 LTA; lymphotoxin alpha (TNF superfamily, member 1)
K03156 TNFA; tumor necrosis factor superfamily, member 2
K04383 IL1A; interleukin 1 alpha
K04519 IL1B; interleukin 1 beta
 
     04930 Type II diabetes mellitus [PATH:hsa04930]
       3630 INS; insulin
       3643 INSR; insulin receptor 
       3667 IRS1; insulin receptor substrate 1
       8660 IRS2; insulin receptor substrate 2
       8471 IRS4; insulin receptor substrate 4
       5295 PIK3R1; phosphoinositide-3-kinase, regulatory subunit 1 (alpha)
       23533 PIK3R5; phosphoinositide-3-kinase, regulatory subunit 5
       5296 PIK3R2; phosphoinositide-3-kinase, regulatory subunit 2 (beta)
       8503 PIK3R3; phosphoinositide-3-kinase, regulatory subunit 3 (gamma)
       5290 PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha 
       5293 PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta 
       5291 PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta 
       5294 PIK3CG; phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma 
       6517 SLC2A4; solute carrier family 2 (facilitated glucose transporter), member 4
       9370 ADIPOQ; adiponectin, C1Q and collagen domain containing
       5594 MAPK1; mitogen-activated protein kinase 1 
       5595 MAPK3; mitogen-activated protein kinase 3 
       2475 MTOR; mechanistic target of rapamycin (serine/threonine kinase) 
       8651 SOCS1; suppressor of cytokine signaling 1
       8835 SOCS2; suppressor of cytokine signaling 2
       9021 SOCS3; suppressor of cytokine signaling 3
       122809 SOCS4; suppressor of cytokine signaling 4
       3551 IKBKB; inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta 
       5599 MAPK8; mitogen-activated protein kinase 8 
       5602 MAPK10; mitogen-activated protein kinase 10 
       5601 MAPK9; mitogen-activated protein kinase 9 
       7124 TNF; tumor necrosis factor
       5580 PRKCD; protein kinase C, delta 
       5581 PRKCE; protein kinase C, epsilon 
       3651 PDX1; pancreatic and duodenal homeobox 1
       389692 MAFA; v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog A
       6514 SLC2A2; solute carrier family 2 (facilitated glucose transporter), member 2
       3101 HK3; hexokinase 3 (white cell) 
       3098 HK1; hexokinase 1 
       3099 HK2; hexokinase 2 
       80201 HKDC1; hexokinase domain containing 1 
       2645 GCK; glucokinase (hexokinase 4) 
       5315 PKM; pyruvate kinase, muscle 
       5313 PKLR; pyruvate kinase, liver and RBC 
       3767 KCNJ11; potassium inwardly-rectifying channel, subfamily J, member 11
       6833 ABCC8; ATP-binding cassette, sub-family C (CFTR/MRP), member 8
       775 CACNA1C; calcium channel, voltage-dependent, L type, alpha 1C subunit
       776 CACNA1D; calcium channel, voltage-dependent, L type, alpha 1D subunit
       773 CACNA1A; calcium channel, voltage-dependent, P/Q type, alpha 1A subunit
       774 CACNA1B; calcium channel, voltage-dependent, N type, alpha 1B subunit
       777 CACNA1E; calcium channel, voltage-dependent, R type, alpha 1E subunit
       8913 CACNA1G; calcium channel, voltage-dependent, T type, alpha 1G subunit
       5590 PRKCZ; protein kinase C, zeta 
K04526 INS; insulin
K04527 INSR; insulin receptor [EC:2.7.10.1]
K16172 IRS1; insulin receptor substrate 1
K07187 IRS2; insulin receptor substrate 2
K17446 IRS4; insulin receptor substrate 4
K02649 PIK3R; phosphoinositide-3-kinase, regulatory subunit
K02649 PIK3R; phosphoinositide-3-kinase, regulatory subunit
K02649 PIK3R; phosphoinositide-3-kinase, regulatory subunit
K02649 PIK3R; phosphoinositide-3-kinase, regulatory subunit
K00922 PIK3C; phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
K00922 PIK3C; phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
K00922 PIK3C; phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
K00922 PIK3C; phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
K07191 SLC2A4; MFS transporter, SP family, solute carrier family 2 (facilitated glucose transporter), member 4
K07296 ACDC; adiponectin
K04371 MAPK1_3; mitogen-activated protein kinase 1/3 [EC:2.7.11.24]
K04371 MAPK1_3; mitogen-activated protein kinase 1/3 [EC:2.7.11.24]
K07203 FRAP; FKBP12-rapamycin complex-associated protein
K04694 SOCS1; suppressor of cytokine signaling 1
K04695 SOCS2; suppressor of cytokine signaling 2
K04696 SOCS3; suppressor of cytokine signaling 3
K04697 SOCS4; suppressor of cytokine signaling 4
K07209 IKBKB; inhibitor of nuclear factor kappa-B kinase subunit beta [EC:2.7.11.10]
K04440 JNK; c-Jun N-terminal kinase [EC:2.7.11.24]
K04440 JNK; c-Jun N-terminal kinase [EC:2.7.11.24]
K04440 JNK; c-Jun N-terminal kinase [EC:2.7.11.24]
K03156 TNFA; tumor necrosis factor superfamily, member 2
K06068 PRKCD; novel protein kinase C delta type [EC:2.7.11.13]
K18050 PRKCE; novel protein kinase C epsilon type [EC:2.7.11.13]
K07594 IPF1; insulin promoter factor 1
K07595 MAFA; transcription factor MAFA
K07593 SLC2A2; MFS transporter, SP family, solute carrier family 2 (facilitated glucose transporter), member 2
K00844 HK; hexokinase [EC:2.7.1.1]
K00844 HK; hexokinase [EC:2.7.1.1]
K00844 HK; hexokinase [EC:2.7.1.1]
K00844 HK; hexokinase [EC:2.7.1.1]
K12407 GCK; glucokinase [EC:2.7.1.2]
K00873 PK; pyruvate kinase [EC:2.7.1.40]
K12406 PKLR; pyruvate kinase isozymes R/L [EC:2.7.1.40]
K05004 KCNJ11; potassium inwardly-rectifying channel subfamily J member 11
K05032 ABCC8; ATP-binding cassette subfamily C (CFTR/MRP) member 8
K04850 CACNA1C; voltage-dependent calcium channel L type alpha-1C
K04851 CACNA1D; voltage-dependent calcium channel L type alpha-1D
K04344 CACNA1A; voltage-dependent calcium channel P/Q type alpha-1A
K04849 CACNA1B; voltage-dependent calcium channel N type alpha-1B
K04852 CACNA1E; voltage-dependent calcium channel R type alpha-1E
K04854 CACNA1G; voltage-dependent calcium channel T type alpha-1G
K06069 APKC; atypical protein kinase C [EC:2.7.11.13]
     04950 Maturity onset diabetes of the young [PATH:hsa04950]
     04932 Non-alcoholic fatty liver disease (NAFLD) [PATH:hsa04932]
       3569 IL6; interleukin 6
       3570 IL6R; interleukin 6 receptor
       9021 SOCS3; suppressor of cytokine signaling 3
       7124 TNF; tumor necrosis factor
       7132 TNFRSF1A; tumor necrosis factor receptor superfamily, member 1A
       4790 NFKB1; nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
       5970 RELA; v-rel avian reticuloendotheliosis viral oncogene homolog A
       3630 INS; insulin
       3643 INSR; insulin receptor 
       3667 IRS1; insulin receptor substrate 1
       8660 IRS2; insulin receptor substrate 2
       5290 PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha 
       5293 PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta 
       5291 PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta 
       5294 PIK3CG; phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma 
       5295 PIK3R1; phosphoinositide-3-kinase, regulatory subunit 1 (alpha)
       23533 PIK3R5; phosphoinositide-3-kinase, regulatory subunit 5
       5296 PIK3R2; phosphoinositide-3-kinase, regulatory subunit 2 (beta)
       8503 PIK3R3; phosphoinositide-3-kinase, regulatory subunit 3 (gamma)
       207 AKT1; v-akt murine thymoma viral oncogene homolog 1 
       208 AKT2; v-akt murine thymoma viral oncogene homolog 2 
       10000 AKT3; v-akt murine thymoma viral oncogene homolog 3 
       2931 GSK3A; glycogen synthase kinase 3 alpha 
       2932 GSK3B; glycogen s